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Abstract
The performance of different bluetongue control measures related to both vaccination and protection
from bluetongue virus (BTV) vectors was assessed. By means of a mathematical model, it was
concluded that when vaccination is applied on 95% of animals even for 3 years, bluetongue cannot be
eradicated and is able to re-emerge. Only after 5 years of vaccination, the infection may be close to
the eradication levels. In the absence of vaccination, the disease can persist for several years, reaching
an endemic condition with low level of prevalence of infection. Among the mechanisms for bluetongue
persistence, the persistence in the wildlife, the transplacental transmission in the host, the duration of
viraemia and the possible vertical transmission in vectors were assessed. The criteria of the current
surveillance scheme in place in the EU for demonstration of the virus absence need revision, because it
was highlighted that under the current surveillance policy bluetongue circulation might occur
undetected. For the safe movement of animals, newborn ruminants from vaccinated mothers with
neutralising antibodies can be considered protected against infection, although a protective titre
threshold cannot be identiﬁed. The presence of colostral antibodies interferes with the vaccine
immunisation in the newborn for more than 3 months after birth, whereas the minimum time after
vaccination of animal to be considered immune can be up to 48 days. The knowledge about vectors
ecology, mechanisms of over-wintering and criteria for the seasonally vector-free period was updated.
Some Culicoides species are active throughout the year and an absolute vector-free period may not
exist at least in some areas in Europe. To date, there is no evidence that the use of insecticides
and repellents reduce the transmission of BTV in the ﬁeld, although this may reduce host/vector
contact. By only using pour-on insecticides, protection of animals is lower than the one provided by
vector-proof establishments.
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Summary
The European Commission has requested the European Food Safety Authority (EFSA) to provide an
updated scientiﬁc advice on bluetongue (BT), due to the recent disease evolution in the European
Union (EU), the experience gained from the BT control policies and possible alternative methods to
ensure safe trade of live animals from BT restricted zones. The scientiﬁc advice asked from EFSA
should serve to review the overall BT policy at the EU level. The terms of reference of this request
covered different topic areas, in particular related to (1) BT control policy through vaccination and
surveillance; safe trade of animals moved from BT virus (BTV) infected to BTV-free country or zone,
both (2) about animal immunity and (3) protection from BTV vectors; (4) classiﬁcation of BT serotypes
and (5) BT listing and categorisation in the framework of the Animal Health law. The present opinion
covered the ﬁrst three categories, the fourth and ﬁfth topic area will be covered in a separate scientiﬁc
opinion.
As regards the ﬁrst topic area about vaccination, eradication and surveillance, it was requested to
assess the most suitable duration of a BT vaccination campaign intended to achieve disease freedom in
a country or region. For that purpose, a mathematical model was developed to analyse the disease
spread according to different duration of vaccination campaigns in different areas in Europe, selected
for their speciﬁc patterns of disease and vector ecology (the UK, France, southern Spain and Sardinia
in Italy). It was concluded that even when the vaccination of 95% of the susceptible cattle and sheep
is constantly applied for three consecutive years, BTV is not eradicated and may re-emerge after a
couple of years. Only after 5 years of vaccination of 95% of susceptible cattle and sheep, the
prevalence of infection is close to eradication levels, although reaching zero values for sheep only in
the scenario of UK, France and Sardinia, but still not reaching zero for the Spanish scenario. These
ﬁndings suggest that speciﬁc conditions related to animal density, meteorological conditions, etc.,
should be considered when planning a vaccination strategy against BT.
Secondly it was requested to assess the probability of BT recurrence in affected areas that have
regained BT freedom, in particular due to BT low level circulation. Possible persistence in livestock was
explored by the above-mentioned model, by inferring what level of virus circulation could be achieved
in a host population on long term without any intervention. It was found out that without any
vaccination the disease can persist for several years, reaching an endemic condition with low level of
prevalence of infection (1.5% in cattle, 0.6% in sheep) and greater seroprevalence levels (45% in
cattle, 14% in sheep).
Further mechanisms for BT persistence were assessed through literature review in particular in
relation to the possible persistence in the wildlife, to the transplacental transmission in the host, to the
length of BTV viraemia or persistence in other host tissues, and to the vertical transmission in the
vectors. The studies carried out on wildlife suggest that among wild ruminant populations, red deer
(Cervus elaphus) is the wild ruminant species most likely to be involved in BTV circulation in Europe,
and it may be possible that BTV infection persist locally in red deer population or in other wild
ruminants in areas of high density of these animals, and where there are a low number of competing
domestic animals and favourable vector conditions. Nevertheless, since this evidence is not conﬁrmed,
annual cross-sectional surveys with a focus on yearlings may need to be conducted to ascertain the
role of wild ruminant population in the BTV circulation and persistence in speciﬁc geographical areas.
Concerning the other persistence mechanisms, there is evidence that transplacental transmission
(TPT) occurs in cattle, sheep and goats, under ﬁeld conditions, for BTV-8. The incidence varies by
animal species and gestational stage of infection. For BTV serotypes other than BTV-8, TPT was
experimentally demonstrated only for BTV-2 in sheep and BTV-11 in cattle and North American elks.
The overall contributions of TPT to the over-wintering mechanism and the epidemiological signiﬁcance
of the presence of BTV RNA in the blood of newborn animals, and whether the level of viraemia is
sufﬁciently high to infect Culicoides are not clear and remain to be investigated.
Concerning the other mechanisms for BT persistence and overwintering, about the length of
viraemia it was concluded that BTV nucleic acid can be detected by reverse transcription polymerase
chain reaction (RT-PCR) in the blood of infected cattle and sheep till 4–5 months after the infection,
and up to 2 months in goats, while infectious virus in the blood can only be detected for up to 50 days
in cattle and up to 30 days in small ruminants in the majority of the cases. BTV presence has been
demonstrated in other organs, including organs containing lymphoid tissue, skin and reproductive
organs. The maximum duration of the presence of BTV is registered in the spleen up to 40 days for
infectious virus and up to 3 months for its nucleic acid. The hypothesis of skin and dermal tissue
potentially playing a role in virus transmission through midge bite needs to be demonstrated. Other
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organs with BTV presence, such as tongue, tonsils, nasal mucosa, may potentially play a role in direct
virus transmission, but the evidence supporting direct BTV transmission is very limited and for the 24
historical serotypes is likely to be infrequent, with limited contribution to BTV spread during epidemics,
in comparison to vector transmission. Concerning vertical transmission of BTV in vectors, to date, there
is no scientiﬁc evidence in support of vertical transmission of BTV in its biological vectors in Europe;
therefore, further studies on virus detection on larvae are recommended, where endemic situations
allows it, particularly with European vector species.
The third question in this topic area regarded the revision of the criteria on surveillance laid down
in Regulation (EC) No 1266/2007 for demonstration of the absence of virus transmission. For this
assessment, reference was made to data of both virus and serological prevalence collected in previous
EFSA work, to the levels of virus circulation estimated with the mathematical model described above,
as well as an analysis of the performance of the surveillance system in place in France both in time of
BT freedom and during the last outbreaks occurred in 2015. The assessment concluded that when
surveillance is being undertaken in a zone or country after the cessation of the vaccination, very low
levels of infection prevalence (virus circulation) are to be expected. In particular, values below 1% can
be observed from the literature review and from the mathematical model developed in this opinion,
which are lower than the values foreseen by the Regulation (EC) 1266/2007. Furthermore, based on
the surveillance in France from 2013 to 2015 with associated detected prevalences, and considering
the reoccurrence of BTV in France in 2015, circulation of BTV might have occurred without being
detected. Therefore, when the objective of the surveillance is to demonstrate freedom (BTV-free
status) following application of a successful vaccination campaign, a design prevalence lower than 5%
as currently set in the Regulation (EC) 1266/2007, i.e. at least equal to 1%, should be taken into
consideration. Furthermore, the evidence suggests that the design prevalence for the surveillance of
BTV cannot be generalised, but should be set on a case-by-case approach after considering the type
of target prevalence (infection or serological prevalence), the geographical unit of concern and the
epidemiological phase appropriate to the area concerned.
As regards the options for safe trade of animals moved from BTV-infected to BTV-free country or
zone, different assessment questions were posed about protection conferred by colostral immunity and
vaccination as guarantee for BT susceptible animals to be moved safely from a BTV-infected to a BTV-
free country or zone. These questions were addressed by systematic literature review. Considering the
duration of protection from BT conferred by the colostral immunity in newborn ruminants from
vaccinated mothers, the literature review highlighted that in general neutralising antibodies can be
considered protective against infection, although a clear and speciﬁc threshold of a protective titre of
BTV-speciﬁc neutralising antibodies cannot be identiﬁed. Still some animals born from vaccinated dams
and without detectable neutralising colostral antibodies have also been shown to be protected. In term
of duration of protection, based on the limited number of studies available, a marked variation in the
level and longevity of neutralising colostral antibodies in lambs and calves (no speciﬁc evidence is
available for goats) from vaccinated dams have been demonstrated, ranging from 16 up to 270 days
in lambs (mean value 210 days) and from 70 to 113 days in calves (mean value 84 days).
The second point to be considered was to assess the minimum age of newborn ruminants where
residual colostral antibodies against BTV do not interfere with vaccine immunisation. Results of the
experimental studies demonstrated that the presence of colostral antibodies interferes with the
induction of the immune response to homologous vaccine in calves and lambs for more than 3 months
after birth (no speciﬁc evidence is available for goats), although further detailed studies are
recommended. Considering this conclusion, during the period of vector activity and potential virus
circulation or when an immediate threat for animal health exists, it would be advisable to vaccinate1
calves and lambs born from vaccinated mothers twice, once before 3 months and then again at about
6 months of age so to ensure maximal protection. Outside these periods, in the absence of BTV
circulation, a single vaccination at about 5–6 months can be adequate.
When assessing the minimum time after vaccination of an animal as immune, it was concluded that
this can be variable ranging from 3 to 48 days depending on the vaccine, the experimental design,
diagnostic tests, animal-related factors and other variables. When commercially available inactivated
vaccines and neutralising antibodies are considered, the majority of animals are positive within 21 days
after vaccination; an increasing proportion of protected animals can be observed at 28 days after
vaccination.
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A speciﬁc situation was asked to be assessed, i.e. whether 14 days of vector protection for
ruminants below the age of 70 days, combined with a negative PCR test at the end of the 14 days or
more, qualify them for a safe movement from a BT-restricted to a BT-free area. It was stated that
these measures are all able to reduce the risk of introducing one or more viraemic animals, both
considered singularly or in combination. Nevertheless, a quantitative estimation of the ﬁnal risk of
introducing a viraemic animal following the above described procedure would be of limited utility, given
the high levels of uncertainties affecting all variables and the large range of epidemiological conditions
inﬂuencing the ﬁnal risk. Given the current uncertainty level, the development of any quantitative
model based on a series of assumptions (e.g. the level of infection in the population of origin, the
period of the year, the vaccination policy in the country of origin, the speciﬁc protocols used for vector
protection and the number of animals to be introduced) would make the outcomes rather unrealistic
and scarcely applicable in practice.
As regards the provisions for safe movement of animals linked to protection from BTV vectors, an
update of the scientiﬁc knowledge about vectors ecology and possible mechanisms of over-wintering
of vectors was conducted through literature review, and the conclusions and recommendations from
previous EFSA opinions were updated. This was completed by an analysis of ﬁeld data on
seroconversion of sentinel animals and entomological surveillance during winter in the same areas
from Italy, as a case study, and by mapping predicted vector activity according to a temperature
threshold of 10°C over Europe, selected according to results from laboratory experiments on Culicoides
development and to the estimation of temperature-dependent R0 threshold values for disease
transmission. All these components of the assessment served for better deﬁnition of the criteria for the
determination of the seasonally vector-free period (SVFP). Regarding these aspects, available data
demonstrate that some Culicoides species, in some geographical areas in Europe (e.g. in
Mediterranean areas and in mild-winter areas), are active throughout the year and that an absolute
SVFP does not exist. In these areas, the continuous Culicoides activity and long-lived infected female
could collectively contribute to the BTV overwintering. On the other hand, in northern Europe, low
winter temperatures mainly inhibit Culicoides life cycle over a period of at least 3 months, and would
not allow continuous transmission or survival of females infected during the prior transmission season.
This is in agreement with ﬁeld data were adult populations of Culicoides are in general absent from
January to April in most of northern European countries. Long-standing practical experience
demonstrates that transmission of BTV is substantially reduced or halted during these periods.
The criteria considered by the Regulation (EC) 1266/20072 for the deﬁnition of the SVFP include the
complete absence of adult Culicoides imicola and less than ﬁve parous females captured in light traps
for the other Culicoides species. Temperature conditions that impact on the behaviour of the vectors
activity and related temperature thresholds are considered as possible additional criteria for the
deﬁnition of the SVFP. Although the available data do not allow the identiﬁcation of more accurate and
applicable criteria for the deﬁnition of the SVFP, the analysis of the data produced by the Italian
entomological surveillance programme agrees with the current provisions of the Regulation (EC)
1266/2007, as no seroconverted sentinels were observed in absence of C. imicola or with less than 5
captured Culicoides recorded.
In relation to the possible deﬁnition of a temperature threshold, the results of the available studies
and analysis of the risk of BT transmission through the calculation of the R0 indicated a possible
temperature threshold for BT transmission between 9.0 and 12.0°C. This temperature values cannot
be taken in absolute way, without considering the different Culicoides species involved and the
eco-climatic conditions of the territory of concern. An in-ﬁeld validation of the criteria currently used
for the SVFP deﬁnition is still needed, the availability of long-term entomological data, coupled with
serological or virological surveillance results in the same locations on animal host and vectors, would
be necessary for the main European ecoclimatic zones and different Culicoides species involved.
Considering these knowledge gaps, a series of investigations and products concerning BT vectors
are recommended to be produced:
• seasonal maps for the presence/absence of the major vector species in Europe;
• validated models based on long-term ﬁeld data of seasonal captures for predicting the vector
seasonality;
• survival rates of adult Culicoides at low temperatures under laboratory conditions;
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• insights on inﬂuence of temperature on BTV replication in Culicoides;
• BTV presence in vector females collected during winter months coupled with new age-grading
methods to detect the infection season.
The third aspect to be assessed in this topic area was the efﬁcacy of insecticides and repellents
against BT insect vectors, and the comparison of that to the protection efﬁcacy provided by vector-
proof establishments. Regarding this aspect, it was concluded that, to date, there is no conclusive
evidence that the use of insecticides or repellents singularly reduce the transmission of BTV in the
ﬁeld. In speciﬁc scenarios, however, they have been shown to either kill Culicoides or reduce
host/vector contact and hence are used as mitigation where vaccines are unavailable. Their use is
modiﬁed by both logistics and cost. One of the main limitations of these treatments is related to their
transient effect which necessitates frequent reapplication, and this is unlikely to be feasible except for
very high value stock. According to scientiﬁc literature reviewed in this opinion, a high level of efﬁcacy
(up to 86%) of pour-on insecticides is difﬁcult to achieve under ﬁeld conditions, and little information
is available about the effect of reduction on the numbers of engorged Culicoides females in relation to
BTV transmission. By only using pour-on insecticides, protection of animals is lower than the one
provided by the vector-proof establishment which is at least 10% higher.
Among other control methods for reducing host/vector contact, it was concluded that stabling is
effective where a high level of containment can be attained. Also, insecticide-treated meshes applied
over windows in stables were demonstrated to substantially reduce vector populations inside stables.
The evidence was derived primarily from studies addressing horses and the logistics and reduced
coverage provided to ruminants may lessen this effect. Application of insecticides in the environment
to kill either adult or larval Culicoides has not been studied since the last EFSA scientiﬁc opinion from
2008 and is unlikely to be effective due to the ubiquitous nature of Culicoides larval development sites
in Europe.
On the light of those conclusions, further studies would be needed to estimate the risk reduction
provided by application of insecticide treatment under ﬁeld conditions. Protocols of usage of insecticides
and repellents on animals should be harmonised in the EU and supported by ﬁeld evidence.
Scientiﬁc opinion on bluetongue
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1. Introduction
1.1. Background and Terms of Reference as provided by the EC
Over the past 15 years, BT incursions of a variety of serotypes occurred and on several occasions
became widespread across many parts of Europe with affected countries sometimes adopting diverse
control policies, particularly as regards vaccination against the disease in order to cope with both the
short as well as the long-term consequences in animal health, animal production and trade on live
animals or their products. Incidences of BT during this period have not only included unexpected
epidemics in areas where it had not appeared for more than 10 years (e.g. BTV-4 in the mainland of
the Balkan Peninsula in 2014) but also low-impact circulation of certain serotypes, some of them of
unclear origin, incursions of new serotypes, vaccine incidents and disease resurgence (BTV-8 in France
in 2015) raising concerns and evidencing new challenges.
The European Commission has repeatedly sought scientiﬁc advice on bluetongue (BT) from EFSA in
the last decade and in response the European Food Safety Authority (EFSA) has produced a number of
scientiﬁc opinions dealing with various aspects of BT epidemiology, surveillance and control which
provided valuable conclusions and recommendations that helped shape the current disease strategy at
the European Union (EU) level. Nevertheless, an update appears necessary in the light of the recent
disease evolution, the current epidemiological situation, the experience gained so far from the
implementation of the various BT control policies and possible alternative methods to ensure safe trade
of live animals from BT restricted zones and the latest scientiﬁc information available. The need to
review the overall BT policy at the EU level is an issue that has been repeatedly emphasised by
national authorities of many Member States and the IV International Conference on Bluetongue and
related Orbiviruses (Rome, 5–7 November 2014) represents a major milestone for taking stock of the
latest state of the art science on BT.
In order to streamline the way forward, the Commission with the Member States have identiﬁed a
series of issues for which concrete elements of science may provide a good basis for reformulating
policies and/or adapting current rules. These are as follows:
1) Safe trade provisions
As regards provisions for safe trade, in particular from BT restricted areas, the European
Commission, on top of those already in place in Commission Regulation (EC) 1266/2007, is keen to
explore other options used by the competent authorities of some EU Member Countries in the
framework of bilateral trade agreements drafted in accordance with Article 8 of the same Regulation.
Article 8 of Commission Regulation (EC) No 1266/2007 foresees that exemptions from the exit ban are
to be based on risk mitigating measures presented in Annex III to the Regulation or on any other
appropriate animal health guarantees based on a positive outcome of a risk assessment agreed
between the competent authority of the place of origin and the competent authority of the place of
destination. Currently, there are such agreements on the movement of live animals concluded between
France and Italy of 2015, France and Spain of 2013 and 2015, Italy and Spain of 2012, Spain and
Portugal of 2014, France and Luxembourg of 2015, and Italy and Austria of 2016.
2) Classiﬁcation of different BT serotypes
There are indications that more than 25/26 different serotypes of the BT virus have been identiﬁed
to date. Each of these serotypes, apart from its speciﬁc genetic and antigenic features, may also be
connected with speciﬁc epidemiological and pathogenicity properties. It is necessary to understand
whether it is possible to use these properties as a set of standard criteria to divide known BT serotypes
in groups, each deserving a distinct treatment as regards surveillance, protection and control measures.
3) BT listing and categorisation in the framework of the AHL
In addition to the classiﬁcation of the different serotypes, BT merits an assessment as part of the
listing and categorisation exercise of animal diseases in the framework of the Animal Health Law (AHL)
in the same manner as it was requested previously for another seven diseases (Ref. SANTE G2/BL/lp
(2015) 4940871).
In the light of the above mentioned ongoing procedure, the Commission is in need of scientiﬁc
advice on the assessment of the signiﬁcance of BT (as an integral disease, or separately for each
serotype or group of serotypes, depending on the outcome of the grouping exercise) also within the
framework of the listing and categorisation according to the AHL. The criteria, provided for ease of
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reference in Annex II and Attachments I to IV thereof, shall be used as a basis for this analytical
assessment. The risk manager needs an updated scientiﬁc advice in order to:
1) assess if the various serotypes or groups of serotypes of BTV cause diseases for which
control measures at the EU level are justiﬁed;
2) proceed with the proﬁling of the diseases caused by the serotypes or groups of serotypes of
BTV as above in view to their categorisation; and
3) assign listed species to the various serotypes or groups of serotypes of BTV identiﬁed as
eligible for EU intervention.
1.1.1. Terms of Reference (ToR)
In view of the above, and in accordance with Article 29 of Regulation (EC) No 178/2002, the
Commission asks EFSA for a scientiﬁc opinion under the following headings:
ToR 1. As regards vaccination, eradication and surveillance
ToR 1.1 Assess the most suitable duration of a BT vaccination campaign intended to achieve
disease freedom in a country or region considering any relevant factors that may affect and inﬂuence
disease spread and persistence.
ToR 1.2 Assess the probability of BT recurrence in BT-affected areas that have regained BT
freedom, in particular due to BT virus becoming endemic with low level circulation in these areas and
reoccurring ‘spontaneously’ (low-noise circulation in livestock or wildlife, maintenance in vectors or
other possible mechanism to be considered).
ToR 1.3 Revise and assess the suitability of the provisions on surveillance laid down in Regulation
(EC) No 1266/2007 to ensure reliable and robust demonstration of absence of virus transmission in a
Member State or epidemiologically relevant area, considering point 1.2 above.
ToR 2. As regards speciﬁc options for safe trade that could be used for exemptions from
the exit ban applicable to movements of live animals from a restricted zone
ToR 2.1 Assess whether maternal immunity against BT of calves, lambs and kids born to and
colostrum fed from vaccinated mothers, constitutes a sufﬁcient guarantee for animals of the above
species to be moved safely from a BTV-infected to a BTV-free country or zone, without a risk for
disease spread, with or without the need for any additional premovement testing regime and indicate
the main parameters that could be used (minimum/maximum age of calves, testing of dams, etc.).
ToR 2.2 Assess the minimum age of calves, lambs and kids after which residual colostral antibodies
against BTV do not interfere any longer with vaccine immunisation of these animals (in an example of
BT bilateral agreement this age limit is set at 90 days).
ToR 2.3 Assess the minimum time after completion of the primary vaccination (1–2 doses as
indicated by the vaccine manufacturer) for the vaccinated animals to be considered immune to be
safely moved from a BT-infected to a BT-free country or zone (currently set at 60 days in paragraph 5
of Annex III to Regulation (EC) No 1266/2007).
ToR 2.4 Assess whether vector protection for 14 days of ruminants below the age of 70 days,
combined with a negative PCR test at the end of the 14 days or more, qualify them for a safe
movement from a BT-restricted to a BT-free area.
ToR 3. As regards protection from BTV vectors and vector based provisions for exemption
from the exit ban applicable to movements of live animals from a restricted zone
ToR 3.1 Review and update previous opinions as regards vectors ecology (models for distribution/
density), in order to have more accurate and applicable criteria for the determination of the seasonally
vector-free period.
ToR 3.2 Review and update previous opinions as regards over-wintering mechanisms and the
duration of the BT viraemia.
ToR 3.3 Review and update previous opinions and provide a scientiﬁc assessment of the
appropriateness of the use of insecticides and repellents against Culicoides as BT competent vectors,
including an assessment of their efﬁcacy and recommendations of adequate protocols for their uses, in
particular as regards their suitability to protect animals against attacks by vectors performing at least
equal to the protection provided by vector-proof establishments – without the need to keep animals in
a vector-protected facility.
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ToR 4. As regards classiﬁcation and grouping of different BTV serotypes according to their
potential impact on animal health
ToR 4.1 Review and update previous opinions providing a short description of existing serotypes in
the EU and elsewhere.
ToR 4.2 Assess, by using appropriate criteria, the feasibility of grouping the currently known BTV
serotypes in appropriately deﬁned groups of serotypes sharing similar properties thus creating a
number of ‘BTV serotype groups’ separated by signiﬁcant different levels of impact on animal health
(e.g. most serious clinical symptoms in many individuals in large areas, mild symptoms to few
individuals within small areas or no symptoms at all in one or more BT susceptible species, etc.).
ToR 4.3 Review and classify the existing serotypes according to the outcome of the assessment in
point 4.2 above and assess whether any of the above serotypes/groups of serotype could be
candidates for a partial or total exclusion from the overall BT policy currently in place in the EU, in
particular, due to their low level of virulence or pathogenicity.
ToR 5. Listing and categorisation of BT in the framework of the Animal Health Law
ToR 5.1 Considering the outcome of the assessments and reviews referred to in paragraph 4 above,
for each of the aforementioned groups of serotypes, or BT in general as appropriate, assess, following
the criteria laid down in Article 7 of the AHL, its eligibility of being listed for Union intervention as laid
down in Article 5(3) of the AHL;
ToR 5.2 Considering the outcome of the assessments and reviews referred to in paragraph 4 above,
for each of the aforementioned groups of serotypes, or for BT in general, if found eligible to be listed
for Union intervention, provide:
a) an assessment of its compliance with each of the criteria in Annex IV to the AHL for the
purpose of categorisation of diseases in accordance with Article 9 of the AHL;
b) a list of animal species that should be considered candidates for listing in accordance with
Article 8 of the AHL.
1.2. Interpretation of the Terms of Reference
1.2.1. ToR1
This ToR is addressed in Sections 3.1 and 3.2. The questions are answered basically by using a
modelling approach, where the difﬁculties related to the models, due to the necessity of accounting for
different ecosystems, including wildlife, climatic and host composition/densities in Europe do not
impede that approach. A choice of the most relevant model compartments balanced with data
availability is performed.
The mechanisms for BT persistence useful to answer ToR 1.2 are addressed in Section 2.2 including
role of wild animals species, transplacental transmission, duration of viraemia (which covers in this way
part of what requested in ToR 3.2), presence of BTV in other tissues and vertical transmission in vectors.
The ToR 1.3 about surveillance performance is addressed in Section 3.3. It was answered by
comparing the sensitivity of the prescribed surveillance systems with the prevalence on the long term
obtained by the model in domestic animals. A case study of the surveillance in place in France at the
time of BT recurrence and how the surveillance was adapted afterwards is also considered.
1.2.2. ToR2
This ToR is addressed in Section 3.4. The approach is to address the ﬁrst three subquestions of the
ToR by a systematic literature review and discussing the results by expert knowledge, taking into
account what is observed at experimental level and on the ﬁeld. The assessment to sub-ToR 2.3 about
the lag time after vaccination for an animal being protected is done at level of individual animal. This
cannot be answered at population level, where if a big number of (correctly) vaccinated animals is
moved, the probability of having at least one ‘not safe’ animal could be as high as 100%.
The ToR 2.4 is addressed in Section 3.4.1, and cannot be answered quantitatively due to the high
level of uncertainty of the many variables involved. About that, a series of considerations are provided
about the level of infection in the population of origin, the period of the year, the vaccination policy, the
speciﬁc protocols used for vector protection and the number of animals to be introduced, which lead to
many different scenarios that should be assessed by a case-by-case approach. Most important is the
high level of uncertainty that would affect the ﬁnal risk estimation when these variables are combined.
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1.2.3. ToR3
The questions posed by this ToR are addressed in Sections 3.5 (vector ecology, overwintering
mechanisms and seasonal vector free period) and 3.6 (vector control).
The ToR 3.1 about reviewing the knowledge of vector ecology is addressed by keeping the last
EFSA opinion from 2008 as basis of knowledge and updating that with the evidence from the new
studies produces since then. An assessment of the validity of conclusions and recommendation from
that opinion is also provided.
It seems that the concept of an absolute seasonal vector-free period (SVFP) is unrealistic for deﬁning
the role of the different vector species during winter when transmission is supposed to be absent or very
low. Nevertheless, the seasonal occurrence of BT in Europe is clearly related to the seasonal pattern of
the vectors throughout the year. The criteria for the vector-free period are assessed comparing those
against ﬁeld entomological and serological data of sentinel animals obtained from Italy.
The sub-ToR 3.3 is addressed by considering the efﬁcacy of repellents and insecticides and
comparing it with the level of protection achievable with vector-proof establishment. Currently,
different approaches are followed in the use of insecticides and repellents in the context of the animal
movement and some clariﬁcations on pros, cons and limits of the different approaches could be of
beneﬁt.
1.2.4. ToR 4 and ToR 5
These two ToR will be addressed in a separate scientiﬁc opinion that will be published separately.
2. Data and methodologies
This opinion has been selected as a pilot opinion to adopt the PROMETHEUS approach. PROmoting
METHods for Evidence Use in Scientiﬁc assessments (PROMETHEUS)3 is an EFSA initiative designed to
foster these principles. It involves a four-step approach that can be tailored to the different
circumstances and requirements of each scientiﬁc assessment:
• upfront planning of the assessment strategy, deﬁning the relevant data and the approach for
collecting, appraising and integrating them;
• conducting the scientiﬁc assessment in line with the plan, and independently of prior
knowledge of the results of the available studies;
• verifying the process to ensure alignment with the plan and the guiding principles;
• documenting and reporting of all steps, including deviations from the original plan.
This approach foresees to develop a protocol that illustrates the WG/Panel’s strategy for the
scientiﬁc assessment on bluetongue. The protocol was developed following the principles and process
illustrated in the EFSA PROMETHEUS project.4 The PROMETHEUS protocol (including considerations
regarding uncertainties) is available as an Annex to this opinion (Annex A).
The methodological approach used in each section is explained as follows.
2.1. ToR 1.1: Assessment of the duration of BT vaccination campaign
intended to achieve disease freedom
A model for simulating the transmission of bluetongue virus within and between farms has been
used to answer ToR 1.1 and ToR 1.2. The model was originally developed to describe the spread of
BTV within and between farms in Great Britain during a single season. However, the model has been
extended to include: (i) vaccination; (ii) host births and deaths; (iii) overwintering of BTV; and
(iv) application of the model to countries other than Great Britain (GB), in particular France, Italy and
Spain, and including parameters related to alternative Culicoides vector species. The full details of the
model structure are provided in Appendix A.
2.2. ToR 1.2: Mechanisms for bluetongue persistence and recurrence
In September 2015 the reoccurrence of serotype 8 of BTV was conﬁrmed in continental France, in
the departement of Allier. The surveillance put in place by the French veterinary authorities allowed the
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detection of additional cases of infection in the central departements of France, close to the Massif
Central area.
The analysis on the sequences of the viral genome conﬁrmed a close match between the BTV-8
strain currently circulating in France and that causing the vast epidemic in 2006–2008. This similarity
with the BTV-8 previously circulating in France and the results of the epidemiological investigations
made by the French Authorities, not revealing any introduction of potentially infected animals, semen
or embryos, suggested a possible re-insurgence of the BTV-8 infection due to the maintenance of the
viral circulation at low level in the host and vector populations since 2009, ﬁnally re-emerging in 2015
as a consequence of the reduction of the immunity in the population of domestic ruminant. This ‘low
level circulation’ mechanism, however, has never been taken into consideration before in Europe to
explain the re-emergence of the infection after a long period of time.
In addition, the results of the French entomological surveillance programme from 2009 to 2012 were
analysed for the departements of Allier and Puy-de-Do^me, where the resurgence of BTV-8 was ﬁrstly
observed (Sailleau et al., 2015; Bournez et al., 2016), and all departements (46) classiﬁed in the same
Culicoides diversity groups, based on the abundance of the different Culicoides species (Figure 1).
The analysis of the data of the French entomological surveillance programme from 2009 to 2012
refutes the existence of possible peculiar entomological conditions in the departements of Allier and
Puy-de-Do^me, where the resurgence of BTV-8 was observed in 2015. In fact, the Culicoides species
diversity in the departements of Allier and Puy-de-Do^me is dominated by the closely related species
Culicoides obsoletus and Culicoides scoticus, for which the females are difﬁcult to identify by
morphology. When the maximum abundance per trap and per month for Allier and Puy-de-Do^me are
compared with the same parameters observed in the rest of the selected departements, it is evident
that the Culicoides population in these two departements was not particularly high compared to the
other selected territories (Figure 2).
Departements were selected by comparison as they belongs to the same Culicoides diversity groups
(brilliant and pale green). Both these diversity groups are dominated by the morphologically close
C. obsoletus/C. scoticus species, with a rarefaction of C. chiopterus and C. dewulﬁ southwards. Data
were obtained from the French surveillance system of Culicoides populations, funded by the French
Ministry of Agriculture.
Figure 1: Map of France, with the departements (Allier and Puy-de-Do^me) where bluetongue
re-emerged in 2015 (area with diagonal lines), and departements selected for comparison
(coloured and highlighted departements)
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As far as the climatic conditions are concerned, the Massif Central region did not experience any
particular climatic events from 2010 to 2014. In 2015, temperatures were 2–4°C higher than normal
seasonal temperatures in July in France and +4°C higher than normal in Massif Central. A severe
dryness was observed from May to July in a large part of France including the Massif Central.5 It is
difﬁcult to state that this warm and dry 2015 summer could have led to a more intense transmission
and thus to the resurgence of BTV-8 in France. The hypothesis of the maintenance of the infection in
host and/or vector population, not detected by the surveillance systems in place in the EU, would in
theory imply the occurrence of one or more of the following mechanisms:
• persistence of the infection in the host populations (domestic or wild) due to a ‘low level
circulation’ of the virus, not detectable by the surveillance systems in place;
• persistence of the infection in the host populations (domestic or wild) due to additional
mechanisms, such as transplacental transmission or the permanence of live virus in organs or
tissues of animal hosts (i.e. the establishment of a long lasting carrier state);
• persistence of the infection in the vector population through vertical transmission.
Figure 2: Maximum number of Culicoides per trap and per month caught in Allier and Puy-de-Do^me
departements (dashed line) and in the other 46 departements classiﬁed in the same
Culicoides diversity groups (boxplots) in 2009, 2010, 2011 and 2012.
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2.2.1. Persistence of the infection in the host populations (domestic or wild) due
to a ‘low level circulation’ of the virus
A disease spread model has been developed to assess the probability of maintenance of infection in
the domestic host population, considering a scenario of ‘low level’ endemic circulation of the virus
persisting for several years (see Section 2.1). The full details of the model structure are provided in
Appendix A.
In relation to the probability of ‘low level circulation’ in wild ruminants, the lack of comprehensive
data on animal density and spatial distribution is hampering the development of any reliable
transmission model. In particular, the limited availability of spatial distribution maps on wild ungulates
in some European regions6 do not provide enough detailed quantitative data to be used as input
values for the transmission model.
The existing knowledge on the possible contribution of the wild ruminant species to the BTV
circulation has been retrieved from the scientiﬁc published literature, with particular reference to the
European situation. The results of a multiannual surveillance carried out in France have been also
analysed (Rossi et al., 2010, 2014a).
2.2.2. Persistence of the infection in the host populations due to transplacental
transmission or the permanence of live virus in organs or tissues of
animal hosts
The evidence already collected in the previous EFSA opinion (EFSA AHAW Panel, 2011b) has been
updated by considering the most recent literature published on the topic and the conclusions and
recommendations assessed for their validity. For that purpose, the data collected in the systematic
literature review conducted in the framework of the EFSA mandate on vector-borne disease (Dorea
et al., 2017) were used.
2.2.3. Persistence of the infection in the vector population through vertical
transmission
To date, there is no scientiﬁc evidence supporting the existence of this mechanism of transmission
in the case of BTV and its vectors, some considerations are addressed based on proxy studies, i.e.
preliminary laboratory trials and/or targeting other viruses different from BTV.
2.3. ToR 1.3 – Suitability of the provisions on surveillance laid down in
Regulation (EC) No 1266/2007
The Regulation (EC) 1266/2007 lays down implementing rules for the control, monitoring,
surveillance of BT. As regulated, the BT monitoring and surveillance programmes shall be aimed at (a)
detecting any possible incursions of the bluetongue virus and (b) where appropriate, demonstrating
the absence of certain serotypes of that virus in a Member State or epidemiologically relevant
geographical area; or (c) determining the seasonal vector free period (entomological surveillance).
The second objective is the relevant one for the question posed by the ToR. The surveillance shall
consist of at least passive clinical surveillance for the detection of suspected cases and active
laboratory-based surveillance based on annual survey based on serological/virological monitoring with
sentinel animals, or targeted monitoring and surveillance based on a risk assessment. Moreover, the
sample size used for the active laboratory-based surveillance must be calculated to detect a prevalence
of at least 5% with 95% conﬁdence. The approach is to assess the possible lowest and persistent
levels of BTV circulation in livestock both by using the model as presented in Section 3.1.1 and cross-
checking values of infection prevalence from the literature and to compare these values with what
prescribed by the Regulation.
2.4. ToR 2: Immunity and vaccines
The ToR 2.1, 2.2 and 2.3 was addressed by systematic literature review on the following risk
questions:
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Q1: ‘What is threshold of BTV-speciﬁc maternal antibody titre considered to provide protection to
an offspring born from vaccinated mother to one/several BTV serotypes?’
Q2: ‘What is the minimum age of calves, lambs and kids after which residual colostral antibodies
against BTV do not interfere any longer with vaccine immunisation of these animals?’
Q3: ‘What is the minimum time after completion of vaccination against BTV and the threshold
BTV-speciﬁc antibody titre considered to provide a protective immune response after vaccination?’
The systematic literature review has been performed to support the assessment. The full protocol
of the systematic review and the critical appraisal of the studies are provided in the Prometheus
protocol published as supplementary information to the present opinion.
The ToR 2.4 about assessing whether vector protection for 14 days of ruminants below the age of
70 days, combined with a negative reverse transcription polymerase chain reaction (RT-PCR) test at
the end of the 14 days or more, qualify them for a safe movement from a BT restricted to a BT-free
area, is addressed based on the ﬁndings of the literature.
2.5. ToR 3: Vector ecology and control
The evidence already collected in the previous EFSA opinion (EFSA, 2008) about vector ecology has
been updated by considering the most recent limited literature published on the topic and the
conclusions and recommendations have been assessed for their validity.
The criteria for the establishment of a SVFP foreseen by the Regulation (EC) 1266/2007 have been
tested through the analysis of a subset of entomological and serological surveillance data provided by
the Italian national veterinary authority. Further insights on the validity of criteria for SVFP are
provided by analysing the basic reproductive number according to different temperatures and numbers
of Culicoides caught.
Finally, the efﬁcacy of vector control tools and protocols are reviewed and compared with the
requirements and efﬁcacy of vector-proof establishments (VPE).
3. Assessment
3.1. Modelling the long-term dynamics of bluetongue virus
3.1.1. Long-term dynamics of bluetongue virus in the absence of control
measures
To explore the long-term dynamics of BTV and, in particular, the possibility of the virus becoming
endemic with low-level circulation in livestock, the model was used to simulate epidemics in south-east
England (speciﬁcally Kent, Surrey and East and West Sussex). This region comprises 5,073 cattle
and/or sheep farms with 212,742 cattle and 825,985 sheep. The model was run for 25 years following
the initial incursion, which was to a randomly selected farm in the region. Spread between farms
occurred via dispersal of infected vectors only; spread via movement of infected animals was not
included in the simulations because, although animal movements can signiﬁcantly alter the spatial
dynamics of an epidemic, the main purpose of the model was to explore the probability of long-term
persistence of the infection in a given population and not to simulate the spread of the disease in
south-east England.
Simulated epidemics persisted for 25 years (i.e. the end-point of the simulations) in a majority of
replicates (Figure 3). After around 5 years, the dynamics of BTV infection settled to a stable pattern of
seasonal outbreaks (Figure 3), with a peak proportion of infected farms of around 50%. The proportion
of animals infected or seropositive in the population was higher for cattle compared with sheep
(prevalence of infection: 1.5% in cattle, 0.6% in sheep; seroprevalence: 45% in cattle, 14% in sheep).
The mean within-herd prevalence of infected animals was similar for both cattle and sheep (5% in
cattle; 5% in sheep), but mean within-herd seroprevalence was higher for cattle compared with sheep
(64% in cattle; 45% in sheep). The differences between sheep and cattle results are determined by the
different parameters describing the population demography and disease-associated mortality.
3.1.2. Dynamics of bluetongue virus in a vaccinated population
To assess the impact of vaccination and, in particular, the duration of a vaccination campaign on
the dynamics of BTV, a range of scenarios were simulated which differed in the level of farm-level
vaccine coverage (i.e. the proportion of farms vaccinated: none, 80% or 95%) and the number of
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years for which vaccine was used (1, 2, 3 or 5 years). In addition, the dynamics of BTV were
simulated for different countries (Great Britain, France, Italy and Spain) to explore the sensitivity of
any conclusions to the effects of host density, population structure, temperature and principal vector
species (C. obsoletus in Great Britain and France compared with C. imicola in Italy and Spain).
3.1.2.1. Great Britain
When applying the model to Great Britain (GB), the full model (i.e. including spread between farms
via animal movements) was used for the simulations. The model was run for 5 years following the
initial incursion, which was to a randomly selected farm in south-east England.
In the absence of vaccination, BTV persisted in most epidemics for the period of the simulations.
The prevalence of infected farms increased over time, reaching around 30% in the ﬁfth year
(Figure 3). Similarly, the prevalence of infected cattle and sheep increased from 1 year to the next
(Figures 4 and 5), although the prevalence was higher in cattle (1.5% after 5 years) compared with
sheep (0.2% after 5 years).
Vaccination contributed to a great decrease in the prevalence of infected farms (Figure 4), cattle
(Figure 5) and sheep (Figure 6), with higher levels of coverage resulting in a greater reduction.
However, even when vaccination was used for 5 years at 95% coverage, BTV was not eradicated from
the population, but persisted at very low levels, although the number of infected farms and infected
cattle was very low (< 100 farms or cattle), and infection was eliminated from sheep.
When vaccination was stopped after 1, 2 or 3 years, BTV re-emerged in subsequent years (typically
in the second year after vaccination ceased) and did not reach the same prevalence as was observed
in the absence of vaccination.
3.1.2.2. Other EU Member States
When applying the model to other EU member states (speciﬁcally, France, Italy and Spain), spread
between farms was via dispersal of infected vectors only and spread via movement of infected animals
was not included in the simulations. The model was run for 5 years following the initial incursion. For
France, the model was applied to the whole of the country, with an incursion into a randomly selected
farm in Nord-Pas-de-Calais, Lorraine or Champagne-Ardenne (chosen to reﬂect the previous incursion
of BTV-8). For Italy, the model was applied to Sardinia alone, with an incursion into a randomly
selected farm in the region. Finally, for Spain, the model was applied to Andalusia alone, with an
incursion into a randomly selected farm in the region. The simulations performed for the scenarios in
these three MSs are shown in Appendix B.
France
The impact of vaccination on the prevalence of infected farms, cattle and sheep in France was
similar to that observed for GB. In particular, vaccination leads to a decrease in the prevalence to low
levels, but without eliminating infection (at least within the 5-year period simulated). Moreover,
stopping vaccination allows the virus to re-emerge, typically in the second year after vaccination
ceased (Figures in Appendix B).
Italy (Sardinia)
Without vaccination BTV spread rapidly in Sardinia, reaching its long-term level after 2 years and
persists at this level for the remaining 3 years of the simulation. In this case, the prevalence of
infected farms was around 30%, the prevalence of infected cattle was around 1% and the prevalence
of infected sheep around 0.5%. Although the prevalence varied seasonally, the amplitude of the
variation was much smaller than that for GB and France. Vaccination reduced the prevalence of
infected farms, cattle and sheep, with the greater reduction seen for higher levels of coverage.
However, BTV was not predicted to be eliminated even after 5 years of vaccination at 95% coverage.
Indeed, the rapid increase in the prevalence of infected farms during the year following the incursion
(i.e. prior to vaccination) means that the peak prevalence of infected herds remains above 5% in all
scenarios, although the prevalence of infected cattle and sheep is suppressed to low levels (< 0.1%).
Again, stopping vaccination resulted in re-emergence of BTV, with the prevalence quickly reaching
levels similar to those in the scenario for which there was no vaccination (Figures in Appendix B).
Spain (Andalusia)
The simulated dynamics of BTV in Andalusia were similar to those for Sardinia, including the impact
of vaccination on the prevalence of infected farms, cattle and sheep. In particular, vaccination reduced
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the prevalence to very low levels in cattle and sheep, but did not eliminate infection even after 5 years
of vaccination at 95% coverage. Consequently, BTV was able to re-emerge if vaccination was stopped
in the simulations (Figures in Appendix B).
The results of the model simulations for C. imicola areas (Italy, Spain) are quite consistent with the
ﬁeld epidemiological data. In Sardinia, for example, even after more than 3 years of vaccination of all
susceptible cattle, sheep and goats, the complete eradication of certain BTV serotypes was never
achieved, although the level of infection decreased to low levels and the direct impacts in animal
health almost eliminated (Paolo Calistri, personal communication).
Top left: Extinction time (in years). Top right: Time course for the proportion (%) of farms with BTV
circulating. Middle: Time course for the proportion (%) of cattle (left) and sheep (right) that are
infected (blue lines) or seropositive (red lines). Bottom: Time course for the mean within-herd
prevalence (%) of cattle (left) and sheep (right) that are infected (blue lines) or seropositive (red
lines). Each ﬁgure shows the mean of one hundred replicates of the model.
Figure 3: Simulated dynamics of bluetongue virus in south-east England over a 25-year period
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 18 EFSA Journal 2017;15(3):4698
The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure 4: Prevalence of infected farms in simulated epidemics of bluetongue in Great Britain and the
impact of vaccination
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The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure 5: Prevalence of infected cattle in simulated epidemics of bluetongue in Great Britain and the
impact of vaccination
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When interpreting the modelling results, it should to be taken into account that the model
considers the same climatic and environmental conditions every year, whereas in the real world, the
natural variability of climatic conditions among years can inﬂuence the vector’s density and behaviour,
thus inﬂuencing the probability of BTV transmission. The presence of less favourable climatic
conditions during one or more years, for example, could facilitate the achievement of the eradication
under one of the vaccination scenarios considered by the model.
3.2. Mechanisms for bluetongue persistence and recurrence
In this section, persistence of the infection in the host populations (domestic or wild) due to a ‘low
level circulation’ of the virus, or due to additional mechanisms, such as transplacental transmission or
the permanence of live virus in organs or tissues of animal hosts (i.e. the establishment of a long
lasting carrier state), and the persistence of the infection in the vector population through vertical
transmission are assessed as possible mechanisms for the maintenance of the infection.
3.2.1. Persistence of the infection in the wild populations
Several species of wild ruminants are susceptible to BTV infection, but few show clinical signs of
disease (Vosdingh et al., 1968; Niedbalski, 2015). Similar to domestic sheep, wild sheep such as bighorn
sheep (Ovis canadensis) and mouﬂon (Ovis aries musimon) can develop fatal clinical disease
(Fernandez-Pacheco et al., 2008). The clinical signs of BT have also been observed after experimental
The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure 6: Prevalence of infected sheep in simulated epidemics of bluetongue in Great Britain and the
impact of vaccination
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infection in pronghorn antelope (Antilocapra americana), American bison (Bison bison) and African
buffalo (Syncerus caffer) (Tessaro and Clavijo, 2001). After experimental infection, clinical disease has
been reported in some North American deer species, such as: white-tailed deer (Odocoileus virginianus),
black-tailed deer (Odocoileus hemionus columbianus) and mule deer (Odocoileus hemionus) (Vosdingh
et al., 1968; Work et al., 1992). Camelids have also been reported to be susceptible to BTV infection.
Clinical signs of disease, with fatal aftermaths, were reported in naturally infected llamas (Lama glama)
(Meyer et al., 2009), whereas alpacas (Vicugna pacos) displayed very mild clinical signs after
experimental infection with BTV-8 (Schulz et al., 2012).
In Europe, BTV infection has been detected in red deer (Cervus elaphus), fallow deer (Dama dama),
Alpine chamois (Rupicapra rupicapra rupicapra), Pyrenean chamois (Rupicapra pyrenaica pyrenaica) and
Alpine ibex (Capra ibex ibex), among other wild ruminants (Rodriguez-Sanchez et al., 2010; Rossi et al.,
2010, 2014b). In particular, high levels of serological positive and RNA-positive animals were observed in
red deer (C. elaphus) (Linden et al., 2008; Rodriguez-Sanchez et al., 2010; Corbiere et al., 2012; Grego
et al., 2014; Rossi et al., 2014a,b), which may be the wild species that most substantially contributes to
BTV circulation in Europe (Table 1).
Few experimental studies on the duration of viraemia in wild ruminants have been published
(Table 2). A single paper reports the estimation of the viraemia length in red deer (Lopez-Olvera et al.,
2010): two groups of four animals each were experimentally infected with BTV-1 and BTV-8,
respectively. The attempts to isolate the virus from the blood of the BTV-8 infected animals were
unsuccessful, but a positive response was observed by RT-PCR until 98 days post-infection. The BTV-1
infected animals showed a prolonged RT-PCR positive response, till 112 days post-infection, although
the virus was isolated only after 12 days post-infection (dpi).
A particularly extreme outcome was reported by Murray and Trainer (1970), who were able to
isolate the BTV-8 on 107 dpi from two experimentally inoculated North American elk (Cervus elaphus
canadensis) after the intramuscular injection of 5 mg of Flumethasone on 105 dpi. Although the results
of this study may suggest the existence of mechanisms able to promote the potential reservoir role of
North American elk, it is not easy to interpret and extrapolate these ﬁndings in a more general
context. Furthermore, the virus strain used in the study performed by Murray and Trainer (1970), and
designed as CA-8, was subsequently identiﬁed as serotype 10 (Maclachlan and Osburn, 2008). These
considerations each suggest that these results need to be interpreted with care.
Divergent opinions exist on the possible epidemiological role of wild ruminants, particularly red
deer, in the maintenance of BTV infection in the absence of apparent virus circulation in domestic
livestock.
In a study performed in France (Rossi et al., 2014b) in 2008 and 2009, high proportions of
seropositive and RT-PCR positive red deer were observed in 2008, suggesting that this species has
been widely infected by BTV-1 and BTV-8 at the peak of domestic outbreaks. However, the observation
of RT-PCR positive results in six of seven red deer populations in 2009 (i.e. with low domestic
incidence) would be consistent with the hypothesis of a role played by red deer in the maintenance of
BTV infection in spite of a very low incidence in the livestock. By contrast, the low prevalence observed
in other wild ungulate species suggests that exposure of these species to BTV in 2008 was uncommon
(Rossi et al., 2014b). In a following study, the same authors reported a low level of seropositivity in
young red deer (less than 2 years old) in 2011–2012, limited to some French regions (Rossi et al.,
2014a). This result suggested a possible maintenance, albeit limited, of virus circulation within the red
deer population. All serological positive animals resulted negative by RT-PCR, reinforcing the
hypothesis of a limited contribution of this animal species on the spread of the infection.
Some authors (Lopez-Olvera et al., 2010; Rodriguez-Sanchez et al., 2010) considered red deer able
to maintain the BTV for long periods, thus acting as a possible reservoir of the infection. In these
studies, however, the estimation of the viraemia duration was mainly based on the detection of viral
RNA in blood through RT-PCR, which can give positive results far beyond the presence of the live virus
in the blood. On the contrary, other authors (Grego et al., 2014), analysing the spleen samples from
hunted red deer (C. elaphus), roe deer (Capreolus capreolus) and Alpine chamois (Rupicapra
rupicapra) by quantitative RT-PCR in two provinces of Piedmont region, Italy, concluded that the
infection in wild ungulates may be considered only as an epiphenomenon, with no importance for the
maintenance and spread of the infection in this geographical area.
The presence of a vector species is a prerequisite for disease transmission. Therefore, knowledge is
needed of the Culicoides species that inhabit areas where wild ruminants are present. As yet, however,
few studies on this aspect have been conducted. In the study by Talavera et al. (2015) samplings
were conducted in Spain in areas inhabited by different wild ruminant species. The most abundant
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vector species were C. imicola and species of the Obsoletus assemblage,7 which represented 15% and
11% of total numbers of specimens collected, over 100,000, respectively. The data suggest that such
species do not exhibit strong host speciﬁcity towards either domestic or wild ruminants and they could
consequently play a prominent role as bridge vectors for different pathogens between both types of
ruminants.
In relation to the French situation, in its opinion issued on 22 December 2015,8 the French Agence
nationale de securite sanitaire de l’alimentation, de l’environnement et du travail (ANSES, 2015)
concluded that the BTV-8 resurgence in France in 2015 was unlikely linked to infection in red deer or
other wild ruminant populations, considering the relative short duration of viraemia in red deer, the
lower level of serological prevalence detected in this animal species in France after the cessation of
virus circulation in domestic populations and the low density of red deer in the Massif Central area.
To date, the information available on the length of viraemia in red deer and in other wild ruminants
as well as the results of ﬁeld surveys do not suggest a substantial role for these animal species in the
maintenance of the virus during interepizootic periods. The results of the serological surveys
performed in France conﬁrm a strict association between the infection in domestic ruminants and the
levels of serological prevalence in red deer (Rossi et al., 2014b). In addition, assuming an equivalent
abundance and composition of vector population, it is reasonable to consider a lower probability of
contact (and bite) between Culicoides vectors and wild hosts, which can be sparsely distributed in a
large geographical scale, than between local Culicoides populations and domestic hosts concentrated
in a farm environment.
Nevertheless, the detection of antibodies in young animals of 1–2 years of age may suggest the
possible persistence of the infection in the red deer population, albeit limited to few circumscribed
areas. The possibility of local maintenance of BTV infection in red deer population, therefore, cannot
be excluded, particularly in those areas where a high density of red deer population, a low number of
competing domestic animals and favourable vector conditions are present (Garcia-Bocanegra et al.,
2011; Falconi et al., 2012).
Scientiﬁc opinion on bluetongue
7 By simplicity, several authors use the term Obsoletus group to refer to some species of the Avaritia subgenus, namely
C. obsoletus, C. scoticus, C. dewulﬁ and C. chiopterus, for which females are relatively morphologically close. Moreover, other
use the term of Obsoletus complex to refer to species for which females are not reliably possible to distinguished by
morphology, namely at least C. obsoletus, C. scoticus and C. montanus. However, phylogenetic studies show that these
assemblages are not phylogenetically consistent, and that the taxon C. obsoletus highlights an important cryptic diversity.
Thus, we use the term ‘Obsoletus assemblage’ to refer by convenience to species morphologically close to C. obsoletus if they
are grouped in the publication.
8 https://www.anses.fr/en/system/files/SANT2015SA0226.pdf
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3.2.2. Persistence of the infection in the host populations due to transplacental
transmission or the permanence of live virus in organs or tissues of
animal hosts
3.2.2.1. Transplacental transmission
Transplacental transmission (TPT) of BTV in cattle and sheep has been extensively investigated
throughout the years, as this mechanism has been indicated to have an impact on the reproductive
performance of infected ewes and cattle causing early embryonic loss, abortion and the birth of
offspring with severe malformations. Furthermore, TPT has been suspected to play a role in the
overwintering of the infection, through the birth of offspring clinically healthy but viraemic, therefore
contributing to maintain the BTV in the host population during the whole winter period in the absence
of an active vector population (Zientara and Ponsart, 2015). Since 1955, TPT has been demonstrated
for several BTV serotypes (BTV-2, BTV-4, BTV-8, BTV-9, BTV-10, BTV-11, BTV-13, BTV-16, BTV-23) in
cattle, sheep, goat, and elk (Cervus elaphus canadensis) (van der Sluijs et al., 2016). However, prior to
the BTV-8 outbreak in northern and central Europe, TPT had generally been associated with strains
adapted to cell cultures, with multiple in vitro passages, or linked to the in-ﬁeld use of live vaccines
(EFSA AHAW Panel, 2011b), although in two studies TPT was observed for BTV-11 ﬁeld strains (Stott
et al., 1982; Castro and Rodgers, 1984). Other strains, attenuated with limited number of in vitro
passages, failed to induce TPT, leading to the hypothesis that the capacity of crossing the placental
barrier was a peculiar property of the live-attenuated vaccine strains only (van der Sluijs et al., 2016).
During the winter 2007–2008, an unprecedented number of cases characterised by lesions in
central nervous system in new-borns, and an increase in abortion and stillbirth of calves and lambs
were observed in Belgium, France and more in general in central Europe (De Clercq et al., 2008;
Desmecht et al., 2008; Saegerman et al., 2011). The incidence was considered to be associated with
the BTV-8 infection and, therefore, studies were conducted to ascertain the capacity of the BTV-8
strain to cross the placental barrier and the possible role of this mechanism for BTV spreading across
central and north Europe under ﬁeld conditions.
BTV-8 in cattle
In Belgium, pairs of dam/calf serum samples were collected from clinically healthy animals and
examined for the presence of antibodies against BTV by competitive ELISA (c-ELISA), resulting in the
detection of 38 serologically positive calves out of 102 c-ELISA positive dams (37%) (Desmecht et al.,
2008).
De Clercq et al. (2008) performed a study including 300 aborted fetuses, 68 from dams with
suspected clinical signs of BT and 232 from dams which aborted without any suspicion of BT. The authors
found evidence of the presence of BTV-8 ﬁeld strain in 41% (CI 95%: 30–53) and 18% (CI 95%: 14–24)
of bovine aborted fetuses, with and without BT suspicion, respectively, that were examined for the
presence of BTV RNA in the spleen. The same authors also took blood samples before colostrum uptake
from 123 dam/calf pairs and 50 ewe/lamb pairs and examined them by c-ELISA and RT-PCR. Three dams
were serologically and RT-PCR negative and the same result was observed in their offspring. Five dams
were positive to both c-ELISA and RT-PCR and from them two out of ﬁve calves were also positive to
both tests (the other two were negative to both tests). Among the 115 calves born from the other dams,
which were only serologically positive, six were RT-PCR positive whereas four resulted positive only for
c-ELISA. In total, therefore, twelve calves were positive (9.8%, CI 95%: 5.7–16.2) by at least one test,
and eight were RT-PCR positive. BTV was isolated from one calf positive to both tests born from dam
positive in both test. The same authors also demonstrated that TPT occurred in the 2% (CI 95%:
1.2–3.1) of calves without clinical signs of infection and born before the end of April 2008 (N = 733)
during a period of the year where no Culicoides were caught in or out the holdings (De Clercq et al.,
2008). In the context of the application of diagnostic tests to allow the animal movement from restricted
areas, it is noteworthy that six RT-PCR negative pregnant dams gave birth to RT-PCR positive calves (De
Clercq et al., 2008; Zanella et al., 2012).
Menzies et al. (2008) described an outbreak of BT in imported cows and their offspring in Northern
Ireland during the vector-free period, as a consequence of TPT of a BTV-8 ﬁeld strain. Of the 21
heifers tested negative by RT-PCR before introduction, eight were c-ELISA positive after their arrival to
Northern Ireland, and two of them gave birth to a total three RT-PCR positive calves, one of which
was also demonstrated viraemic by virus isolation.
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In France, the investigation of 780 cases of abortion in cattle occurring from November 2008 to
April 2009 in the Nievre departement revealed that 128 fetuses were BTV positive (16%, CI 95%:
14–19), either by RT-PCR or c-ELISA (Zanella et al., 2012). Out of 97 RT-PCR positive dams, 49 (50%)
had BT positive fetuses. The authors did not estimate the TPT rate, since dams were sampled only
once (at the time of abortion) and the RT-PCR status of the dams during the ﬁrst months of gestation
was unknown (Zanella et al., 2012).
In the United Kingdom, 61 calves born during the vector-free period (December 2007–March 2008)
from naturally infected dams were tested by RT-PCR and 21 of them had detectable levels of BTV RNA
in their blood or organs (33%, CI 95%: 22–47) (Darpel et al., 2009).
BTV-8 in sheep
The study of De Clercq et al. (2008) conducted on 50 ewe/lamb pairs did not observed any TPT in
these animals. Saegerman et al. (2011) demonstrated for the ﬁrst time the occurrence of BTV-8 TPT in
the ﬁeld in sheep analysing lambs and aborted fetuses in a sheep ﬂock in Belgium that experienced
severe BTV outbreak. TPT was demonstrated in aborted fetuses from 20 serologically positive ewes by
the ﬁnding of 4 RT-PCR positive samples from the spleen Desmecht et al. (2008). In lambs, the
presence of antibodies at birth, before the colostrum intake, was demonstrated in nine lambs out of
476 (1.9%, CI 95%: 0.9–3.6). After 14 days, seven out of these nine animals were also RT-PCR
positive (Saegerman et al., 2011).
BTV-2 in sheep
For the ﬁrst time, TPT of BTV-2 strain has been showed in experimental studies suggesting that
such transmission might be more frequent than previously thought (Rasmussen et al., 2013). The
authors inoculated 24 pregnant ewes (four groups of six animals each) with BTV-2 and BTV-8 wild-
type (wt) isolates with minimal passages on cell cultures (passaged once in Culicoides KC cells and
once in mammalian cells), and BTV-2 and BTV-8 strains obtained by reverse genetics (rg), both
isolated during outbreaks in Sardinia in 2001 and 2000, respectively. No major or signiﬁcant
differences were noted among results from wt and rg BTV by BTV-8 and BTV-2, suggesting that
ﬁndings of experimentally challenged infected sheep with cell-adapted BTV may be valid also for wild-
type strains of the virus. BTV-2 demonstrated high TPT efﬁciency as six lambs born from 13 BTV-2
infected ewes had BTV RNA detectable in their blood at birth. All the six lambs were viraemic, ﬁve at
birth before colostrum intake and one at 3 days of age. Considering only BTV-2 wt, two infected and
infectious lambs (RNA detectable and infectious virus recovered at birth) out of six challenged ewes
were found (Rasmussen et al., 2013).
BTV-8 in goats
Evidence of TPT of BTV-8 in goats has recently been reported (Belbis et al., 2013; Coetzee et al.,
2013). Coetzee et al. (2013) inoculated four Saanen goats with the European strain of BTV-8 at
62 days of gestation. Viral RNA was detected by RT-PCR in blood and tissue samples from three
fetuses harvested from two goats at 43 days post-infection. Belbis et al. (2013) performed two
studies. In the ﬁrst, they inoculated nine goats with BTV-8 strain at the 61st day of pregnancy, and
fetuses were collected 21 dpi. BTV-8 was evidenced by RT-PCR and by viral isolation using blood from
the umbilical cord and the spleens of 3 out of the 13 fetuses. The observed TPT transmission rate was
equal to 33% (3/9). In the second experiment, 10 goats were infected with BTV-8 at 135 days of
pregnancy. Kids were born by caesarean section at the programmed day of birth (15 dpi). BTV-8 could
not be detected by RT-PCR in blood or spleen samples from the kids.
Chauhan et al. (2014) reported seven abortions and six stillbirths in 25 pregnant goats (about
3 months of pregnancy) on a farm in the Gujarat region, India, in July 2007, due to infection with
BTV-1 ﬁeld strain. Two viruses were isolated from the spleen of aborted fetuses, and a closely related
virus was isolated from Culicoides captured on the same farm 1 month later. As in that Region and
anywhere else in India, attenuated or laboratory-adapted BTV-1 strains were never used, that ﬁnding
has been interpreted as evidence of TPT of the wild-type strain in goats (Chauhan et al., 2014).
Genetic determinant
The genetic determinant responsible for the transplacental transmission of BTV has not been
identiﬁed for either BTV-8 modiﬁed live vaccine or laboratory-adapted strains (Zientara and Ponsart,
2015), and more research should be necessary for better understanding the mechanism underlying the
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genotypic changes that drive the ability to cross the placenta in order to avoid unnecessary stringent
control measures causing damage to the livestock industry (van der Sluijs et al., 2016).
3.2.2.2. Duration of BT viraemia
For the purposes of this Opinion, the same deﬁnition of viraemia already set in previous EFSA
documents on bluetongue is considered: ‘circulation and replication of competent virus in the blood of
the mammalian host as detected by virus isolation (EFSA, 2007a)’. It is relevant to clarify that BTV
nucleic acid can be detected by RT-PCR assay in the absence of infectious virus in the blood of
ruminants following infection, especially as the time interval, subsequent to infection, increases.
Therefore, results of studies on viraemia duration based on RT-PCR methods must be carefully
interpreted, since a positive result in blood samples to viral genomic detection techniques does not
automatically prove the presence of live virus in the blood. On the other hand, the presence of live
virus in the blood is always associated to a positive result to RT-PCR, given the sensitivity of the test.
From the systematic literature review conducted in the framework of EFSA mandate on vector-
borne disease (Dorea et al., 2017), data about duration of BT viraemia in animals (cattle, sheep and
goats) experimentally infected by intravenous or subcutaneous virus inoculation were extracted from
selected papers according to the animal species and the test used for detecting the virus or its nucleic
acid. The distribution of the minimum and maximum day of the detection is shown in the Figure 7. For
graphical reasons, outliers are indicated out of the graph, i.e. two values of maximum detection in
cattle by RT-PCR of 156 (Barros et al., 2009) and 167 (Bonneau et al., 2002) days, respectively, and in
sheep by RT-PCR of 140 (Worwa et al., 2010) and 222 days.2
The systematic literature review conﬁrms the conclusions made in previous EFSA Opinions. It is
clear that BTV infection of ruminants is prolonged but not persistent and that the duration of viraemia
in BTV-infected ruminants reﬂects in part the lifespan of circulating red blood cells carrying the virus
(MacLachlan, 2004; Melville et al., 2004; White and Mecham, 2004; Lunt et al., 2006).
Figure 7: Minimum and maximum day of detection of BTV or nucleic acid in blood of cattle, sheep
and goats after experimental infection (in brackets the number of samples)
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The OIE considers an infective period of 60 days for BTV-infected ruminants on the basis of an
analysis of data which indicated a > 99% probability of detectable BTV viraemia ceasing before
9 weeks in adult cattle (OIE, 2014).
This approximately 60-day infective period is considerably shorter than the interval (up to 7 months
or even longer) during which BTV nucleic acid may be detected in ruminant blood by RT-PCR assays
(MacLachlan et al., 1994; Bonneau et al., 2002). Thus, the RT-PCR assay is overly sensitive in
identifying BTV virus-positive animals.
3.2.2.3. Persistence of BTV in other organs or tissues
From the systematic literature review conducted in the framework of EFSA mandate on vector-
borne disease, data about the presence of BTV in different tissues other than blood, in cattle, sheep
and goats experimentally infected by intravenous or subcutaneous virus inoculation were extracted
from 25 papers (Dorea et al., 2017), and grouped according to the test used for detecting the virus or
its nucleic acid. The distribution of the values of the maximum day of the BTV or nucleic acid detection
in these tissues is shown in Figure 8. The data are not stratiﬁed by animal species because of the
limited number of data. For graphical reasons, outliers are indicated out of the graph scale, i.e. two
values of maximum detection by RT-PCR in spleen and tonsils of 151 and 88 days, respectively.
The values of the duration of BTV presence range from 6 to 40 days in thymus and spleen,
respectively, detected by virus isolation, and from 8 to 151 days in lymph nodes and spleen by RT-PCR
(Figure 8).
Some limitations remain in clarifying the distinction between ‘virus replication’ and ‘virus presence’.
Indeed, this difference is important for the implication in term of BTV persistence in certain organs. In
the study by Darpel et al. (2012), BTV replication and organ tropism were studied in a wide range of
infected sheep tissues by immunoﬂuorescence-labelling of non-structural or structural proteins using
confocal microscopy to distinguish between virus presence and replication. Replication was
demonstrated in vascular endothelial cells and agranular leucocytes, thus in blood and lymphatic
vessels and lymphoid tissue (lymph nodes, spleen, thymus, etc.), respectively. Skin and tonsils were
shown to support relatively high levels of BTV replication, although they have not previously been
proposed as important replication sites during BTV infection.
Few of the tissues that support BTV presence or persistence could potentially play a role for virus
transmission through vectors, apart from blood. For example, the BTV replication in the skin or dermal
tissue is thought to be of some signiﬁcance for the transmission of BTV. A mechanism that supports
the role of skin in favouring BTV transmission was also observed in the study by Takamatsu et al.
(2003). Skin ﬁbroblasts interact with BTV-infected T-cells, inducing lytic reaction and increased virus
release. Since Culicoides midges induces skin inﬂammation and thus the recruitment of activated
T-cells in the biting site, the interaction of persistently infected T-cells with skin ﬁbroblasts would result
in increased virus production at the biting site, favouring transmission to the insect vector. This
hypothesis still needs to be conﬁrmed by further studies.
Limited evidence is available for other infected tissues implied in vector-free horizontal transmission.
van der Sluijs et al. (2016) recently review this aspect. BTV infection of cattle through direct contact
was observed, both due to ingestion of BTV contaminated placentas (Menzies et al., 2008), or, in an
experimental setting, by colostrum spiked with BTV-8 infected blood (Backx et al., 2009). Direct
contact transmission of BTV-26 was observed in goats under experimental conditions and BTV-26 RNA
was detected in nasal swabs. BTV-8 and BTV-1 were observed to be transmitted horizontally between
sheep in a vector-free environment (van der Sluijs et al., 2011, 2013b), most likely orally through
contamination of feed and drinking water with saliva or nasal discharge from infected animals. The
same authors, however, considered the vector-free horizontal transmission mechanism infrequent and
requiring the close contact of animals and able to inﬂuence the morbidity rates only within farm and
not supporting between herds spread (van der Sluijs et al., 2016).
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3.2.3. Persistence of the infection in the vector population through vertical
transmission
Vertical transmission (VT) in vectors is deﬁned as the transmission of an arbovirus from adult
females to immature stages being therefore the offspring infected with the virus and leading to adults
of next generations capable of virus transmission. Transovarial transmission (TOT), that is infection of
the germinal tissue of the female vector, is recognised as the most efﬁcient mechanism of VT. This
mechanism would provide a way of interseasonal transmission for the virus and has been described for
some arboviruses transmitted by mosquitoes such as La Crosse, Dengue and West Nile viruses
(Lequime and Lambrechts, 2014). However, up to date, there are no scientiﬁc systematic evidences to
support such mechanism of transmission in the case of BTV and its biological vectors. Previous studies
about transovarial transmission of BTV in North America were conducted by White et al. (2005) ﬁnding
BTV nucleic acid in ﬁeld-collected larvae of Culicoides sonorensis and Culicoides crepuscularis.
However, these ﬁndings have not been conﬁrmed by a recent work conducted by Osborne et al.
(2015), where colony-reared adult females of the North America vector C. sonorensis were fed with
BTV serotype 17 spiked blood and posteriorly qRT-PCR analysed for virus detection. BTV was detected
very scarcely in eggs, but neither larvae nor pupae nor adults showed any presence of the virus (Ct
values > 40). In addition to the same experiment, virus particles were not detected in C. sonorensis
larvae (2,171 specimens) collected in wastewater ponds in different farms in California.
Transovarial transmission could be also found by detecting virus particles in nulliparous females.
This was evidenced for Schmallenberg virus (Orthobunyaviridae) in Poland since ﬁeld-collected
nulliparous females of the ‘Obsoletus complex’ (C. obsoletus and C. scoticus) and Culicoides punctatus
gave Ct values < 40. However, their role in transmission was not determined since the obtained Ct
values corresponded to subtransmissible infection (Larska et al., 2013). Up to date, there are no
similar works conducted for BTV; therefore, the role of BTV-infected nulliparous females could not be
determined. In addition, despite the most used technique to identify nulliparous and parous females is
based on the examination of abdomen pigmentation developed by Dyce (1969), there is a series of
limitations of this technique as demonstrated by Braverman and Mumcuoglu (2009) that found that
some old nulliparous females of C. imicola also show pigmented abdomen. This fact was later on also
observed by Harrup et al. (2013) in C. obsoletus females obtained by emergence traps.
3.3. Review of the suitability of the provisions on surveillance laid down
in Regulation (EC) No 1266/2007
Due to the recurrence of BTV in apparently BT-free areas, a critical review of the performance of the
surveillance in place in the EU as laid down by the Reg. (EC) 1266/2007 is needed. In the Reg. (EC)
1266/2007, the monitoring and surveillance programme that aims at demonstrating the absence of BTV
circulation must include a passive clinically based and an active laboratory-based surveillance. The latter
must consist of an annual programme of at least one, or a combination of, serological/virological
monitoring with sentinel animals, serological/virological surveys or targeted monitoring and surveillance
based on a risk assessment. The sample size used for the active laboratory-based surveillance must be
calculated to detect an infection prevalence (prevalence of the virus infection) of 5% with 95%
conﬁdence. The geographical unit of reference for the purposes of BT monitoring and surveillance is
deﬁned by a grid of around 45 9 45 km or by subnational administrative units. For the purpose of
regaining the free status, the results of the surveillance programme must demonstrate the absence of
BTV circulation during a period of at least 2 years, including two seasons of vector activity.
In order to assess the suitability of the provisions for surveillance as in the Reg. (EC) 1266/2007,
the possible lowest and persistent levels of BTV circulation in livestock were explored both by using the
model as presented in Section 3.1.1, and by cross-checking values of infection prevalence from the
literature.
3.3.1. Review of EFSA opinion on BTV surveillance and monitoring
In a scientiﬁc opinion delivered in 2011 (EFSA AHAW Panel, 2011a), the Panel on Animal Health
and Welfare of EFSA was asked to provide a scientiﬁc advice on the expected prevalence (design
prevalence) under different circumstances and on the size of the relevant geographical area for the
purpose of monitoring and surveillance programmes for bluetongue.
Five epidemiological phases of a BTV infection in a population were distinguished, each with a
speciﬁc goal for monitoring and surveillance:
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 32 EFSA Journal 2017;15(3):4698
• Phase 1 is a BTV-free population without a history of infection (i.e. fully susceptible). The
objective of the surveillance in this phase is the early detection of outbreaks.
• Phase 2: upon introduction of BTV, virus transmission will result in a rise in the prevalence of
BTV positive animals. The objective of the surveillance in this phase is establishing the extent
of the infected area identifying the potentially useful interventions.
• Phase 3: a rise in the prevalence of seropositive animals until a plateau. The objective of the
surveillance in this phase is the same as in phase 2 and in addition to monitor the impact of
the interventions on the prevalence of infected animals.
• Phase 4: the prevalence drops again to an endemic equilibrium or to zero. The objective of the
surveillance in this phase is the same as in phase 3.
• Phase 5: if the prevalence has dropped to zero, the area is again free from BTV infection, but
at this point there is a history of infection. The objective of the surveillance in this phase is
demonstrating freedom from the disease.
To obtain estimates of the expected prevalence, a systematic literature review (SLR) and a review
of monitoring and surveillance data from the EU Member States (MSs) were performed in order to
obtain the prevalence observed in the MSs. The infection and serological prevalence values (virus and
antibody prevalence) at herd and animal level obtained from the SLR and from the MSs are reported in
Tables 3 and 4 (EFSA AHAW Panel, 2011a).
On average, the median of the overall observed seroprevalence at animal level in epidemic phase 2
was 2% (Table 3) and 1.6% (Table 4) as deriving from SLR and MSs data, respectively. In phase 3,
the median of the observed prevalence was 30% (38% in the SLR and 24% in MSs data; Table 3 and
Table 4). The observed seroprevalence of BTV-8 infected ruminants in North-western Europe was
markedly higher than that of other serotypes in Southern Europe. In phase 4, the median of the
observed prevalence was 1.4% and 1.6% in vaccinated and unvaccinated populations, respectively
(Table 4).
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3.3.2. Modelled BTV serological and infection prevalence
The model presented in Section 3.1.1 was used to estimate the levels of infection and the
serological prevalence of BTV in a pooled (perfectly mixed) population of cattle and small ruminants
after a certain number of years from the infection introduction and without the application of any
control measure (Figure 9).
In relation to the levels of serological prevalence, the results of the model indicate a value of 10.4%
as the lowest possible level (2.5th percentiles as worst-case scenario) of BTV serological prevalence in
the long term. Conversely, when the levels of infection prevalence are considered, a value of 0.4% is
the lowest level of infection that can be observed each year. These two levels can be considered the
design prevalence values for surveillance programmes based on serology or RT-PCR, respectively.
When the results of the model are compared with the values obtained from the SLR and the review
of monitoring and surveillance data from EU MSs (Phases 4a and 4b of Tables 3 and 4), the values of
serological prevalence estimated by the model are in agreement with those reported by the SLR
(median: 38%), but higher than those reported by the EU MSs (median: 1.4–1.6%). On the other
hand, the infection prevalence estimated by the model is quite in line with the values observed in the
EU MSs (median: 0.65%, Phase 4b of Table 4).
It is important to clarify that the scenario considered by the model is related to the persistence of
BTV infection during years after its introduction in a previously free area and without the application of
any control measures. The estimated seroprevalence, therefore, is the effect of the BTV infection only.
In case of low-level BTV circulation following the vaccination of susceptible host populations, similar
values of infection prevalence as estimated by the model can be considered under the endemic scenario
(i.e. 0.4%), but completely different values should be taken into account for the serological prevalence.
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The bold line is the median, the dot lines are the 97.5th and the 2.5th percentiles. The latter can be
considered as the lowest possible level of both infection and serological prevalence on the long term.
Figure 9: Serological and infection prevalence in cattle and small ruminants after a certain number of
years from the infection and without the application of any control measure
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In fact, in the case of a vaccinated population, after the cessation of the vaccination campaign the
great majority of the animals are supposed to be already serologically positive. Under the hypothesis of
a low-level circulation, only new-born replacing animals are exposed to the infection with an infection
rate similar to the one estimated by the model (i.e. 0.4%). Therefore, a seroprevalence close to the
infection rate is expected during the ﬁrst year after the cessation of vaccination in non-vaccinated
animals born after the end of the vaccination campaign. After 2 years from the end of the vaccination
campaign, a seroprevalence close to the double of the infection rate can be roughly expected in animals
born after the cessation of vaccination. And so on for the following years, till reaching the
seroprevalence values close to those predicted by the model when no more vaccinated animals will
remain in the population. These considerations imply that, whereas a 0.4% threshold can be considered
for the infection rate (e.g. detected by RT-PCR), the design prevalence for the serological surveillance in
non-vaccinated animals varies with the time since the end of the vaccination campaign. The closer to
the end of the vaccination activities, the lower is the design prevalence to be considered.
3.3.3. Case study: the surveillance system in France in 2013–2016
3.3.3.1. Surveillance in the period of freedom 2013–2015
Bluetongue appeared in northern Europe for the ﬁrst time in 2006. In that year, an epidemic of BT
caused by serotype 8 (BTV-8) affected ﬁve countries: Germany, Belgium, France, Luxembourg and the
Netherlands. Alongside the health measures implemented, campaigns of mandatory immunisation, using
inactivated virus vaccines against serotypes 1 and 8, were implemented on the French mainland in spring
2008, until autumn 2010. In France, the last outbreak of BTwas identiﬁed in June 2010, in the departement
of Alpes-Maritimes (serotype 1). France was recognised BTV-free in December 2012 (Sailleau et al., 2015).
Following the recognition of the free status at the end of 2012, from the year 2013, the French
authorities applied a surveillance system in compliance with the provisions of the Reg. (EC) 1266/2007,
which for the purpose of detecting any possible incursions of BTV, requires the establishment of a
monitoring and surveillance programme, based on passive clinical surveillance and active laboratory-
based surveillance. The latter must be designed in such a way that the samples are taken from
susceptible animals (that is animals which have not been vaccinated and which have been exposed to
the competent vector), which are representative of the structure of the susceptible species population
in the epidemiologically relevant geographical area and the sample size must be calculated to detect
the appropriate design prevalence based on the known risk of the target population with 95%
conﬁdence in the susceptible species population of that epidemiologically relevant geographical area.
In the absence of scientiﬁc information on the expected prevalence for the target population, the
sample size must be calculated to detect a prevalence of 20%.
Therefore, the French surveillance system in place from 2013 to 2015 was based on the annual
random selection and serological testing of 15 animals (5 animals selected in 3 different farms) for
each departement. Target animals were bovines less than 2 years old, not vaccinated against BTV and
exposed to Culicoides vectors (ANSES, 2015).
In order to calculate the effective sample size when considering other type of sampling schemes
than the simple random sampling has been extensively studied. Several authors have studied how to
adjust the sample size calculation according to the type of design used (Kish, 1965, 1990, 1992;
Spencer, 2000; Valliant et al., 2013, 2015). For the calculation of the effective sample size (neff), we
have used the proposed approached by Gabler et al. (1999) in which the actual sample size is divided
by the design effect (deff). The deff is considered to be the combination of two separate design effects,
one due to unequal selection probabilities, deffp, and one due to clustering of samples, deffc. Gabler
et al. (1999) proposed to use these two quantities in a multiplicative way to deﬁne the overall design
effect (deff). The deﬁnition of each of the design effects can be found in Gabler et al. (1999). In order
to calculate the deffp, the total number of farms and animals in the regions were extracted from
EUROSTAT, to calculate the selection probability of a farm and an animal within a farm for each region
(department) considering the sampling scheme followed in France. Once the totals were known, using
the actual number of farms and animals within a farm sampled per region the deffp was calculated.
Function deffK from Package PracTools in R was used to calculate deffp (Valliant et al., 2015). In order
to calculate the design effect due to clustering, the within-herd correlation reported in (Meroc et al.,
2008)9 was used (0.41, CI: 0.36–0.47), since no available published intraclass correlation values is
Scientiﬁc opinion on bluetongue
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available for France up to date. The cluster size used was the maximum number of animals sampled in
a farm within a region, following precautionary principles. Considering the actual number of samples
taken in each department and how samples were collected (design used), the effective sample sizes
were calculated and the design prevalence that would be able to detect such sampling schemes was
computed (Figure 10).
Considering a 95% conﬁdence level, the detectable serological prevalence by the French
surveillance system in place from 2013 to 2015 varied between 41–47% and 3.5–4.1% at departement
and country level, respectively. If the intraherd correlation coefﬁcient would be lower e.g. three times
smaller than the value as previously reported in Belgium, the detectable design prevalence for the best
case scenario at NUTS3 and at country level would vary between 20–22% and 1.57–1.72%,
respectively.
3.3.3.2. Surveillance in the period 2015–2016
At the end of August 2015, a ram located in central France (departement of Allier) showed clinical
signs suggestive of BTV infection, but none of the other animals located in the herd showed any signs
of bluetongue disease. Laboratory analyses identiﬁed the virus as BTV serotype 8 and the intraherd
virological and serological prevalences were 2.4% and 8.6% in sheep and 18.3% and 42.9% in cattle,
respectively. Phylogenetic studies showed that the sequences of this strain were closely related to
another BTV-8 strain that has circulated in France in 2006–2008 (Sailleau et al., 2015).
The re-occurrence of BTV-8 in France in 2015 posed new questions about the possible source of
this BTV re-emergence. The French agency ANSES, conducted a thorough risk assessment about the
origin of the re-occurrence of BTV-8 in continental France and concluded that the likely source was a
continual low level of circulation since the previous epizootic in 2007–2008 (ANSES, 2015). According
to ANSES experts, apparently the surveillance system was not sensitive enough to detect BTV
circulation at low level.
After the re-occurrence in 2015 of the BTV-8, a national cross-sectional survey was conducted in
October 2015 to assess the epidemiological situation with more precision than the surveillance
previously implemented (Bournez et al., 2016). Sixty herds per administrative Region (NUTS 3) were
selected and 30 animals per herd were tested by PCR in order to detect an animal prevalence at the
region level of 5% (with 95% conﬁdence), based on a 5% intra herd prevalence. Thus, 1,338 herds
and 39,513 animals were sampled. The map in Figure 11 shows the results of this surveillance.
Figure 10: Detectable prevalence at departement (left) and country (right) levels considering the
sampling procedure used in France from 2013 to 2015
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After the winter 2015–2016, a new surveillance protocol was introduced in France in the summer
2016. In the departements without BTV outbreaks, the system aims at demonstrating the absence of
seroconversion on sentinel animals at risk, thus ensuring the absence of virus circulation in the
departement of the free zone and in those of the restricted zone which have not been affected
(Figure 12).
Source: (Bournez et al., 2016).
Figure 11: Detection of PCR positive herds as from the cross-sectional survey carried out in France in
October 2015
Source: (French Ministry of Agriculture, 2016).
Figure 12: Zoning map of BT serotype 8 in France up to 29 September 2016 and surveillance
objectives set for 2016
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The sample in each departement consists in 180 seronegative at risk animals randomly selected. This
number of animals can detect a minimum prevalence of 2%, with the 95% of conﬁdence. This sample
size is a compromise between the 5% design prevalence required by the Regulation (EC) 1266/2007 and
the departement level selected that is larger than the 45 km x 45 km grid considered in the legislation,
which is indeed rather closer to the size of a district (arrondissement). This protocol also considers the
complementarity of different types of surveillance (passive + serological surveillance + strengthened
programme on output movements from the restricted zones). In practice, this corresponds to select at
least nine herds and follow about 20 seronegative cattle per herd. The sampling frequency is monthly. To
ensure a good spatial distribution, about three herds per district should be selected with a minimum of
nine herds and target of 180 seronegative animals minimum by departement. The objective of nine
herds is proposed by considering what seems feasible in practice for the departement.
The recruitment criteria are the following:
• unvaccinated livestock against BT (otherwise the risk of exposure is reduced; some vaccinated
animals may of course be present without exceeding a threshold of 10% of animals);
• no preference on the type of production;
• focus on cattle rather than other species;
• farms that are not more than 1,000 m above sea level (Culicoides are less present in altitude)
• farms with pasture access;
• priority of herds which are surrounded by farms of susceptible species;
• focus on big size farms (the number of Culicoides is more important and it seems to promote
circulation).
Guided by these criteria, a random selection was made where possible. The serological test used is
the c-ELISA, with a sensitivity of 99.7% and speciﬁcity of 98.2%.
According to the above-mentioned surveillance scheme, data about sampling of herds in each
departement and the number of animals sampled in each herd were obtained for 33 French
departements, where there is sentinel surveillance. These data were used to explore the achievable
design prevalence with 95% conﬁdence interval according to Valliant et al. (2013). A curve was drawn for
the worst- and best-case scenario at NUTS 3 level (corresponding to the French departement)
considering the amount of farms and animal sampled within a farm in each departement (Figures 13–14)
and for the scenario at national level (Figure 15).
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Figure 13: Worst-case scenario for detectable prevalence given the sample survey at NUTS3 level
(the French departement)
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This high values of detectable prevalence, thus leading to relatively low performing surveillance
within department, are linked to the small sample size in term of farms inside each department and
the relatively high correlation of samples within farm considered in the present estimation – the value
as observed in Belgium (0.47%) is applied here, since no available published intraclass correlation
values are available for France up to date, although these values could be different. The lower this
value, more independent would be the samples within farm, thus even a low number of farms would
be representative of the department. For example, if the correlation would be three times smaller than
the reported ones, the detectable design prevalence for the best and worst case scenario at NUTS3
level would vary between 3.8–4.8% and 8.8–10.8%, respectively.
The same kind of assessment was done for the scenario at national level, thus considering all farms
and animal sampled within a farm for all sampled department (Figure 15).
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Figure 14: Best-case scenario for detectable prevalence given the sample survey at NUTS3 level (the
French department)
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Figure 15: Scenario for detectable prevalence given the sample survey at national level for France
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3.4. Maternal immunity and vaccines
The ﬁrst three ToRs related to ToR 2 about (i) protection of maternal immunity, (ii) its interference
with vaccines and (iii) the time lag after vaccination to consider animals as protected were addressed
by a systematic literature review, while the fourth ToR of the ToR 2 is addressed in Section 3.4.1. The
literature search identiﬁed a total of 287 articles. Title and abstract screening led to the exclusion of
184 articles, 103 articles were considered eligible for full-text screening, 17 did not report data suitable
for the data extraction phase and 52 were ﬁnally considered eligible for inclusion in the systematic
review. In Figure 16 the workﬂow of search and selection of the studies is displayed.
Q1: ‘What is threshold of BTV-speciﬁc maternal antibody titre considered to provide
protection to an offspring born from vaccinated mother to one/several BTV serotypes?’
For the ﬁrst review question about the threshold of BTV-speciﬁc maternal antibody titre considered
to provide protection to offspring born from vaccinated mothers to one/several BTV serotypes, the
systematic review led to the identiﬁcation of four studies (Savini et al., 2004a; Oura et al., 2010; Vitour
et al., 2011; Leemans et al., 2013).
In the study by Vitour et al. (2011), 22 dams/calves pairs was considered, and cows were
vaccinated 5 months before giving birth. The 22 calves were followed until 118 days, when 13 of them
were vaccinated with an inactivated BTV-8 vaccine. Kaplan–Meier survival curves showed that the
apparent interval after birth required for loss of passively acquired antibodies depended upon the
serological test used, and was found to be earlier by virus-neutralisation test (VNT). The median time
after birth when calves become seronegative was 112 days by c-ELISA (range 70–173) and 84 days by
VNT (range 70–113 days). The time of pregnancy when mothers were vaccinated was not indicated.
Figure 16: Workﬂow of search and selection of the studies in the SLR
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The critical appraisal of this study about study design, methodology used, statistics and reporting
quality was assessed as high, but the appropriateness of the controls was considered not satisfactory.
However, in the ﬁeld study by Savini et al. (2004a,b),1,005 cows of various breeds and ages were
randomly selected from 10 herds in Sardinia island. The cows were vaccinated against BTV-2 with a
live-attenuated vaccine and blood samples were taken monthly for 3 months after vaccination and
tested for the presence of antibodies by c-ELISA and VNT. To assess the duration of colostral
antibodies in calves born from these vaccinated dams, the sera of 47 calves divided in three age
groups were screened using c-ELISA and VNT. Antibodies were detected in 68.2% calves at 1–25 days
of age and in 46.1% of the calves at 26–39 days old. The older calves (40–60 days) were all
serologically negative. Due to the small number of animals tested, the probability curves were very
wide and, for the oldest group of animals, the lower and upper 95% conﬁdence levels for the
observed serological prevalence were 0.2% and 21%. No details were provided about titres or
whether animals were positive to the c-ELISA alone or VNT too. The time of pregnancy when mothers
were vaccinated was not indicated. It must be also taken into account that this was a ﬁeld study, and
therefore, the effects of the not correct vaccine conservation and administration, and variability in the
colostrum uptake by calves could not be excluded. The critical appraisal of this study about study
design, methodology used and statistics was assessed as high, but the reporting quality and the
appropriateness of the controls were considered not sufﬁcient.
In the study by Oura et al. (2010), the extent and length of colostral antibody protection as well as
the degree of colostral antibody induced interference of the immune response to BTV-8 in sheep were
investigated. Lower titres of neutralising antibodies were detected in colostrum-fed lambs born from
sheep vaccinated once than from those vaccinated twice (single vaccine in the ﬁrst year and a booster
vaccine in the second year of BTV-8 inactivated vaccine). Of the 16–36-day-old lambs born from these
single vaccinated ewes, none had c-ELISA antibodies detectable, 31% of the lambs had antibodies
detected by double-antigen sandwich ELISA (s-ELISA) and only 6% of the lambs had detectable
neutralising antibodies.
On the contrary, the 22 lambs born from the double vaccinated ewes were all positive to s-ELISA
and VNT, and 19 out of 22 lambs were also positive to c-ELISA when they were 6–10 weeks old. When
the lambs were 13–14 weeks old, all were still positive to s-ELISA, 9 out of 22 were positive to c-ELISA,
and 14/22 tested positive by VNT, although at low titre.
Considering the protection from infection, the lambs born from sheep vaccinated twice, with the
second booster dose given approximately 1 month prior to lambing, were challenged with BTV-8.
Neutralising antibodies were found until 22 dpi. No lamb showed any clinical sign when challenged by
BTV-8 subcutaneous inoculation at 13–14 weeks old. Fourteen of these lambs had circulating
neutralising antibodies at the time of challenge and were fully protected both clinically and virologically
from BTV-8 challenge. Three of the seronegative lambs were also protected both clinically and
virologically, and the remaining ﬁve lambs with no detectable neutralising antibodies at challenge
became BTV RNA positive by RT-PCR, the virus was isolated from the blood of these animals and a
signiﬁcant increase of neutralising antibody titres was observed after challenge. The time of pregnancy
when mothers were vaccinated was not indicated. The critical appraisal of this study about study
design, controls, methodology used, statistics and reporting quality was assessed as high. The results
from this study show that neutralising antibodies in lambs protects against homologous challenge (no
viral RNA detected in blood). This is consistent with previous studies in which vaccinated animals with
neutralising antibodies are generally protected against infection, although also some of the vaccinated
animals not showing detectable neutralising antibodies may be protected.
Finally, in the study by Leemans et al. (2013), 35 lambs born from naturally infected and yearly
vaccinated ewes were followed for 10 months, vaccinated at different times, and then challenged. At
36–48 h after birth, all lambs were positive for BTV-8 (median titre of neutralising antibody: 2.16) with
values ranging from 1.68 to 3.12 log10 PD50.10 Neutralising antibody titres gradually decreased until
7 months old. A Kaplan–Meier survival analysis pooling data from different groups estimated that the
median time after birth required for complete loss of passively acquired neutralising antibody was
7 months (range: 5–9 months). The critical appraisal of this study about study design, controls,
methodology used, statistics and reporting quality was assessed as high.
The Table 5 shows the main results of the selected studies in relation to the duration of maternal
antibodies in calves and lambs.
Scientiﬁc opinion on bluetongue
10 The titres are expressed as the log10 of the serum dilution causing a 50% reduction in cytopathic effect (log10 PD50).
www.efsa.europa.eu/efsajournal 43 EFSA Journal 2017;15(3):4698
Q2: ‘What is the minimum age of calves, lambs and kids after which residual colostral
antibodies against BTV do not interfere any longer with vaccine immunisation of these
animals?’
For the second question about the age until when residual colostral antibodies may interfere with
vaccine immunisation, only two papers were considered eligible (Vitour et al., 2011; Leemans et al.,
2013). The critical appraisal of these studies related to this review question about study design,
controls, methodology used, statistics and reporting quality was assessed as high.
Currently, the recommended age for vaccination of calves with inactivated BTV-8 vaccines varies
from 1 to 3 months, depending on the vaccine manufacturer. However, these recommendations have
not been based on extensive study, especially considering the impact of colostral antibodies on the
vaccinal response. In the study by Vitour et al. (2011), a group of 22 pregnant cows were vaccinated
against BTV-8 with an inactivated vaccine 5 months before giving birth. The 22 calves were followed
until around 118 days when 13 of those were vaccinated with the same inactivated vaccine. In most
calves, vaccination elicited a weak immune response, with c-ELISA seroconversion in only 3 out of 13
calves. The amplitude of the humoral response to vaccination was inversely proportional to the
maternal antibody level prior to vaccination.
Leemans et al. (2013) assessed the interference of colostral antibodies in the immunological
response to a BTV-8 inactivated vaccine in lambs born from immune ewes. Lambs born from naturally
infected and yearly vaccinated mothers were followed for 10 months, vaccinated at different times,
and then challenged. They were allocated to ﬁve groups (7 lambs each group), four vaccinated at
different ages (3, 5, 7 and 9 months) and one left unvaccinated. Among lambs vaccinated at
3 months, three (3/7) did not respond to vaccination and were not protected from challenge infection.
The others animals (4/7) were fully protected from clinical disease and viraemia in accordance with
their seropositive status at time of challenge. BTV-8 vaccination performed at 5 months of age or later
led to seroconversion and full clinical and virological protection in 100% of vaccinated lambs. It can be
concluded that maternally derived antibodies interfere with the immune response to BTV-8 vaccination
in lambs for at least 3 months after birth.
Table 5: Range of duration of colostral Abs as reported in the selected studies
Species
Mother immunity
Sample
size
Study
setting
Test
%
positive
Duration
(days)
mean
Duration
(days)
min
Duration
(days)
max
ReferencesVaccination
dose/type
Time of
vaccination
Calves One dose/
inactivated
5 months
prepartum
22 Experimental c-ELISA 100 112 70 173 Vitour et al.
(2011)
One dose/
inactivated
22 Experimental VNT 100 84 70 113
Lamb One dose/
inactivated
20–40 days
prepartum
45 Experimental c-ELISA 0 – 16 36 Oura et al.
(2010)VNT 6 – 16 36
s-ELISA 31 – 16 36
Double dose/
inactivated
25–34 days
prepartum
22 Experimental c-ELISA 86 – 24 40
VNT 100 – 24 40
s-ELISA 100 – 24 40
c-ELISA 40 – 52 56
VNT 63 – 52 56
s-ELISA 100 – 52 56
Lamb Triple dose 3 months
prepartum
35 Experimental VNT 100 210
(median)
150 270 Leemans
et al.
(2013)
Calves One dose na 47 Field study VNT 68.2 – 1 25 Savini et al.
(2004a)46.1 – 26 39
0 40 60
VNT: virus-neutralisation test; c-ELISA: complement-enzyme linked immunosorbent assay.
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Q3: ‘What is the minimum time after completion of vaccination against BTV and the
threshold BTV-speciﬁc antibody titre considered to provide a protective immune response
after vaccination?’
Concerning the third question on ‘what is the minimum time after completion of vaccination against
BTV and the threshold BTV-speciﬁc antibody titre considered to provide a protective immune response
after vaccination’, 51 papers were considered eligible to answer this question (see data extraction table
in Appendix C). When the results of these studies are compared, high variability and uncertainty seem
affecting the results. Various different vaccines, study designs, methods for vaccination, challenge and
testing were used. In particular, the time/level of protection seems difﬁcult to assess partly due to the
variety of the laboratory methods used (e.g. different ELISAs, VNT titre, RT-PCR, etc.). Consequently,
the studies are very difﬁcult to compare. Nevertheless, some considerations could be formulated. In
relation to the minimum time after vaccination (‘minimum protection day’ (MPD)) Figure 17 reports the
earliest point in time (day) after vaccination when a positive immune response was observed. Some
papers included more than one study, e.g. papers that included experimental data from more than one
animal species or more than one vaccine type.
When the MPD following the vaccination of commercial inactivated vaccines and detected by VNT
only are considered, the following results can observed:
• Cattle: In the 40.4% of animals, the MPD was within 14 days, in 61.1% within 21 days and in
96.7% within 28 days.
• Sheep and goats: In the 52.9% of animals, the MPD was within 14 days, in 78.7% within
21 days and in 84.7% within 28 days.
When the results to c-ELISA are considered in animals vaccinated with commercial inactivated
vaccines, the MPD was within 21 days post-vaccination in 94.0% and 98.0% of cattle and small
ruminants, respectively.
Sheep. The results obtained from 35 studies were variable, and indicated a lower value of MPD when
ELISA is used (in the majority of cases between 6 and 10 days after vaccination) in comparison with
VNT (mainly between 14 and 21 days).
Cattle. The results from a total of 15 studies indicated that the MPD varied from 3 to 42 days post-
vaccination depending on the method used to assess the antibody response, bearing in mind that the
results are also inﬂuenced by the vaccine used and other factors such as the study design and sample
size. One study reported a MPD equal to 3 days when using a commercial c-ELISA. Four studies
indicated a MPD of 14 days post-vaccination when VNT is used.
Goats. The results from one study suggested that the MPD were 10 and 21 days after vaccination
when ELISA test and VNT are used, respectively.
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3.4.1. Guarantee of safe movement of animals under a speciﬁc conditions
The ToR 2.4 pose a very speciﬁc question in relation to the risk of introducing the infection (i.e.
introducing viraemic animals) into BT-free areas through the introduction of not vaccinated animals from
BT-infected areas, when a series of risk mitigation measures are applied. In particular, it is asked to:
‘Assess whether vector protection for 14 days of ruminants below the age of 70 days, combined
with a negative PCR test at the end of the 14 days or more, qualify them for a safe movement from a
BT restricted to a BT-free area’.
In particular, the following risk reduction measures are considered:
1) The animals are up to 70 days old and born from vaccinated mothers.
2) The animals are kept for 14 days under vector protection conditions.
3) They are tested by RT-PCR at the end of the 14 days period, before being moved to the
ﬁnal destination.
Any quantitative estimation of the ﬁnal risk of introducing a viraemic animal following the above
described procedure would be affected by high levels of uncertainties in the components of this
scenario, thus making the risk estimation relatively useless for the purpose of the risk management.
In fact, the following aspects must be taken into consideration:
• The initial risk of having a viraemic animal in the lot of animals to be moved depends from the
incidence of disease transmission in the place of animal’s origin. In Section 3.1.1, the
simulation model identiﬁed level of infections between 0.6% and 1.5% in sheep and cattle,
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Each point represents the minimum value of days for each study (considering ‘one study’ that
performed in a single animal species, with a speciﬁc diagnostic test and one type of vaccine: CIN:
Commercial Inactivated Vaccine; CLA: Commercial live-attenuated Vaccine; EX: Experimental vaccine).
Figure 17: Plot of values of minimum days after vaccination when a seroconversion was observed by
c-ELISA or VNT in cattle, sheep and goats
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respectively. These values, however, have to be applied for the 70 days period of animal life
and considering the speciﬁc epidemiological conditions of that place and period of the year.
The resulting probability of having a viraemic animal, therefore, can vary signiﬁcantly in
relation to the above mentioned factors.
• The probability that the animal has maternal antibodies and is protected at 70 days of age is
inﬂuenced by the amount of colostrum uptake, the type of vaccine used, the number of doses
administered and the stage of pregnancy at which the mother has been vaccinated. In Section 3.4,
some studies on the level of passive immunity induced by vaccination against BTV in cattle and
sheep are reported. All 22 lambs born from 19 ewes vaccinated with two doses of an inactivated
vaccine against BTV-8 had neutralising antibodies at 6–10 weeks of age, but ﬁve of them (22.7%),
when challenged at 12–13 weeks of age, developed a detectable viraemia (Oura et al., 2010).
Similarly, 22 calves born from cows vaccinated with one dose of an inactivated vaccine against
BTV-8, became seronegative at 84 days by VNT (range 70–113 days) (Vitour et al., 2011).
• The level of vector protection can vary signiﬁcantly according to the methods applied. An almost
perfect (i.e. close to 100%) vector protection can theoretically be achieved when animals are
kept in well implemented vector-proof establishments (see Section 3.6), but this approach is
commonly recognised applicable for small numbers of animals, under speciﬁc market conditions
which make economically advantageous the application of such an expensive solution. In case
of more common use of pour-on insecticides, the efﬁcacy of these substances in term of risk
reduction can vary greatly in relation to the application protocols used, the frequency of
administration and the environmental conditions (e.g. animals kept outdoor, exposed to
rainfalls, etc.). As reported in Section 3.6.2, some in-ﬁeld studies assessed the efﬁcacy of pour-
on insecticides, with dissimilar results. Good results were obtained in Spain, where Mullens
et al. (2010) showed good protection of sheep against feeding activity of Culicoides spp. by
applying 7.5% deltamethrin (Butox 7.5) directly on exposed skin (face, ears and belly) and a
reduction up to 50% of the number of midges associated to animals was obtained in sheep by
(Grifﬁoen et al., 2011) using a 3.6% permethrin pour-on solution (1 mL/10 kg bodyweight;
Virbac Animal Health) in the Netherlands. In Germany, Weiher et al. (2014) assessed a dosage
of 10 mL of Butox® pour-on (Intervet, France) on Merino sheep and obtained an efﬁcacy that
ranged from 0% (2 weeks post-treatment) to 71.0% (3 weeks post-treatment).
• The diagnostic sensitivity of RT-PCR is close to but not 100%, and therefore, a certain number of
false negative animals must be expected. In this context, the objective of RT-PCR testing is to
detect infected and possibly viraemic animals, which can transmit the infection. Therefore, false
negative results are of particular concern, whereas false positive cases are of no interest.
Vandenbussche et al. (2008) estimated the speciﬁcity and sensitivity of c-ELISA and RT-PCR under
ﬁeld conditions during the epidemic in Belgium in 2006. The estimated sensitivity values for RT-PCR
were 99.55% (95% CI: 99.03–99.98%) in sheep and 99.50 (95% CI: 99.02–99.97) in cattle.
In addition to the above reported considerations, a critical aspect inﬂuencing the ﬁnal risk of
introducing viraemic animals into a BT-free area is related to the number of animals introduced. In
fact, even considering to test all animals by RT-PCR (probability of having false negative
results = 1  sensitivity = 0.45%), depending on the levels of infection in the population of origin,
when more than 10,000 animals are introduced, one or more viraemic heads are expected among the
introduced animals (Table 6). This simple consideration is also conﬁrmed by past experiences, when,
for example, the BTV-8 infection was introduced in Italy in 2007 with animals entered from France,
despite the application of animal testing by RT-PCR (Giovannini et al., 2008).
Table 6: Number of expected infected animals in 10,000–25,000–50,000–100,000 introduced
animals, according to different levels of infection in the population of origin and
considering to test all animals by RT-PCR (sensitivity = 99.55%)
Level of infection in the population (%)
Number of introduced animals
10,000 25,000 50,000 100,000
2.0 0.9 2.25 4.5 9
1.0 0.45 1.125 2.25 4.5
0.5 0.225 0.5625 1.125 2.25
0.1 0.045 0.1125 0.225 0.45
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3.5. Review of vector ecology
In this section, updated knowledge of Culicoides ecology is provided, including distribution, host
preference, vector competence and seasonality. A speciﬁc section is dedicated to reviewing
overwintering mechanisms and an assessment of the criteria for the determination of the SVFP. Further
information are also provided in the story map on bluetongue developed in the framework of the EFSA
project on development of infographics on vector-borne diseases (EFSA-Q-2016-00433).11
3.5.1. Geographical distribution in Europe
3.5.1.1. Culicoides (Avaritia) imicola Kieffer, 1913
The last update of the distribution of the Afro-tropical species C. imicola shows that is present in at
least seven EU countries (Portugal, Spain, France, Italy, Greece, Malta, Cyprus).12 The northernmost
detection was up to the 43.6°N parallel, considering that records, such as the one in the southern
Switzerland (Cagienard et al., 2006), remains anecdotic since there have been no further captures of
this species at so northern latitudes. C. imicola has been considered often as an expanding species,
particularly related to climate change (Purse et al., 2005; Calvo et al., 2009). However, new records
attributed to ‘recent invasion’ or ‘recent colonization’ should be interpreted with caution since based on
phylogeographical and population genetic studies (Jacquet et al., 2015). C. imicola has been present in
the Mediterranean basin since late Pleistocene or early Holocene (10,000 years ago), and has
colonised the southern Europe at least one hundred years ago with recurrent migrations since then.
Changes in the northern distribution limits are relatively limited. The expansion range of C. imicola
over the 2004–2010 period is estimated in the Var departement at 14.5 km/year, and limited by
topography and vegetation cover (Venail et al., 2012). In Italy, 8 years of entomological surveillance
showed no evidence of C. imicola geographical range expansion (Conte et al., 2009). Genetic analysis
of the populations are important to determine the origin of recent records, for example, C. imicola was
detected in 2008 in Pyrenees-Orientales in France and after a 5 years surveillance and analysis of
samples, it has been recently demonstrated to have been originated in Corsica and not from the most
neighbouring population (< 80 km) of the northeast Spain (Jacquet et al., 2016).
3.5.1.2. Other species of the Avaritia subgenus
The main abundant and widespread species of the Avaritia subgenus in non-Mediterranean areas
are C. obsoletus (Meigen), 1818, C. scoticus Downes and Kettle, 1952, Culicoides dewulﬁ
Goetghebuer, 1936 and Culicoides chiopterus, (Meigen), 1830. This Obsoletus assemblage is therefore
widely distributed in the entire EU territory. Probably, there are no countries in the EU that could
report absence of any of the species included in this assemblage.
The species C. obsoletus and C. scoticus have a large Palaearctic distribution and females are
highly morphologically close. Microscope mounting is needed and therefore differentiation based on
morphology is difﬁcult, requires crossing multiple criteria to be reliable, and then is time consuming
(Garros et al., 2014). Due to this, all European national entomological surveillance programs include
data on the both species grouped together.
For example, in France, in the non-Mediterranean temperate areas, C. obsoletus/C. scoticus are
largely dominant, associated with C. dewulﬁ and C. chiopterus on the Channel coast, and almost solely
with C. chiopterus in north-east. These two latter species breed on animal dung, thus their spatial
distribution is inﬂuenced by also by livestock densities and presence, although this is not sufﬁcient
condition. Elsewhere, C. obsoletus/C. scoticus are mostly found alone, except locally. Reversely in
Corsica, C. obsoletus/C. scoticus are secondary to C. imicola, and on the Mediterranean coast,
Culicoides newsteadi is dominant (Balenghien et al., 2012).
Modelling the spatial distribution of C. obsoletus/C. scoticus suggests impact of forest cover and
vegetation activity on distribution, as well as shaded breeding site requirements (Kluiters et al., 2013).
Previous ﬁeld observations are consistent with this, suggesting as breeding sites forest leaf litter,
stagnant water and marshy areas (EFSA, 2008).
The main abundant and widespread species of the Culicoides subgenus in Europe are C. newsteadi
Austen, 1921, C. punctatus (Meigen), 1804, Culicoides pulicaris (Linnaeus), 1758 and Culicoides lupicaris
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Downes and Kettle, 1952. The speciﬁc status of this latter species is still controversial and needs to be
resolved (Harrup et al., 2014).
Although widely distributed in Europe, C. newsteadi is abundant in Mediterranean areas, where it
could be the dominant species. C. pulicaris is widely distributed, including northern European areas.
C. lupicaris seems to be less abundant, but difﬁculty to distinguish C. pulicaris and C. lupicaris and the
doubts of the speciﬁc status of C. lupicaris lead many authors and national surveillance systems to
group this species together. C. punctatus seems to be widespread in non-Mediterranean areas and
could reach important abundances either in Denmark or in Portugal.
3.5.2. Breeding habitats
General habitats for the European BTV vector species were described in EFSA previous opinions
(EFSA, 2007b, 2008). Works conducted in Italy have conﬁrmed the presence of C. imicola associated
to farm environment such as in mud 20 cm around a pond shoreline (Foxi and Delrio, 2010). This
species is considered to be farm associated to moist soil enriched with organic matter located nearby
farms were drippings, sewage leakages and drainage channels are common. In consequence, changes
in the environment due to farm practices (i.e. irrigation) and/or climate change, may create new
favourable breeding sites and increase the spread of this species in Europe (Guichard et al., 2014).
Dung pats as breeding habitats have been conﬁrmed for C. chiopterus and C. dewulﬁ in studies
conducted in Germany (Steinke et al., 2014; Luhken et al., 2015).
In the case of C. obsoletus, this species breeds in a wide range of habitats (EFSA, 2007b, 2008).
Recent works have described breeding in broadleaved wood-land leaf litter, broadleaved woodland
vegetation, marginal vegetation surrounding open water, muck heaps and organically enriched
substrates in the UK (Harrup et al., 2013), different types of manure (old and composted manure,
manure mixed with organic matter, and fresh manure) in Spain (Gonzalez et al., 2013), silage residues
associated to farms (maize, grass, sugar beet pulp and their combinations) (Zimmer et al., 2013), as
well as components of a chicken coop, leftover feed along the feed bunk and a compost pile of sugar
beet residues and soil of a livestock trampling area (Zimmer et al., 2014) in Belgium. Alternative
substrates could be also used as breeding sites, as for example slurry in the case of C. obsoletus, as
demonstrated by Thompson et al. (2013) in Northern Ireland. Indoor breeding sites for C. obsoletus
has been identiﬁed in Belgium in dung adhering to walls inside cowsheds (Zimmer et al., 2010) and in
France in old litter left inside dairy cow buildings (Ninio et al., 2011).
Breeding habitats of other species such as C. pulicaris has been found in soil samples from grazed
ﬁeld with manure in Denmark (Kirkeby et al., 2009).
3.5.3. Adult feeding habits/host preferences
Since the last EFSA opinion (EFSA, 2008), there have been several works updating host preferences.
In France in 2009, host preferences were checked by collecting Culicoides on different hosts (horse,
cattle, sheep, goat and poultry) using sticky covers (Viennet et al., 2012a). Attraction was much higher
on horse compared to other species. In Germany in 2012, host preferences were checked by collecting
Culicoides by different methods (direct aspiration and drop trap) on sheep and cattle. The species
C. obsoletus/C. scoticus correspond to 79.6% of the collected individuals on cattle and to 44.8% on
sheep, whereas C. chiopterus correspond to 3.5% on cattle and to 15.1% on sheep (Ayllon et al., 2014).
In the Netherlands in 2013, host preferences were checked by collecting Culicoides by two different
methods, black-light suction trap and aspiration (Elbers and Meiswinkel, 2014). Using comparable
collection periods, 9.3 times more Culicoides were caught on the cow than on the sheep and 25.4 times
less in the black-light suction trap compared to the sheep. Mean Culicoides biting rates on the cow across
the 7-h collection period were 4.6, 3.5, 1.0, 1.0 and 0.5/min for C. dewulﬁ, C. obsoletus/C. scoticus,
C. chiopterus, C. punctatus and C. pulicaris, respectively; for the sheep, they were 0.6, 0.4 and 0.1/min
for C. obsoletus/C. scoticus, C. dewulﬁ and C. punctatus, respectively. The presence of a vector species
is a prerequisite for disease transmission thus the knowledge of the composition of the Culicoides species
communities that inhabit areas where there are wild ruminants is important, although few studies on this
aspect have been conducted. In the study by Talavera et al. (2015), samplings were conducted in Spain
in areas inhabited by different wild ruminant species. The most abundant vector species were C. imicola
and C. obsoletus/C. scoticus, which represented 15% and 11% of total numbers of specimens collected,
over 100,000, respectively. The data suggest that such species do not exhibit strong host speciﬁcity
towards either domestic or wild ruminants and that they could consequently play a prominent role as
bridge vectors for different pathogens between both types of ruminants.
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 49 EFSA Journal 2017;15(3):4698
Molecular techniques, such as analysis of cytochrome b gene (Calvo et al., 2012), and barcoding
techniques (Martinez-de la Puente et al., 2012, 2015) conducted in Spain showed that some species
feed in a opportunistic manner from different types of hosts and could not be considered purely
mammophilic or ornitophilic.
3.5.4. Hours of attack and dispersal
In the Netherlands, efﬁcacy of light traps was compared with aerial sweeping, and correlated
against light intensity (Meiswinkel and Elbers, 2016). C. chiopterus and C. obsoletus/C. scoticus
differed critically in their hours of peak activity, being largely crepuscular and nocturnal, respectively.
This difference may explain why, routinely, the C. obsoletus/C. scoticus dominates light trap collections
and C. chiopterus does not. This discrepancy between UV light trap and animal-bait collections was
already described by Carpenter et al. (2008)). However, Viennet et al. (2012a,b) showed that UV light
trap collections were linearly correlated to attack rates on animals for C. obsoletus (overestimation by
light trap), C. dewulﬁ (underestimation by light trap), C. brunnicans (no bias), but not for C. scoticus.
Moreover, using a vehicle-mounted trap during 52 collections (2 years), Sanders et al. (2011b)
conﬁrmed that Culicoides of the Obsoletus assemblage (C. obsoletus 50%, C. scoticus 15%, C. dewulﬁ
4% and C. chiopterus 4%) were mostly crepuscular – C. chiopterus having a greater range of activity
recorded across solar incidence and was less conﬁned to sunset, even if some activity could be
recorded thought the diel especially when light suddenly decreases for instance due to a cloud
passage (Viennet et al., 2012b). Thus, temperature and sunlight causes a swift on crepuscular to
diurnal activity as was recorded also for C. sonorensis in California (Mayo et al., 2014) and for
Obsoletus assemblage in France by Balenghien et al. (2008).
Moreover, Meiswinkel and Elbers (2016) suggested that at latitudes beyond 45°N, the progressive
northward lengthening of the twilight period may have an increasingly adverse impact upon the
efﬁcacy of the light trap as a vector surveillance tool. However, up to 10,000 Culicoides could be
collected in two consecutive collection nights at 68.7°N using an Onderstepoort-type light traps in
August, including about 5,000 C. punctatus, about 5,000 Grisescens group females, about 760
C. obsoletus/C. scoticus and about 100 C. chiopterus (VectorNet, unpublished data).
During blood-meal identiﬁcation studies, Garros et al. (2011) found engorged females of
C. chiopterus positive for cattle whereas only sheep were present in the collection farms. The closer
cattle were present in a surrounding 2 km buffer zone in pasture areas, suggesting dispersion of
blood-fed females over 1 or 2 km.
Dispersal studies using mark-release-recapture technique suggested possible dispersal distance of
1.75 km per 24 h in Denmark and of 1.50 km per 24 h in the UK (Kluiters et al., 2008; Kirkeby et al.,
2009). The ﬂight altitude was assessed by Sanders et al. (2011a) in the UK recording adult biting
midges at 200 m above land using a tethered balloon.
3.5.5. Vector status
3.5.5.1. Culicoides species implicated in BTV transmission
The genus Culicoides (Diptera: Ceratopogonidae) has nearly 1,350 worldwide distributed species (at
least 117 in Europe) and it is characterised by a diversity of biting midges whose haematophagous
females can transmit a variety of ﬁlarial worms, protozoans and arthropod-borne viruses to man and
wild or domestic animals (Foxi et al., 2016). Only around 30 species have been associated with BTV
transmission.
In Europe, Culicoides species that have been implicated as potential vectors of BTV generally
belong to the subgenera Avaritia and Culicoides. Potential BT vector species were identiﬁed from
studies based on virus isolation or detection by RT-qPCR in ﬁeld-collected parous females, detection of
virus dissemination in ﬁeld individuals, and arboviral infection in laboratory assays. C. (Avaritia) imicola,
C. (Avaritia) obsoletus and C. (Avaritia) scoticus are presently considered conﬁrmed BTV vectors, while
C. (Avaritia) chiopterus, C. (Avaritia) dewulﬁ, C. (Culicoides) pulicaris and C. (Culicoides) punctatus as
probable vectors (Purse et al., 2015; Foxi et al., 2016).
The implication of C. imicola as a vector of BTV in Europe is based on its distribution and
abundance on farms, in outbreak areas and historical evidence of its role in transmission elsewhere.
Few direct vector competence experiments with European C. imicola have been undertaken and results
remained limited (Biteau-Coroller, 2006), due to the difﬁculties in feeding and maintenance in the
laboratory and limited number of specimens captured on the ﬁeld. However, an extensive work have
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been conducted with this species in South Africa where its role for transmission of BTV, African horse
sickness virus (AHSV) and epizootic haemorrhagic disease virus (EHDV) has been widely demonstrated
by vector competence studies (Venter et al., 2009, 2010, 2011b; Del Rio et al., 2012).
Large-scale entomological surveillance programmes have been carried out in many countries affected
by BTV using standardised sampling methods to investigate the role of several species in the distribution
of BTV and quantiﬁcation of the seasonal activities of the vectors. To maximise the efﬁciency of the trap
and sampling of populations, protocols recommend sampling within the farms or animal shelters. By
contrast, very few studies have reported sampling performed outside the farms, in the surrounding
landscape. In pastures, decreasing numbers of Culicoides females as a function of the distance to the
farm was observed. In woodlands, higher abundance of Culicoides than expected considering the
distance of the sampling sites to the farm, was observed, although this varied according to species
(Rigot et al., 2013). Talavera et al. (2015) showed that C. imicola and C. obsoletus/C. scoticus are found
either in farms and in natural areas were wild ruminants species are the main hosts.
The Obsoletus and the Pulicaris assemblages have been clearly implicated in the outbreak of
bluetongue in north-western Europe in August 2006, since surveillance from Germany during winter
2007–2008 showed that 11 pools of biting midges were RT-PCR positive to BTV-8 including pools of
non-engorged midges (Clausen et al., 2009).
During the BT outbreak in Italy in 2012–2014, almost 3,000 pools with over 83,000 midges were
sorted and tested for BTV (Goffredo et al., 2015). They were composed by C. obsoletus/C. scoticus
(43.2%), C. imicola (23.4%), C. newsteadi (10%), Pulicaris assemblage (9.4%), C. pulicaris (6.8%),
C. punctatus (5%), C. dewulﬁ (1.9%) and Nubeculosus assemblage (0.3%). In total, 1,107 pools of no
blood-engorged parous females were positive for BTV resulting in a minimum infection rate of over
1%. All the taxa tested resulted positive to BTV, at least once. In particular, C. imicola, C. newsteadi,
C. pulicaris and C. obsoletus/C. scoticus were found positive during the three epidemics 2012–2014.
Based on these ﬁndings, C. newsteadi appears as a new potential vector for BTV in southern Europe.
The relationship between temperature and the extrinsic incubation period (EIP) was estimated by a
statistical methodology and applied to both published and novel data on virus replication for three
orbiviruses (AHSV, BTV and EHDV) in their Culicoides vectors (Carpenter et al., 2011). Differences in
vector competence for different orbiviruses in the same vector species and for the same orbivirus in
different vector species were detected. Both the rate of virus replication (approximately 0.017–0.021
per degree-day) and the minimum temperature required for replication (11–13°C), however, were
generally consistent for different orbiviruses and across different Culicoides vector species. According to
this ﬁnding, the replication rate and threshold temperature were previously underestimated because the
statistical methods they used included an implicit assumption that all negative vectors were infected.
3.5.6. Vector seasonality
The seasonal annual pattern of the biological vectors of BTV determines the occurrence of the
disease in a given year. The seasonality of the vectors is inﬂuenced by climate and speciﬁc factors,
such as conditions related to breeding sites. Since immature stages of Culicoides require humid
conditions for developments, humidity and temperature appear to be the main regulating factors.
The adult Culicoides seasonal annual pattern is species-dependent and even considering the same
species the seasonality could vary depending on the climatological conditions. In general, it is considered
that cold temperature climate (i.e. those occurring in the northern Europe) correspond to short seasonal
activity, meanwhile warmer ones (i.e. those taking place in the southern Europe) allows a longer seasonal
activity of adults. In addition, fauna of Culicoides from southern and northern Europe differs in some of
the major species, such as C. imicola which is not present in northern Europe (Versteirt et al., 2017).
For practicality, we have divided two major regions in terms of seasonality, South Europe and North
Europe.
3.5.6.1. South Europe
Adult annual activity was described for southern Europe in the opinion published by EFSA (EFSA,
2008). In general, the major species C. imicola shows a maximum peak of activity in September–October.
On the contrary, other species of the Avaritia subgenus, such as C. obsoletus/C. scoticus and species of
the Pulicaris assemblage, generally show the maximum peak of activity during the spring, from April to
June, with a potential second and lower peak after summer.
In Sardinia, populations of C. imicola appeared only from April to December, meanwhile
C. obsoletus, C. newsteadi and C. pulicaris were captured all year around (Foxi and Delrio, 2010; Foxi
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et al., 2011). Pili et al. (2010) conﬁrmed that C. scoticus was most abundant from late winter to early
spring, whereas C. obsoletus was prevalent in early summer. A similar pattern was also found in
Corsica (Venail et al. 2012). All year around activity of C. obsoletus/C. scoticus was also detected in
Spain, with a peak in spring and summer (Romon et al., 2012; Gonzalez et al., 2013).
3.5.6.2. North Europe
Information from North Europe has been extensively produced since the last EFSA opinion
published in 2008 (EFSA, 2008; Foxi et al., 2011; Romon et al., 2012; Gonzalez et al., 2013).
Several examples of vector seasonal pattern are available from the Netherlands, Sweden, the UK,
Germany, Austria and France.
In the Netherlands, Takken et al. (2008) and Meiswinkel et al. (2014) found C. obsoletus/
C. scoticus, C. dewulﬁ and C. chiopterus (Obsoletus assemblage) from May (when temperatures raised
above 10°C) to July. Adult captures were null during the winter, with the exception of capturing few
females (46) that were newly hatched nulliparous (Meiswinkel et al., 2014).
In Sweden, the Obsoletus assemblage and C. punctatus were recorded from March to November,
and as in the above studies, no biting midges were collected during winter (Ander et al., 2012).
This pattern of seasonality is also similar to the one found in the UK by (Searle et al., 2014).
Species of the Obsoletus assemblage started on average in late May and lasted until the end of
October. Therefore, the overwintering period was estimated on average in 185 days for the Obsoletus
assemblage.
On the contrary, in Germany, outdoor adults of the Obsoletus assemblage were captured during
winter months and the peak of abundance was located generally in August (in less frequency
September), while low captures (< 30 individuals) were recorded from January to April. Other species,
such as C. pulicaris, was mainly captured in May (Balczun et al., 2009; Clausen et al., 2009; Kiel et al.,
2009; Vorsprach et al., 2009; Santiago-Alarcon et al., 2013).
Similar results were also obtained in Austria, where the peak for species of the Obsoletus
assemblage species peak located in July or August depending on the year (Brugger and Rubel, 2013).
Seasonality in France was summarised by Venail et al. (2012). In mainland France, the dominant
species, C. obsoletus/C. scoticus, highlighted bimodal patterns of population abundance in southern
regions of France, meanwhile unimodal patterns were frequent in the north of the country. Culicoides
activity was detected in most French continental areas from April and declined in November
(Balenghien et al., 2011). Nevertheless, annual activity and overwinter period depended on the region
and the Culicoides species in each region. Indeed, adults could be detected continuously all year
around in some locations with mild winter (Venail et al., 2012).
Modelling has also contributed to understand the seasonality of Culicoides in different parts of
Europe.
The effects of relevant ecological factors and meteorological parameters on Culicoides vector
abundances during the BTV-8 epidemic in the Netherlands in 2007 and 2008 were quantiﬁed within a
hurdle modelling framework (Scolamacchia et al., 2014). Vector abundance was found to be inﬂuenced
by edaphic factors, likely related to species-speciﬁc breeding habitat preferences that differed markedly
among some species. Smoothing techniques and generalised linear mixed models have been used to
relate environmental drivers to key phenological patterns of Culicoides spp., as in the study by (Searle
et al., 2013), for the species C. pulicaris and C. impunctatus. The importance of land-cover and
climatic variables in determining the seasonal abundance of these two vector species was
demonstrated, as well as the need for more empirical data on the effects of temperature and
precipitation on the life history traits of Palaearctic Culicoides spp. in Europe.
A dynamic model describing the effect of ecoclimatic indicators on the monthly abundances of
C. imicola in Sardinia was developed (Rigot et al., 2012). A ﬁrst-order autoregressive cofactor, a digital
elevation model and MODIS Land Surface Temperature (LST) or temperatures acquired from weather
stations explained around 77% of the variability encountered in the samplings during 6 years. On
average, dynamics simulations showed good accuracy. Although the model did not always reproduce
the absolute levels of monthly abundances peaks, it succeeded in reproducing the seasonality in
population level and allowed identifying the periods of low abundances and with no apparent activity.
On that basis, the C. imicola monthly distribution over the entire Sardinian region was mapped. Such a
model could be used to predict monthly population abundances on the basis of environmental
conditions, and hence can potentially reduce the amount of entomological surveillance.
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Table 7: Data of presence and peak of abundance based on trapping studies (x: presence; xx: peak of abundance)
Predominant species Winter Spring Summer Autumn Location Reference
South Europe
C. imicola x x xx Sardinia (Italy) Foxi and Delrio (2010)
C. newsteadi x
C. imicola x x x Foxi et al. (2011)
C. obsoletus,
C. newsteadi and
C. pulicaris
x x x x
C. scoticus x x Pili et al. (2010)
C. obsoletus x x
North Europe
C. obsoletus/C. scoticus x xx xx x Basque country Romon et al. (2012)
C. obsoletus/C. scoticus x xx xx xx Gonzalez et al. (2013)
C. obsoletus/C. scoticus,
C. dewulﬁ and
C. chiopterus
x x Netherlands Takken et al. (2008)
C. obsoletus/C. scoticus,
C. dewulﬁ,
C. chiopterus and
C. pulicaris
xx x Meiswinkel et al. (2014)
C. obsoletus and
C. scoticus
Dominant species Sweden (Nielsen et al., 2010)
C. obsoletus,
C. chiopterus,
C. pulicaris, C. scoticus
and C. punctatus
x x x Ander et al. (2012)
C. obsoletus/C. scoticus x x xx x Northwest Germany Kiel et al. (2009)
C. pulicaris xx
C. obsoletus x xx Germany Balczun et al. (2009)
C. scoticus x xx xx
Culicoides spp. outdoor x x xx xx Clausen et al. (2009)
Culicoides spp. indoor x x xx xx
C. obsoletus x xx x Vorsprach et al. (2009)
C. obsoletus/C. scoticus x xx Austria Brugger and Rubel (2013)
C. obsoletus xx x Southwestern Germany Santiago-Alarcon et al. (2013)
C. obsoletus, C. scoticus,
C. dewulﬁ and
C. chiopterus
x x x UK Searle et al. (2014)
C. obsoletus/C. scoticus x x xx x Mainland France Venail et al. (2012)
Culicoides spp. x xx x (Balenghien et al. (2011, 2012)
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3.5.7. Adult vector overwintering and role of transmission
The capacity for diapause, which could be deﬁned as the arrest in development accompanied by
suppressed metabolism, is widespread among insects allowing them to bridge harsh winters, dry
seasons, or other seasonally inimical conditions. Most commonly, short day lengths of late summer
signal the advent of winter to temperate zone species (facultative diapause), and thus winter is
anticipated long before the onset of low temperatures. For instance, short day lengths change the
behaviour of newly emerged Culex pipiens females which will feed with plant sugar to store energy
reserves, seek a protected site for overwintering and show no host-seeking behaviour.
Some diapause mechanisms have been evidenced in Culicoides, allowing avoiding the risk of adverse
climatic conditions after summer (Rieb, 1987), but it is not yet clearly established if the apparent
absence of Culicoides adults in winter months is due to ‘true’ diapause mechanisms or to the increase in
larval development duration due to the decrease in temperature. Indeed, in Palaearctic zone, adult
Culicoides activity could be continuously recorded at least some favourable years in the Mediterranean
areas, whereas larval development could take up to 2 years in arctic conditions (Downes, 1962). Rieb
(1987) established that diapause mechanisms exist at least in shoreline river Culicoides species. On
contrary, Meiswinkel et al. (2008) reported that low numbers of adult Culicoides principally C. obsoletus/
C. scoticus, including freshly blood-fed individuals, and quasi-exclusively nulliparous females were
occasionally captured in light traps operated throughout the winter in Belgium, northern France and the
Netherlands (Meiswinkel et al., 2008). This could be explained by recent emergences due to transient
increase of temperature or by sporadic diapause endings in some larvae as reported by Rieb (1987). In
France, the duration of the apparent Culicoides adult absence seem to be spatially structured by climate,
with for instance quite continuous activity throughout the year along the Atlantic coast, suggesting that
predominance of direct temperature effect on larval development, rather than ‘true’ diapause
mechanisms at least in C. obsoletus/C. scoticus species (Thomas Balenghien, personal communication).
In Mediterranean area, Foxi et al. (2016) recently conducted a retrospective analysis of ethanol
preserved Culicoides collected in Sardinia in 2001 for BTV detection by RT-qPCR. BTV RNA was
detected in C. obsoletus and in C. newsteadi species. Foxi et al. (2016) considered the presence of
two cryptic species A and B in the C. newsteadi taxon from January to May, meanwhile BTV positive
C. imicola were only detected from September to November. The authors concluded that the presence
of Culicoides with high viral load in winter–spring in conjunction with low seroconversion rate in
animals in Sardinia would support a continuous cycle of infection and transmission between ruminants
and midge vectors. Similar results were found by Mayo et al. (2014) in California where BTV-positive
parous females of the vector C. sonorensis were found during winter time, whereas authors suggest,
in the absence of animal seroconversion, that long-lived females, infected with BTV during the prior
transmission season, could be the main mechanism in the area for bridging the interseasonal period.
In non-Mediterranean areas, however, where the winter is cold, the temperatures do not allow to
collect parous females. For instance, Meiswinkel et al. (2014) recorded more than 100 days without
collecting any parous females. Authors suggested that this evidences that long-live females, potentially
BTV infected during prior season could not survive during winter months, probably because they are
decimated once temperatures remain below approximately 5°C. Moreover, in these areas, newly emerged
nulliparous females, which would feed on viraemic animals, would not be able to replicate the virus as
temperatures would be under 11–13°C considered as the replication threshold for Orbivirus (Carpenter
et al., 2011). However, if these females could survive, it is possible that these infected females, with a
load under the detection threshold, would be able to replicate the virus later when temperatures would
increase, as it is demonstrated for West Nile virus and mosquitoes (Reisen et al., 2006).
3.5.7.1. Mapping threshold temperature for Culicoides development during winter
European climate is under the inﬂuence of two gradients, one South/North gradient delimiting
mainly Mediterranean and non-Mediterranean areas, and one West/East gradient reﬂecting the
transition from oceanic to continental climate. Some non-Mediterranean areas could present a
relatively mild winter mostly along the Atlantic coast. In Figure 18, maps of Europe are shown to
illustrate temperatures upper a threshold of 10°C during winter months since 2009 until 2014 (see
Appendix D for the maps about all the months between 2009 and 2014). This threshold is close to the
Orbivirus replication threshold and to the larval development threshold of C. sonorensis under
laboratory conditions (Mullens and Rutz, 1983). In some winter months, such as January 2010 and
2011, large areas in the northern Europe, e.g. continental France, showed favourable conditions for
Culicoides activity and potential BTV replication (Figure 18).
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Figure 18: Opportunity map for vector activity in Europe considering minimum temperature above
10°C, where the blue zones represent the areas in which Culicoides spp. inability to
complete the life cycle (from egg/larvae to adult) according to temperature and the shades
of green indicate conditions are favourable for completing the life cycle (from egg/larvae to
adult) (expressed in number of days in the month, darker colours indicating longer periods
in the month with favourable conditions), black represents regions with no information on
temperature for that year
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3.5.8. Vector-free period and criteria for its determination
In the Regulation (EC) 1266/2007, the deﬁnition of the seasonal vector-free period (SVFP) is mainly
based on the complete absence of adult Culicoides (speciﬁcally C. imicola) captured in light traps and
the determination of a certain threshold of Culicoides abundance for the other non-imicola species.
When the cited threshold was not possible to be determined, then a general criterion of less than ﬁve
captured parous females of those suspected vector species has been recommended to be adopted
(EFSA, 2007b, 2008). SVFP is determined until now on the basis of the results of light trap collections
of Culicoides spp.
The complete cessation of vector activity measured by means of light traps seems to be restricted
during winter to Afro-tropical species such as C. imicola and only in speciﬁc areas of southern Europe,
meanwhile in other areas such cessation is too short (< 15 days) or never reached (Ortega et al.,
1997; Miranda et al., 2004; Calvete et al., 2006). In addition, it has been demonstrated that other
species of the Avaritia subgenus, including C. obsoletus/C. scoticus, can be captured throughout the
year both in southern (Foxi and Delrio, 2010; Foxi et al., 2011) and northern Europe (Balczun et al.,
2009; Clausen et al., 2009; Kiel et al., 2009; Vorsprach et al., 2009; Santiago-Alarcon et al., 2013),
indicating that in certain areas, their activity does not stop during the winter time. However, during
winter, quite only nulliparous females are collected in northern Europe, and in extremely low numbers
(Takken et al., 2008; Ander et al., 2012; Meiswinkel et al., 2014; Searle et al., 2014).
It seems that the concept of an absolute SVFP is unrealistic for deﬁning a period of the year during
winter when transmission is supposed to be absent. Nevertheless, the seasonal occurrence of BT in
Europe is clearly related to the seasonal pattern of the vectors throughout the year.
The validity of ﬁve parous females as a threshold for declaring SVFP has been tested through the
analysis of a subset of entomological and serological surveillance data provided by the Italian
veterinary authority. Since 2002, a robust surveillance system for BT is in place in Italy. It comprises a
network of more than 30,000 sentinel animals monthly tested all over the country and around 300
Culicoides Ondersterpoort black-light suction traps, operating weekly all over the year (Giovannini
et al., 2004). Three-year data (2013–2015) on seroconverted animals during winter months
(December–February) were considered. For each seroconverted farms, all results of the entomological
catches performed in a radius of less than 5 km during the probable exposure time interval (from the
previous negative to the positive serological result in the same animal) were analysed. The total
numbers of Culicoides caught were considered. Only for four seroconversions out of 99 (two in
Sardinia and two in Sicily regions), matching the given conditions during the period of time considered
(Table 7), data on Culicoides catches performed within a 5 km radius were available. In all cases a
number of more than ﬁve Culicoides was observed, all belonging to the C. imicola species.
Although related to four cases only, the analysis of the data produced by the Italian entomological
surveillance programme is in agreement with the current provisions set by the Regulation (EC) 1266/2007,
and no seroconverted sentinels were observed in the absence of C. imicola or with less than ﬁve captured
Culicoides (EFSA, 2007b).
Among the criteria considered by the Regulation (EC) 1266/2007 for the deﬁnition of the SVFP,
temperature conditions that impact on the behaviour of the vectors activity could also be considered.
When temperatures thresholds are used, values around 10°C are frequently considered on the basis of
the results of studies performed in northern America and in Europe (EFSA, 2008).
For the deﬁnition of possible temperature thresholds, an approach that could be followed is based on
the estimation of the basic reproduction number (R0) under different temperature conditions. A simpliﬁed
formula for the calculation of R0 for vector-borne diseases is the following (Thomas et al., 2008):
Table 8: Results of the analysis of Italian bluetongue surveillance data
Farm Region
Probable BTV exposure time interval
(date of negative – date of positive
serological result on the same sentinel
animal)
Total no. of Culicoides caught during
the exposure time interval in a 5 km
radius from the seroconverted farm
#1 Sicily 2/10/2013–2/12/2013 6
#2 Sardinia 28/11/2012–28/12/2012 418
#3 Sardinia 14/12/2012–15/1/2013 7
#4 Sicily 27/11/2013–13/1/2014 68
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R0 ¼ a
2bMpn
Nrð ln pÞ
where, a = vector biting rate; b = transmission rate; M = vector population density; p = vector survival
(per day); n = number of days needed to be infective (vector) [extrinsic incubation period]; N = host
population density; r = recovery rate.
Vector biting rate, vector survival and the extrinsic incubation period are inﬂuenced by
temperatures. The parameter functions as applied for the calculation of the basic reproduction number
in Brugger et al. (2016) were used, and very conservative values for the probability of transmission
(equal to 1) and host population density (equal to 1) were chosen in order to possibly overestimate
the values of R0. The values of R0 were calculated for a range of temperatures from 0 to 30°C and
varying the number of Culicoides caught by the traps (the vector density was estimated by assuming
that trap catches reﬂect 1% of the local vector population) (Hartemink et al., 2009).
The Figure 19 shows that R0 exceed the value of 1 for temperatures ranging from 9.1 (in case of
20 Culicoides caught) to 11.5°C (in relation to 5 Culicoides caught), thus roughly conﬁrming possible
thresholds around 10°C for disease transmission.
3.6. Vector control: insecticides and repellents and vector-proof
establishments
The ToR 3.3 request for an assessment of the appropriateness of the use of insecticides and
repellents against Culicoides, including an assessment of their efﬁcacy and recommendations of
adequate protocols for their uses, in particular, as regards their suitability to protect animals against
attacks by vectors performing at least equal to the protection provided by vector-proof establishments
(VPE) – without the need to keep animals in a vector protected facility.
At the beginning of this chapter, an analysis of the current available vector control strategies and
tools is presented (Sections 3.6.1–3.6.6), then in Section 3.6.6.1 a comparison of the effectiveness of
those measures with the VPE is discussed.
In theory, vector control of Culicoides both larvae and adults appears as a method to reduce BTV
transmission in scenarios when vaccine for a particular serotype is not available, there are several
serotypes circulating, the serotype/strain is low pathogenic and/or movement restrictions and
protection of animals from vector bites are the only way to reduce transmission. Vector control could
be also appropriate under emergency outbreak situations or where vaccines are not economically
Figure 19: Estimation of R0 values considering different temperatures and numbers of Culicoides
caught in the traps
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affordable (Harrup et al., 2015; Purse et al., 2015). In practice, the control of Culicoides and its impact
on virus transmission at farm level is still poorly implemented and in most of the cases impractical from
an environmental and technical point of view.
Here, the general classiﬁcation of control methods are considered in (i) mechanical, (ii) chemical,
(iii) biological (iv) genetic and (v) biotechnological. These methods have been reviewed in several
works (Carpenter et al., 2008; Maclachlan and Mayo, 2013; Harrup et al., 2015; Mullens et al., 2015;
Pfannenstiel et al., 2015). Here the focus is mainly on updates published after the last EFSA opinion in
2008 (EFSA, 2008).
3.6.1. Mechanical control
3.6.1.1. Habitat modiﬁcation and source reduction
Larval habitats of Culicoides spp. include a wide variety of humid substrates, from organic matter
enriched soils, litter, rotten vegetables, to dung pats, manure heap and farm-associated wastewater
lagoons and were reviewed in previous EFSA opinions (EFSA, 2008). Breeding sites for some of the
major vector species in Southern Europe, such as C. imicola, has been recorded around farm premises
favoured by organic matter and water losses produced during farm practices (Braverman and Galun,
1973). Species included in the Obsoletus complex (C. obsoletus/C. scoticus) present a wide variety of
breeding sites, including farms and deciduous forest. Other species such as C. pulicaris breed near
swamp vegetation and C. dewulﬁ and C. chiopterus in dung pats.
Reducing breeding sites a priori seems feasible only for those species that are located in particular
substrates as dung pats or manure heaps. For the other species, breeding in soil and litter surface,
larvae control seems to be very impractical. There are only few experiences on source reduction for
Culicoides spp. and none of them have demonstrated to have an impact on vector population. Mayo
et al. (2014) compared two farms in California where the main breeding site for C. sonorensis
(wastewater lagoon) was removed in one of the farms. They found no difference in the population
abundance between the two farms, and therefore, it was assumed that breeding site removal would
have no effect on BTV transmission in the area. In the UK, Harrup et al. (2014) showed that muck
heaps covered with tarpaulins had no effect on the overall vector population when compared to
controls. In the same sense, L€uhken et al. (2014a) found that mechanical disturbance of cow-pats had
no effect on the populations of C. chiopterus, C. dewulﬁ and C. scoticus. Interestingly, in a different
study demonstrated that ﬂooded cow-pats had an effect on Culicoides larvae survival, meanwhile dry
cow-pats showed no effect when compared to control (L€uhken et al., 2014b).
Stabling and screens
Stabling animals seems to be a reasonable way to protect animals from the bites of Culicoides spp.
Meiswinkel et al. (2000) demonstrated that gauzing windows and closing doors in horse stables in
South Africa reduced by 14-fold the presence of C. imicola and Culicoides bolitinos inside the stable.
From the last EFSA opinion (EFSA, 2008), several trials have been conducted to test protection of
animals either by housing or by using screens in stables. In the UK, Baylis et al. (2010) showed by
comparing trap catches of Onderstepoort traps inside and outside stables, that cattle housed at night
were less exposed to biting midges activity, particularly during periods of maximum activity of exophilic
species (i.e. C. obsoletus) when blood-fed females were 3–4 times more frequent outside stables than
inside. Lincoln et al. (2015) tested different protection systems in horse stables in Switzerland. For
that, polypropylene nets (Ultravent® Bemisia TIP 250. Micrometric mesh of 0.1825 mm2, Texinov,
France) alone and in combination with fans (ZOO No. 1400, BM Haus Agrotech, Switzerland) were
used to protect animals against Culicoides in three stabling systems. Efﬁcacy was measured by
assessing the blood-fed rate of females captured in Onderstepoort light traps. Nets provided signiﬁcant
reduction of blood-engorged females rate (from 98% to 65% reduction) when compared to control
stables, but fans alone and combined with nets did not signiﬁcantly differed from control.
3.6.2. Chemical control
3.6.2.1. Repellents
Up to date, the only repellent registered in Europe that could be used to protect livestock against
midges bites is N,N-diethyl-meta-toluamide (Appendix E). Approved topical repellents are commonly
used on horses and for protection of humans (Carpenter et al., 2008; Harrup et al., 2015). Repellents
for protecting humans have been further explored in comparison to those for application on animals.
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Examples of current works conducted on repellents for humans include species which are not major
vectors of BTV, such those conducted in Scotland against C. impunctatus (Logan et al., 2009), in
Australia against C. ornatus and Culicoides immaculatus (Greive et al., 2010) and in Colombia against
Culicoides pachymerus (Santamarıa et al., 2012). In regards to research of repellents for animals, most
of the studies have been conducted in laboratory testing the repellence of several organic acids
compounds on Y-tubes or using light traps as a proxy to animals attraction to Culicoides (Venter et al.,
2011a; Gonzalez et al., 2014). Results showed that light traps equipped with a mesh impregnated with
a mixture of octanoic, decanoic and nonanoic fatty acids collected less Culicoides spp. when compared
with control traps. In South Africa, Venter et al. (2014) also tested commercial peel-stick patches with
a combination of citronella and lemon eucalyptus oil using light traps. Results showed no repellent
effect against C. imicola and no differences were found between treated and control traps in regards
to the different gonotrophic stages of females. However, up to date, no ﬁeld trials on animals have
been conducted using those compounds. In the UK, Robin et al. (2015) tested the possible repellent
effect of pour-on 1% solution of the insecticide deltamethrin (‘Spot on’, Zoetis; Zoetis UK, London, UK)
when applied on horses. They found no differences between treated and untreated horses in regards
to the number of blood-engorged females captured by Ondersterpoort traps placed nearby the
animals. Lincoln et al. (2015) also tried a similar approach to protect horses by applying a spray
solution containing permethrin insecticide and DEET (Flymax, 6 mg/mL permethrin and 20 mg/mL
DEET, Audevard Ltd., France). The product was applied to the neck, abdomen, ﬂank, back and croup,
and efﬁcacy was measured by estimating the rate of blood-engorged females captured in
Ondersterpoort traps. Obtained results indicated that no signiﬁcant differences were found between
captures of blood-fed females between the treated and control horses. Also, directly on animals,
Reeves et al. (2010) tested the repellent effect of ear-tags (Python: 10% zeta-cypermethrin 9.8 g/tag
and 20% piperonyl butoxide) and a low-volume-spray ready-to-use sheep insecticide (Y-TEX: 2.5%
permethrin and 2.5% piperonyl butoxide, 12 mL/sheep) separately and in combination on
C. sonorensis laboratory-reared adults. Insects were exposed to treated sheep using feeding tubes in
the axillary area. All tested compounds, either individually or in combination, were effective for
decreasing feeding rates of C. sonorensis up to 4 weeks; however, no data on mortality was provided,
therefore, results in terms of efﬁcacy are difﬁcult to interpret. Insecticide spraying showed to give
protection to animals immediately and resulted to be cheaper when compared to ear-tags,
nevertheless, those showed long-tasting repellence.
Compounds derived from the Neem tree (Azadirachta indica A. Juss; Meliaceae) have shown
antilanding and antifeeding effect on adults of a colony of Culicoides nubeculosus and ﬁeld-collected
C. impunctatus (Blackwell et al., 2004). Leaves of neem tree are usually burned for protecting cattle in
India; however, no references are available about its efﬁcacy (Harrup et al., 2015).
3.6.2.2. Insecticides
In vitro assays
Unlike repellents, insecticide usage against biting midges has experienced an important
development in the last decade. Several products are commercially available in Europe and broadly
used in the MS. The effect of insecticides of Culicoides spp. adults has been demonstrated in vitro
adapting WHO testing protocols for mosquitoes to Culicoides. The protocol basically consists on
exposing adult Culicoides to insecticides-impregnated papers of different concentrations and therefore
LD50 and LD90 could be estimated. In France,Venail et al. (2011, 2015) obtained high mortality (i.e.
100% after 1 h exposure 0.0025% deltamethrin) for either colony-reared adults of C. nubeculosus and
ﬁeld-collected adults of C. obsoletus and C. imicola to different concentrations of deltamethrin-
impregnated papers at 24 h after 1 h exposure. In Spain, Del Rio et al. (2014b) performed a similar
test on ﬁeld-collected Culicoides spp., results showed that individuals of the C. obsoletus were highly
susceptible to doses above 0.001% of deltamethrin, being 3.5 more sensitive to all deltamethrin tested
concentrations than the one tested by Venail et al. (2011). In the UK, Onuike et al. (2015) carried out
also a WHO protocol trial using deltamethrin-impregnated papers at different concentrations and
adults of a C. nubeculosus colony in the same way as Venail et al. (2011),but testing also effect of
treatment and post-treatment at different temperatures, as well as blood-feeding behaviour and
oviposition after being exposed to deltamethrin. The highest mortality (up to 90%) was observed at
24 h post-treatment with a concentration of 0.05%. Knock-down effect was observed after 1 h of
exposure, but posterior recovery of midges at 24 h post-treatment was recorded at low concentrations
of deltamethrin. Also, exposure to impregnated papers at different temperatures (25, 20, 15 and 10°C)
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had no signiﬁcant effect on mortality, however, higher mortality was observed at 10°C but no clear
explanation was provided in the study about the role of lower temperatures on Culicoides mortality.
The effect of temperature (25, 20, 15 and 10°C) during the post-treatment period was only signiﬁcant
at 10 vs 25°C. Interestingly, there was no signiﬁcant effect of deltamethrin in the feeding behaviour,
but numbers of eggs laid by insecticide-exposed insects were signiﬁcantly less than the control ones.
From the last EFSA opinion (EFSA, 2008), several works have tested insecticides in vitro by
exposing colony-reared or ﬁeld-collected adults to hair or wool clippings from insecticide-treated
animals. In Germany, Schmahl et al. (2008) tested OxyﬂyTM (lambda-cyhalothrin, Novartis), a
microencapsulated insecticide that is applied to surfaces of walls where insects rest. In this work, ﬁeld-
collected C. obsoletus and C. pulicaris were killed in 9–20 s when exposed to plates that were
insecticide impregnated 2 weeks before. In the UK Carpenter et al. (2007) tested the pour-on
insecticides Coopers’ Spot OnTM (1.25% w/v high-cis cypermethrin based pour-on at 450 mg/m2,
Schering-Plough Animal Health, UK) and deltamethrin (1% at 60 mg/m2) in sheep and cattle. Both
products showed high mortality for adults exposed in the lab, but low mortality to hair clipped from
belly and legs of treated sheep. Interestingly, Coopers’ Spot On showed signiﬁcant mortalities when
applied to cattle for up to 7 days after treatment. In a study conducted in Germany (Liebisch and
Liebisch, 2008) tested in vitro efﬁcacy of placing 1 and 2 ear-tags (Flectron® Flytags, 1,067 g
cypermethrin per ear-tag. Fort Dodge Animal health) per animal in heifers and dairy cows. The in vitro
assay using hair clippings from the dorsal line and the ventral abdomen from animals conﬁrmed ﬁeld
observation on the toxic efﬁcacy for 14 days with 1 ear-tag and up to 21 days with 2 ear-tags. In
similar trials, Schmahl et al. (2009a) treated cattle and sheep with Butox® 7.5 (7.5 g deltamethrin per
litre of ready-to-use solution, Intervet, Netherlands) and Versatrine® (1 g deltamethrin per 100 mL
excipient, Schering-Plough Veterinaire, France). Hair clippers were collected from feet of animals at
intervals of 7, 14, 21, 28 and 35 days after treatment and were put in contact with unidentiﬁed ﬁeld-
collected Culicoides spp. Both products showed to kill adult Culicoides even 35 days after treatment. In
a further study, cattle and sheep were treated with Flypor® (4% w/v of permethrin ready-to-use
solution, Novartis, UK), Arkoﬂy® (6 g fenvalerate per 100 mL of the ready-to–use spray, Novartis,
France) and Acadrex® 60 (6 g fenvalerate within 100 mL excipient solution, Novartis, France). Results
were similar to those obtained in the previous trial and all products showed a killing effect on adult
Culicoides 35 days after treatment (Schmahl et al., 2009b), however, neither in this work nor in the
previous ones, the percentage of mortality was estimated and therefore comparison with further
studies are difﬁcult to assess. Papadopoulos et al. (2009) also tested the killing effect on colony-reared
adults of C. nubeculosus of hair clippers obtained from leg, belly and back of sheep and calves treated
with Dysect Cattle Pour-On (15 g/L alphacypermethrin) and Dysect Sheep Pour-On (12.5 g/L
alphacypermethrin), respectively. Adult Culicoides showed high mortality (near to 100%) up to 21 days
post-treatment. A similar trial (Papadopoulos et al., 2010) was performed applying cypermethrin
(Deosect Spray, 5.0% w/v, Fort Dodge Animal Health) to face, legs, back and hindquarters of horses.
Percentage of mortality ranged from near 80% at day 7 to 50% at day 35 post-treatment, being hair
clippers from the back those that showed highest killing effect.
Semiﬁeld testing
Semiﬁeld testing includes the use of animals for testing the efﬁcacy of pour-on insecticides in
enclosed conditions; therefore, data resulted from direct contact of biting midges to the body of
animals and not to hair or ﬂeece clippers. Venail et al. (2011) tested the killing effect of Butox® 7.5
pour-on (Intervet International B.V., The Netherlands, 7.5% w/v deltamethrin) on nulliparous females
of a colony of C. nubeculosus directly exposed to shorn sheep at 1, 4, 6 and 13 days after treatment.
In this work, the maximum mortality reached the 45% on day 4 after treatment and the persistence of
the lethal effect was estimated to be less than 10 days. This study, as others conducted elsewhere
(Carpenter et al., 2007; Bauer et al., 2009; Papadopoulos et al., 2009, 2010), concluded that diffusion
of active ingredients on the hair/ﬂeece of target livestock species is a key issue for reaching success in
deterring Culicoides midges feeding activity.
Field testing
In regards to ﬁeld trials, several studies have been conducted with commercialised pour-on
insecticides and impregnated ear-tags to protect horses, cattle and sheep. Concerning systemic
biocides, no updates have been available since EFSA (2008).
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3.6.2.3. Pour-on insecticides:
In the Netherlands, De Raat et al. (2008) tested permethrin pour-on insecticide (Tectonik ® 36 g/L;
doses 10 mL/100 kg) on horses assessing ﬁeld Culicoides feeding rate by aspirating adults from a
mosquito net tent trap. The most abundant species showed to be C. obsoletus and C. pulicaris and the
pour-on treatment decreased by 82% the number of individuals collected from treated horses;
however, there was no statistical difference when compared to the control. In consequence, the
permethrin pour-on treatment showed poor efﬁcacy to avoid feeding midges on horses. Limited killing
effect from different parts of the body of the animal (i.e. back, belly, legs) may explain the poor
efﬁcacy of pour-on treatments. Better results were obtained in Spain, where Mullens et al. (2010)
showed good protection of sheep against feeding activity of Culicoides spp. by applying 7.5%
deltamethrin (Butox 7.5) directly on exposed skin (face, ears and belly) and therefore strictly not being
a pour-on treatment. In this case, authors attribute the relative success in preventing midges to feed
on sheep to the ad-hoc way of applying the product on animals. Also on sheep, Grifﬁoen et al. (2011)
tested the efﬁcacy of Tectonik 3.6% permethrin pour-on solution (1 mL/10 kg bodyweight. Virbac
Animal Health) in the Netherlands, on a mixed group of sheep breeds by using tent traps from where
biting midges were aspirated. The most common species were C. chiopterus and C. obsoletus and
according to the results, the pour-on treatment reduced up to 50% the number of midges associated
to animals as well as the number of engorged females that fed on animals. In a more robust trial,
Weiher et al. (2014) performed a study in Germany assessing a dosage of 10 mL of Butox® pour on
(7.5 mg deltamethrin/mL, Intervet, France) on Merino sheep. Engorged females and rate of feeding
efﬁcacy was measured by using a drop trap and direct aspiration of midges. Pour-on treatment
showed an efﬁcacy that ranged from 0% (2 weeks post-treatment) to 71.0% (3 weeks post-
treatment). Overall efﬁcacy reduced 86.4% of engorged females in the pour-on treated animals from
24 h to 5 weeks of treatment and maximum efﬁcacy on reducing feeding rate was obtained in day 21
(94.6%). According to the authors, low efﬁcacy of the product during the ﬁrst 24 h after treatment
and insufﬁcient spread to different parts of the animal body (i.e. legs, feet, belly, face) are considered
main limitation on pour-on insecticide treatments.
3.6.2.4. Ear-tags
Insecticide impregnated ear-tags are commercially available in Europe and represent an alternative
to pour-on treatments. In North Germany, Liebisch and Liebisch (2008) tested the efﬁcacy of placing 1
and 2 ear-tags (Flectron® Flytags, 1,067 g cypermethrin per ear tag, Fort Dodge Animal health) per
animal in heifers and dairy cows. Midge abundance was measured by suction light traps and direct
aspiration from the skin of the animal. According to authors, C. obsoletus, C. pulicaris and C. dewulﬁ
were the dominant species. The results of the study are limited since no speciﬁc result is given about
the decrease of feeding activity of midges on tested animals. Apparently, the toxic efﬁcacy duration
was estimated at 14 days when using 1 ear-tag and up at 21 days for 2 ear-tags. This result was also
conﬁrmed in vitro by exposing ﬁeld-collected Culicoides to hair clippers (see in vitro section). In
another trial conducted in Germany by Bauer et al. (2009), protection of bulls inside a pen by using
insecticide-treated ear-tags (Auriplak®) containing 1.2 g of permethrin as well as ﬁve pour-on
treatments with deltamethrin (Butox 7.5; 750 mg/100 mL) failed to reduce the number of engorged
midges captured by BG-Sentinel traps placed inside the bull pens.
3.6.2.5. Insecticide-treated materials
Insecticide-treated materials are generally nets (insecticide-treated nets (ITN)) which are
recommended to be placed on windows and doors to avoid biting midges to contact with animals.
Their efﬁcacy generally depends on the species endo- and exophilic behaviour (indoor/outdoor), as
well as the characteristics of the ITN to kill adults or to preclude its movement into stables.
Since the last EFSA opinion (EFSA, 2008), there have been trials using ITNs for assessing its effects
on Culicoides adults basically by placing them on doors and windows of stables or around light traps.
In regards to trials performed using ITNs to protect animals inside stables, Bauer et al., 2009
tested insecticide-treated mosquito fences (100 mg/m2 deltamethrin – 180 cm height – 1 9 2 mm
mesh) around bull pens in Germany aiming to reduce numbers of engorged females. Midge population
measured inside the pens by using BG-Sentinel traps showed no signiﬁcant difference with control;
consequently, exhibiting poor action in reducing attack of Culicoides. Since there is little information
about the ﬂying behaviour of Culicoides, it was assumed that adults were ﬂying over the fence to
avoid its contact. In Spain, Calvete et al. (2010) tested cypermethrin manually impregnated on canvas
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barriers (2.6 m height; 0.5 g/L cypermethrin) aimed to protect yearly ewes. Efﬁcacy was measured by
comparing Culicoides captures in CDC mini-UV light traps inside and outside the pens. The canvas
barriers showed only partial (50–78.8%) or no protection against C. imicola, the most abundant
species in the area and the major BTV vector in Southern Europe. According to the authors, this
species seemed to be able to ﬂy above the barrier avoiding contact with the insecticide impregnated
canvas.
Regarding trials assessing the efﬁcacy of ITNs by using light traps as a proxy to the attraction to
animals, Del Rıo et al. (2014) tested blue shading nets, made from inert polyethylene ﬁbres (ﬁbre
wideness: 1 mm, gap between ﬁbres: 2 mm), manually impregnated with 1 L of cypermethrin solution
1% and placed in a cylinder (1.5 m high and 1 m wide) with an Onderstepoort light trap inside. There
were no statistical differences between ITN and control net in regards to C. imicola populations. In the
same sense, no signiﬁcant difference in mortality after 24 h was found between ITN and control net,
indicating that midges were able to pass through the net without any virtual contact with the
insecticide impregnated ﬁbres. Interestingly, signiﬁcant differences were obtained for non-targeted
species, demonstrating the knock-down effect of the ITN. The same authors (Del Rio et al., 2014a)
tested commercial polyethylene nets (ZeroVector® Durable Lining; Dart Association, Lausanne,
Switzerland) impregnated with 4.4 g/kg  15% of deltamethrin in vitro and in ﬁeld using the same
method as mentioned above. Results showed that 100% mortality was reached after 17 min. of exposure
to the net in vitro. However, not signiﬁcant difference was found between the ITN trap and control. As in
the previous trial, although ITN did not prevent midges to pass through the net, the mortality rate of
Culicoides collected in the ITN trap (84.9  10.5%) was signiﬁcantly higher than that of midges collected
in the control trap (72.3  5.9%). In a trial conducted in South Africa (Page et al., 2014), high-density
polyethylene nets (HDPE) manually impregnated with alphacypermethrin (20–40 mg/m2) and tested
using Onderstepoort black-light traps, failed to show any repellent effect on Culicoides spp. when
compared to untreated one but reducing Culicoides captures in 7.2 times when compared to control. The
same nets were tested in a contact bioassay using C. imicola nulliparous females and after 1 and 3 min of
exposure, 100% of mortality was reached. Baker et al. (2015) tested seven different commercially
available insecticides on a black polyvinyl-coated polyester mesh (PetMesh. Fine Mesh Metals, Telford,
UK; 1.6 mm aperture; 1.6 mm thickness) using WHO cone test and adults of a colony of C. nubeculosus
at 1, 7 and 14 days after treatment. Insecticides included were Agropharm’s Dairy Fly Spray (Pyrethrins
including cinerins 0.25% w/w, Agropharm Ltd, Penn, UK); Degrain Insectaclear C (Cypermethrin 0.1%
w/w, Lodi UK, Kingswinform, UK); Fly Free Zone (Permethrin 0.1% w/w; Tetramethrin 0.04% w/w; Fly
Away Ltd, Stourbridge, UK); Protector C (Cypermethrin 0.09% w/w, Agropharm Ltd, Penn, UK);
Strikeback Insect Killing Spray (Cypermethrin 0.01% w/w, Group 55, Preston, UK); Tri-Tec 14®
(Cypermethrin 0.15% w/w; Pyrethrins 0.2% w/w, LS Sales (Farnham) Ltd, Bloxham, UK) and Insecticide
Ultrashield EX (Permethrin 0.5% w/w; Pyrethrins 0.1% w/w, W.F. Young, Inc, East Longmeadow, MA,
USA). Insecticide Tri-Tec 14®A demonstrated to be the most effective on the WHO cone test (100%
mortality) and therefore was applied in two ﬁeld trials where efﬁcacy was assessed by comparing
captures from a CDC mini-UV light trap placed into wooden frame covered with the insecticide-treated
mesh, as well as covering entrance of stables with the treated mesh and measuring Culicoides abundance
by the same type of traps. Results obtained either from the traps placed into the wooden frames or
the stables showed that there was no signiﬁcant difference on the number of females Culicoides between
the treated and non-treated mesh. Interestingly, the mesh either treated or non-treated, decreased the
number of Culicoides when compared with the control uncovered wooden frames or stables. In addition,
a mean coefﬁcient of protection from intrusion (CPI; % comparing inside captures with no-mesh and
mesh) of 88% was obtained for the untreated mesh and 100% for the treated one in wooden frames.
When the mesh was placed in stables, CPI of 71% and 96% were obtained for untreated and treated
mesh, respectively. These results indicate that either untreated-mesh or mesh treated with the insecticide
Tri-Tec 14® signiﬁcantly reduced the entry of Culicoides into stables.
3.6.3. Biological control
Biological control in entomology has been deﬁned as ‘The use of living organisms to suppress the
population density or impact of a speciﬁc pest organism, making it less abundant or less damaging
than it would otherwise be’ (Eilenberg et al., 2001).
In regards to entomopathogenic fungi a recent review conducted by de Souza et al. (2014)
summarises fungal and Oomycete infecting Culicomorpha (Simuliidae, Ceratopogonidae and
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 62 EFSA Journal 2017;15(3):4698
Chironomidae). Mortality of Culicoides larvae caused by entomopathogenic fungi has been reported by
Wright and Easton (1996) which found 31% mortality when exposing Culicoides molestus Skuse to
Lagenidium giganteum Couch. Using colony-reared larvae of Culicoides nubeculosus, Unkles et al.
(2004) observed killing effect of the mosquito pathogen fungus Culicinomyces clavisporus only after
72–96 h post-treatment. Among all entomopathogenic fungi tested, Metarhizium anisopliae has
showed to be the most effective against several species of biting midges. Ansari et al. (2010) proved
on C. nubeculosus colony that M. anisopliae (Metchnikoff) killed larvae from 81% to 100% of mortality
and adults (Ansari et al., 2011) were killed at lethal time 90 (LT90) of 3.26 days when exposed to dry
conidia at dose of 1.5 9 108/m2. Similarly, Nicholas and McCorkell (2014) showed signiﬁcant mortality
of Culicoides brevitarsis adults reared from dung to M. anisopliae at day 8, also conidia applied to
dung signiﬁcantly decreased the emergence rate of adults. Narladkar et al. (2015) also tested
M. anisopliae and Beauveria bassiana against adults and larvae of Culicoides peregrinus in India. Killing
effect on larvae was found to last only 7 days while adults were killed in 24 h according to authors;
however, no details were provided about the measure of the efﬁcacy.
The Sporulaceae bacteria Bacillus thuringiensis var. israelensis (Bti) is a lethal bacterium for
mosquito larvae that has been widely used for mosquito control programmes during the last decades.
However, Culicoides are poorly affected by the same bacteria, which make its use completely
inefﬁcacious for biting midge control. Several authors have demonstrated the low efﬁcacy of Bti on
C. sonorensis, Culicoides occidentalis, Culicoides mississippiensis and Culicoides guttipennis (Kelson
et al., 1980; Lacey and Kline, 1983) as well as on C. impunctatus (Blackwell and King, 1997).
Entomopathogenic viruses to Culicoides has been occasionally isolated but never applied for control.
The Iridescent viruses (IIVs) (family Iridoviridae; genus Iridovirus) are the most common viruses infecting
biting midges (Williams, 2008). Rates of infection has been described up to 28% on C. sonorensis
(Mullens et al., 1999), 1% on Culicoides odibilis, Culicoides cubitalis and Culicoides clastrieri (Rieb et al.,
1982) and 4.7% on C. barbosai (Fukuda et al., 2002).
Nematodes of the family Mermithidae are commonly found parasiting biting midges and its use as
agent of control has been reviewed by Mullens et al. (2008). The species Heleidomermis magnapapula
(Poinar and Mullens, 1987) appears as an adequate candidate for biological control, since it has been
described to reach up to 69% of parasitism on C. sonorensis (up to), Culicoides lahontan,
Culicoides boydi and Culicoides cacticola (Poinar and Mullens, 1987; Paine and Mullens, 1994; Mullens
et al., 1997). Other species such as Heleidomermis cataloniensis was found on adults of
Culicoides circumscriptus (Poinar and Sarto i Monteys, 2008). Basic studies on the biology of the species
H. magnapapula for improving its use has been conducted by Mullens and Velten (1994), Luhring and
Mullens (1997), Mullens et al. (1995) and Mullens and Luhring (1996). Mullens et al. (2008) conducted
an inundative semiﬁeld trial in California using H. magnapapula on C. sonorensis breeding sites. A
reduction of 84% of adults emerged was found; however, those adults that succeeded in emerge showed
a low level of parasitism, as in previous trials, it may result up to a 17% (Mullens and Velten, 1994; Paine
and Mullens, 1994).
Other organisms that may be used for vector control are heritable endosymbiotic bacteria such as
Wolbachia. There has been an increase of interest of this type of bacteria due to the current research
for applying in mosquito control programs. Heritable bacteria cause changes in host longevity, virus–
host interaction and reproduction compatibility that may lead to control insect populations. Detection
of endosymbiotic bacteria in biting midges has been reported by Nakamura et al. (2009) in
Culicoides paraﬂavescens in Japan and in Culicoides wadai, C. brevitarsis and C. imicola in Australia by
Mee et al. (2015). Up to date, Wolbachia has not been detected in European Culicoides species,
alternatively, the genus Cardinium was detected in C. punctatus and C. pulicaris in the UK (Lewis
et al., 2014). Despite the recent interest on endosymbiotic bacteria, its current application for
Culicoides control is far away of being a reality on the ﬁeld.
3.6.4. Genetic control
The current development of genomic and transcriptomic techniques has allowed to better
understand genes expression and biology of processes such as blood feeding and vector competence.
The study of the transcriptome of C. sonorensis has allowed to better know the functionality of the
genome, identifying mid-gut transcripts in EHDV-infected adults (Campbell and Wilson, 2002), midgut
transcripts associated to antihaemostatic and immunomodulatory functions (Campbell et al., 2005) and
the genetic bases of sugar/blood feeding and vitellogenesis (Nayduch et al., 2014b). Despite no
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current control technique of biting midges is based on genetic methods, analysis of the transcriptome
may provide new methodologies for vector control (Nayduch et al., 2014a).
Other genetic control tools include the use of RNA interference (RNAi) that avoids arbovirus
replication. This type of RNA has been described in C. sonorensis-derived KC cells (Schnettler et al.,
2013) and artiﬁcially induced by intrathoracically injecting double-stranded RNA (dsRNA) (Mills et al.,
2015). As in the case of other genetic control tools, such as Release of insects carrying a dominant
lethal genetic system (RIDL), Incompatible Insect Technique (IIT) and Sterile Insect Technique (SIT)
(Alphey, 2014), are still of very limited application on Culicoides control due to the lack of basic
studies.
3.6.5. Biotechnological control: pheromones and semiochemicals, traps and
attractants
Chemical ecology is of great importance for insects, since mating, oviposition and feeding among
others processes, are based on the detection of volatile compounds in the environment. Commercially
available compounds, such as kairomones, are used for vector control and monitoring, as in the case
of mosquitoes. However, in the case of Culicoides, most of the products remain under experimental
framework and those available for mosquitoes have limited action on Culicoides.
Several compounds have been tested either in lab or ﬁled conditions (see Harrup et al. (2016) for
review), including 1-octen-3-ol, L-(+)-lactic acid, butanone, acetone among others. None of these
compounds has showed a strong attractant effect on Culicoides spp. and therefore its use for control
remains limited.
Commercial traps combining several types of stimuli (i.e. CO2, octenol, heat) are available for
mosquito control, and in some cases, they have been tested against Culicoides. The ABC Pro insect
suction traps and the Mosquito Magnet® (MM) trap were not effective for controlling biting midge
population in Florida (Cilek et al., 2003; Cilek and Hallmon, 2005), but more promising results were
obtained by Lloyd et al. (2008) by continuous trapping using Mosquito Magnet®, MM-FreedomH and
MM-Liberty PlusH against Culicoides furens, Culicoides barbosai and Culicoides mississippiensis.
3.6.6. Comparison of efﬁcacy between vector-proof establishment and
repellents/insecticides
The establishment of VPE requires several interventions and activities, including13:
• the implementation of physical barriers to reduce the probability of Culicoides entry;
• the application of insecticides-impregnated screens;
• the elimination or limitation of Culicoides-breeding sites in the proximity of the farms;
• the implementation of a constant Culicoides surveillance inside and outside the stables.
Although a 100% vector-proof level is very hard or even impossible to obtain, a correct application
of all measures can signiﬁcantly reduce the exposure of animals to Culicoides bites, thus providing
substantial assurances for the trade of animals and animal products. However, usually the costs related
to the implementation of a VPE are quite high and such solution may be cost-effective for highly value
animals only.
Stabling of animals, usually without screening openings, and the use of repellents/insecticides have
been general measures recommended in BTV and AHSV outbreak scenarios to protect animals from
Culicoides bites (Meiswinkel et al., 2000; Baylis et al., 2010). From the previous EFSA opinion (EFSA,
2008), it is known that stabling of animals may lead to a decrease of exposure of animals to Culicoides
populations. However, there is little information about the general use of these measures in the current
farm practices at European level.
A further step was achieved when VPE were deﬁned at the EU level to decrease the risk of BTV
transmission in animals moved from one to another MS.
The criteria for the VPE are laid down in Annex II of the Regulation (EC) 1266/2007 as amended by
Commission Regulation (EC) No 456/2012, and are based on those in the OIE Terrestrial Animal Health
Code (OIE, 2014).
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A VPE shall at least comply with the following:
a) it must have appropriate physical barriers at entry and exit points;
b) openings must be vector-screened with mesh of appropriate gauge which must be
impregnated regularly with an approved insecticide according to the manufacturers’
instructions;
c) vector surveillance and control must be carried out within and around the establishment;
d) measures must be taken to limit or eliminate breeding sites for vectors in the vicinity of the
establishment;
e) standard operating procedures must be in place, including descriptions of back-up and
alarm systems, for operation of the VPE and transport of animals to the place of loading.
The competent authority shall approve an establishment as vector protected, if the criteria in point
1 are met. It shall verify at the appropriate frequency, but at least three times during the required
protection period (at the beginning, during and at the end of the period) the effectiveness of the
measures carried out by means of a vector trap inside the VPE.
It should be pointed out that the Commission Regulation (EC) No 456/2012 considers VPE ‘to be
worthwhile for high value livestock or artiﬁcial insemination centres for which other means of exiting
the restriction zone (i.e. vaccination, natural immunity or movement during a vector-free period) are
not an option’. Therefore, its application for major movements of commercial animals seems not to be
feasible. Italy is one of the EU MS which has more experience in the implementation of VPE. A very
detailed and speciﬁc procedure is in place for the approval of the establishment and its registration
into the national list (EC, 2012). The current approved establishment includes mainly bovine genetic
centres, interested in the international trade of semen (Calistri, personal communication).
3.6.6.1. Efﬁcacy of VPE and ITNs-screened stables compared to repellent/insecticide
efﬁcacy
Vector protection of the establishment is achieved by combining different methods, such as treating
walls and surfaces of VPE with residual insecticides, treating animals with authorised insecticides prior
to entrance to the facility, and more importantly, by use of nets of appropriate size (no greater than
1.6 mm2) and preferably insecticide impregnated, to avoid Culicoides to enter the premises.
Efﬁcacy of VPE is exclusively measured by using UV light traps (CDC and Onderstepoort types)
inside and outside the VPE. The aim is to demonstrate no presence of adult Culicoides inside the VPE
despite the abundance outside.
According to Commission Regulation (EC) No 456/2012, the frequency of operating vector traps
should be conducted at least three times: at the beginning, during and at the end of the required
protection period. However, each MS could propose its own regime of sampling. For example, in Italy,
weekly collections for at least 10 consecutive days during the period of vector activity of the inside and
outside trap is considered sufﬁcient to demonstrate no presence of the vector in the VPE; in Spain, it is
advised to operate the traps for two consecutive nights/fortnightly.
There is no scientiﬁc literature about the efﬁcacy of VPE implemented in different MS. However, data
on Culicoides trapping from 2009 to 2012 in a VPE of central Italy provide clear evidence that VPE
achieved a mean reduction of 99.7% of Culicoides population when captures from the inside trap are
compared to those obtained outside. The maximum number of adult Culicoides collected inside was 14
compared to 23,492 adults collected outside the VPE premises (Calistri, personal communication).
The use of nets of appropriate size to avoid Culicoides to enter the premises is the basis of VPE. In
general, it is recommended to have all openings protected by ﬁlters or mesh impregnated with insecticide
(ITNs) and with a maximum mesh size no greater than 1.6 mm2. There is more information available
about the efﬁcacy of the ITNs than that for VPE. As mentioned in Section 3.6.2, in general, ITNs used
elsewhere have shown reduction of the Culicoides population but not total protection of animals.
Deltamethrin ITN for protecting conﬁned bulls used by Bauer et al., 2009 showed no efﬁcacy, meanwhile
the study from Calvete et al. (2010) showed partial protection of sheep (50–78.8%) when using ITN’s
impregnated with cypermethrin. Del Rio et al. (2014a) showed increased mortality (84.9  10.5%) of
Culicoides when using deltamethrin ITN tested on traps, while alphacypermethrin nets used by Page
et al. (2014) showed 7.2 times reduction of Culicoides UV light trap captures when compared to control
trap. Protection provided by a cypermethrin + pyrethrin ITN reached a range between 78 and 96% in the
trial conducted by Baker et al. (2015) on horse stables. We could not consider the above mentioned
works equal to the requirements that must be fulﬁlled by an ofﬁcial VPE, but they give an estimation of
the potential protection (up to 96%) that could be provided by different ITN when installed in VPE.
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As mentioned in Section 3.6.2, there are no currently authorised repellents in the EU to be used on
livestock and only the repellent effect of some approved insecticides could be considered in this
category (see Section 3.6.2 for details). Efﬁcacy of repellents used experimentally to protect animals
has shown to be very low elsewhere for different active ingredients (octanoic, decanoic and nonanoic
fatty acids, citronella and lemon eucalyptus oil, deltamethrin, permethrin and DEET). In consequence,
the use of repellents to protect animals against Culicoides biting could not be recommended and
therefore reduction of Culicoides bites could not be achieved by using only repellents.
Several types of insecticides have been broadly tested in laboratory conditions against Culicoides in
the last decade (EFSA (2008) and Table 9). In general, the great majority of works have shown a high
killing effect of insecticides (usually 90–100% mortality after 1 h exposure) such as deltamethrin,
cypermethrin, alphacypermethrin, lambda-cyhalothrin, fenvalerate, zeta-cypermethrin and permethrin
when tested either on hair clippers (Liebisch and Liebisch, 2008; Schmahl et al., 2009a); Papadopoulos
et al., 2009, 2010), WHO testing tubes contacting directly animal hair (Reeves et al., 2010; Venail et al.,
2011, 2015; Del Rio et al., 2014b; Onuike et al., 2015); or material substrates (see Section 3.6.2 for
details) such as plates and nets (Schmahl et al., 2008). However, in some cases, interpretation and
comparison among studies are difﬁcult due to the lack of information about the efﬁcacy, times and mode
of exposure to insecticides of Culicoides in testing cages or tubes (Harrup et al., 2016). Unfortunately,
the promising results on vector mortality obtained in laboratory conditions, are usually not reproduced at
the same level of efﬁcacy when insecticides are applied in ﬁeld conditions.
Several pour-on insecticides are approved at the EU level for ﬁeld use (see Appendix E). Permethrin
and deltamethrin are the most common used insecticides in pour-on formulations. Results on efﬁcacy
of pour-on insecticides obtained in experimental trials show a wide variety of results depending on the
host species and particularities on the application of the topical insecticides. Mullens et al. (2000)
obtained up to 80% of protection of calves that were treated with permethrin on the belly but null
protection on those treated on the backline with permethrin (5%) and pirimiphosmethyl (27%). Also,
in later studies, Mullens et al. (2001) showed that protecting ventral line of heifers by using permethrin
(0.2%) was not sufﬁcient to avoid seroconversion of animals. In general, pour-on application shows
less efﬁcacy when compared to whole body application, as obtained by Mullens et al. (2010) when
100% protection was achieved when applying deltamethrin (7.5%) to different parts of the body of
sheep (face, legs, belly) and not the backline only. The work by De Raat et al. (2008) using permethrin
(3.6%) pour-on insecticide showed 82% reduction of Culicoides trapped around treated horses only
48 h after the treatment, while Bauer et al. (2009) failed to protect bulls after ﬁve pour-on treatments
with deltamethrin (7.5%) on conﬁned bulls, Grifﬁoen et al. (2011) showed 50% protection of sheep
using permethrin and Weiher et al. (2014) obtained overall efﬁcacy of 86.4% (from 24 h to 5 weeks)
of deltamethrin (7.5%) applied on sheep. Therefore, the range of protection of insecticides is
substantially variable according to the active ingredient and the animal species aimed to be protected.
A general range of protection of pour-on insecticides from 50 to 86% could be extracted from scientiﬁc
literature mentioned above. Problems of the fully spread of the insecticide over the entire body of
animals has been described by several authors either in ﬁeld and in vitro testing and different diffusion
of the pour-on insecticides is known for hair and ﬂeece (Bauer, 1995; Carpenter et al., 2007;
Papadopoulos et al. (2009, 2010)). This should be taken into account when using pour-on insecticides
to protect animals against Culicoides bites, particularly when there are differences among species on
the preferred feeding region on animals (i.e. belly, legs, face). Viennet et al. (2012a) showed
differences on the preferential landing sites of Culicoides on sheep, thus C. dewulﬁ preferred upper
parts of animal while C. obsoletus preferred lower parts.
Table 9: Summary table of insecticides, type of application and the reported efﬁcacy in the different studies
Active
substance
Commercial name
Type of
application
Culicoides sp. Country Host
Efﬁcacy
(in vitro
semiﬁeld, ﬁeld
trials)
Reference
Field testing
Permethrin Y Tectonik® 36 g/L; doses
10 mL/100 kg
Pour-on C. obsoletus,
C. pulicaris
Netherlands Horses 82% De Raat et al.
(2008)
Tectonik 3.6%
(1 ml/10 kg bodyweight,
Virbac Animal Health)
Pour-on C. chiopterus
and C. obsoletus
Netherlands Sheep 50% Grifﬁoen
et al. (2011)
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When comparing protection provided by VPE to that provided by insecticides only, we should
consider that the criteria for VPE also includes the use of insecticide/repellents, that means that the
protection provided by conﬁnement of animals and use of ITNs is added to the partial protection
provided by applying insecticides. In consequence, even if Culicoides are found inside the VPE
premises, we should add the efﬁcacy of pour-on insecticides (50–86%) to that of VPE (96%). That
decreases the probability of contact between animals and Culicoides inside VPE. Therefore, by only
using pour-on insecticides, protection of animals could not be considered as equal as the protection
provided by the VPE which is at least 10% superior on efﬁcacy compared to pour-on insecticides. One
open question is to know if a protection up to 86% provided by pour-on insecticides would be
sufﬁcient to avoid BTV transmission or biting of BTV-infected Culicoides. According to scientiﬁc
literature reviewed in this opinion, high level of efﬁcacy of pour-on insecticides is difﬁcult to achieve
Active
substance
Commercial name
Type of
application
Culicoides sp. Country Host
Efﬁcacy
(in vitro
semiﬁeld, ﬁeld
trials)
Reference
Deltamethrin Y 7.5% deltamethrin (Butox
7.5)
Whole body Culicoides spp. Spain Sheep 100% Mullens et al.
(2010)
10 mL of Butox® pour on
(7.5 mg deltamethrin/mL,
Intervet, France)
Pour-on Culicoides
Avaritia
subgenus
Germany Sheep Reduced 86.4%
of engorged
females
Weiher et al.
(2014)
In vitro
0.0025%
deltamethrin
Exposure on
impregnated
paper
Colony of
C. nubeculosus,
ﬁeld-collected
C. obsoletus and
C. imicola
France – 100% after 1 h
exposure
Venail et al.
(2011, 2015)
0.001% of
deltamethrin
Exposure on
impregnated
paper
Field-collected
C. obsoletus
Spain – 100% Del Rio et al.
(2014a)
0.05% of
deltamethrin
C. nubeculosus
colony
UK 90% mortality Onuike et al.
(2015)
Lambda-cyhalothrin OxyﬂyTM (Novartis) Application
on walls
where insects
rest
Field-collected
C. obsoletus and
C. pulicaris
Germany 100% Schmahl
et al. (2008)
1.25% w/v high-cis
cypermethrin
Coopers’ Spot OnTM,
Schering-Plough Animal
Health, UK
Pour on Culicoides spp. UK Sheep
and
cattle
High mortality Carpenter
et al. (2007)
1,067 g
cypermethrin per ear
tag
Flectron® Flytags, Fort
Dodge Animal Health
Ear tags Culicoides spp. Heifers
and dairy
cows
Efﬁcacy for
14 days with 1
ear tag and up to
21 days with 2
ear tags
Liebisch and
Liebisch
(2008)
12.5–15 g/L
alphacypermethrin
Dysect Cattle Pour-On
and Dysect Sheep
Pour-On (Zoetis)
Hair clippers
obtained from
leg, belly and
back
Colony-reared
adults of
C. nubeculosus
GR Sheep
and
cattle
Near to 100%) up
to 21 days post-
treatment
(in vitro)
Papadopoulos
et al. (2009)
Cypermethrin 5.0% Deosect Spray, Fort
Dodge Animal Health
Hair clippers Culicoides spp. GR Horses 80% at day
7–50% at day 35
post-treatment
Papadopoulos
et al., 2010)
Semi ﬁeld testing
7.5% w/v
deltamethrin
Butox® 7.5 Pour On
(Intervet International
B.V., The Netherlands)
Pour on Nulliparous
females of a
colony of
C. nubeculosus
exposed to
shorn sheep
France Sheep 45% on day 4th
after treatment.
persistence of the
lethal effect was
estimated to be
less than 10 days
Venail et al.,
2011
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and little information is available about the effect of reduction on the numbers of engorged Culicoides
females in relation to BTV transmission. In fact, different methods for assessing insecticide
performance may lead to different results when considering the effect on engorged females (Harrup
et al., 2016). For example, it is well known that UV light traps underestimate the number of blood-
engorged females when compared to other methods, such as drop traps (Carpenter et al., 2008;
Mullens et al., 2010).
Increasing the protection of animals, by applying insecticides to different parts of the body and not
only the backline (pour-on), may increase the level of protection against bites of Culicoides. In fact,
these measures are already included in, e.g. the bilateral agreement between France and Spain14 and
application of certain doses of insecticide is recommended according to the animal species to be
carried out on the backline and legs of animals. Speciﬁc commercial products for this purpose should
be approved at the EU level since the currently available products have a pour-on mode of application
only. Impact of increasing use of insecticides on animals, including animal health, residues in meat and
milk, withdrawal periods, impact on biodiversity and the environment, as well as risk of Culicoides
increasing resistance to insecticides, should be addressed before recommending this type of measure.
4. Conclusions and recommendations
TOR 1. As regards vaccination, eradication and surveillance
ToR 1.1. Assess the most suitable duration of a BT vaccination campaign intended to achieve disease
freedom in a country or region considering any relevant factors that may affect and inﬂuence disease
spread and persistence.
Conclusions
The results of the model simulations clearly indicate that:
• without any vaccination, the disease can persist for a long time, reaching an endemic condition
with low level of prevalence of infection (1.5% in cattle, 0.6% in sheep) and greater
seroprevalence levels (45% in cattle, 14% in sheep);
• even when the vaccination of 95% of the susceptible cattle and sheep is constantly applied for
three consecutive years, BTV is not eradicated and may re-emerge after a couple of years;
• only after 5 years of vaccination of 95% of susceptible cattle and sheep, the prevalence of
infection is close to eradication levels, although reaching zero values for sheep only in the
scenario of France, Sardinia and the UK, but still not reaching zero for the Spanish scenario.
Recommendations
• Speciﬁc conditions (e.g. animal density, meteorological conditions, etc.) should be considered
when planning vaccination strategy for eradication purposes. The results from one case to
another cannot be generalised, but a case-by-case approach should be used.
ToR 1.2. Assess the probability of BT recurrence in BT affected areas that have regained BT freedom,
in particular due to BT virus becoming endemic with low level circulation in these areas and
reoccurring ‘spontaneously’ (low-noise circulation in livestock or wildlife, maintenance in vectors or
other possible mechanisms to be considered).
Role of wildlife
Conclusions
• The results of available studies on European wild ruminant populations suggest that red deer
(C. elaphus) is the wild ruminant species most likely to be involved in BTV circulation in
comparison to the other European wild ruminants.
• Considering the divergent and sometimes contrasting results of the currently available
information, it is possible that BTV infection may persist locally in red deer population or in
other wild ruminants in areas with high density of these animals, and where there are a low
number of competing domestic animals and favourable vector conditions.
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Recommendations
• Annual cross-sectional surveys with a focus on yearlings may need to be conducted to
ascertain the role of wild ruminant population in the BTV circulation and persistence in speciﬁc
geographical areas.
Role of transplacental transmission
Conclusions
• Strong evidence exists that TPT occurs in cattle, sheep and goats, under ﬁeld conditions, for
BTV-8. The incidence varies by animal species and gestational stage of infection.
• For BTV serotypes other than BTV-8, TPT was experimentally demonstrated only for BTV-2 in
sheep and BTV-11 in cattle and North American elks.
• The overall and relative contributions of TPT to the over-wintering mechanism are not clear
and remain to be investigated.
• The epidemiological signiﬁcance of the presence of BTV RNA in the blood of newborn animals,
and whether the level of viraemia is sufﬁciently high to infect Culicoides are not clear and
remain to be investigated.
Role of length of BTV viraemia
Conclusions
• BTV nucleic acid can be detected by RT-PCR in the blood of infected cattle and sheep till
4–5 months after the infection, and up to 2 months in goats, while infectious virus in the blood
can only be detected for up to 50 days in cattle and up to 30 days in small ruminants in the
majority of the cases (75% cases, upper quartile).
Persistence of BTV in other tissues
Conclusions
• BTV presence has been demonstrated in different organs, including lymphoid tissue, skin and
reproductive organs. The maximum duration of the presence of BTV is registered in the spleen
up to 40 days for infectious virus and up to 3 months for its nucleic acid.
• Skin and dermal tissue could, in addition to blood, may potentially play a role in virus
transmission through midge bite. However, this hypothesis still needs to be demonstrated.
• Other organs with BTV presence may potentially play a role in direct virus transmission, such
as tongue, tonsils, nasal mucosa. Nevertheless, the evidence in support of direct BTV
transmission is very limited, and as regards the 24 historical serotypes, it is likely that direct
transmission is infrequent, with a limited contribution to BTV spread during epidemics, in
comparison to vector transmission.
Role of vertical transmissions in vectors
Conclusions
• To date, there is no scientiﬁc evidence in support of vertical transmission of BTV in its
biological vectors.
Recommendations
• Further studies on virus detection on larvae are recommended, where endemic situations allow
it, particularly with European vector species.
ToR 1.3. Revise and assess the suitability of the provisions on surveillance laid down in Regulation
(EC) No 1266/2007 to ensure reliable and robust demonstration of the absence of virus transmission in
a Member State or epidemiologically relevant area, considering point 1.2 above.
Conclusions
• The design infection prevalence for surveillance aiming at demonstrating the absence of BTV
circulation should be deﬁned after considering the type of target prevalence (for example,
infection prevalence detected by RT-PCR, serological prevalence by c-ELISA), the geographical
unit of concern (in case of low-level circulation the BTV may circulate in small geographical foci
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 69 EFSA Journal 2017;15(3):4698
and not randomly distributed in large areas), and the epidemiological phase of concern, as
deﬁned in a previous EFSA opinion (EFSA AHAW Panel, 2011a).
• When surveillance is being undertaken in a zone or country following the cessation of the
vaccination, very low levels of infection prevalence are expected. In particular, infection
prevalences below 1% can be observed from the literature and from the mathematical model
developed for this opinion. These are much lower than the value foreseen by the Regulation
(EC) 1266/2007.
• Furthermore, based on the surveillance in France from 2013 to 2015 with associated detected
prevalences, and considering the reoccurrence of BTV in France in 2015, circulation of BTV
might have occurred without being detected.
Recommendations
• The low level of prevalence at least equal to 1% should be taken into consideration when
surveillance is designed to demonstrate freedom (BTV-free status) especially during the years
immediately after the application of a successful vaccination campaign.
• The design prevalence for the surveillance of BTV cannot be generalised, but must be set on a
case-by-case approach after considering the type of target prevalence (infection or serological
prevalence), the geographical unit of concern and the epidemiological phase appropriate to the
area concerned.
TOR 2. As regards speciﬁc options for safe trade that could be used for exemptions from
the exit ban applicable to movements of live animals from a restricted zone
ToR 2.1. Assess whether maternal immunity against BT of calves, lambs and kids born to and
colostrum fed from vaccinated mothers, constitutes a sufﬁcient guarantee for animals of the above
species to be moved safely from a BTV-infected to a BTV-free country or zone, without a risk for
disease spread, with or without the need for any additional premovement testing regime and indicate
the main parameters that could be used (minimum/maximum age of calves, testing of dams, etc.).
Conclusions
• In general, neutralising antibodies can be considered protective against infection, although a
clear and speciﬁc threshold of a protective titre of BTV-speciﬁc neutralising antibody cannot be
identiﬁed.
• Some animals born from vaccinated dams and not showing detectable neutralising colostral
antibodies have also been shown to be protected.
• Given the limited number of studies available, a marked variation in the level and longevity of
neutralising colostral antibodies in lambs and calves (no speciﬁc evidence is available for goats)
from vaccinated dams have been demonstrated, ranging from 16 up to 270 days in lambs
(mean value 210 days) and from 70 to 113 days in calves (mean value 84 days).
ToR 2.2. Assess the minimum age of calves, lambs and kids after which residual colostral antibodies
against BTV do not interfere any longer with vaccine immunisation of these animals (in an example of
BT bilateral agreement this age limit is set at 90 days).
Conclusions
• The results of the currently available experimental studies demonstrated that the presence of
colostral antibodies interferes with the induction of the immune response to homologous
vaccine in calves and lambs at least during 3 months after birth (no speciﬁc evidence is
available for goats).
Recommendations
• During the period of vector activity and potential virus circulation, or when an immediate
threat for animal health exists, calves and lambs (no speciﬁc evidence is available for goats)
born from vaccinated mothers may be vaccinated1 twice, once before 3 months and then
again at about 6 months of age, to ensure maximal protection. Outside these periods, in the
absence of BTV circulation, a single vaccination at about 5–6 months can be adequate.
• Due to the limited experimental evidence on interference between colostral and vaccine
immunity, further detailed studies are recommended.
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ToR 2.3. Assess the minimum time after completion of the primary vaccination (1–2 doses as
indicated by the vaccine manufacturer) for the vaccinated animals to be considered immune to be
safely moved from a BT-infected to a BT-free country or zone (currently set at 60 days in paragraph 5
of Annex III to Regulation (EC) No 1266/2007).
Conclusions
• Based on the literature review conducted in order to answer this subquestion, the minimum
time after completion of vaccination against BTV considered to provide a protective immune
response can be variable ranging from 3 to 48 days depending on the vaccine, the
experimental design, the diagnostic tests, the animal related factors and other variables.
• When commercially available inactivated vaccines and neutralising antibodies are considered,
the majority of animals are positive within 21 days after vaccination, an increasing proportion
of protected animals can be observed at 28 days after vaccination.
ToR 2.4. Assess whether vector protection for 14 days of ruminants below the age of 70 days,
combined with a negative PCR test at the end of the 14 days or more, qualify them for a safe
movement from a BT restricted to a BT-free area.
Conclusions
• The measures considered (animals less than 70 days of age and born from vaccinated dams,
kept under vector protection conditions for 14 days and tested with negative result by RT-PCR
at the end of the vector protection period) to allow the movement of animals from a BTV-
infected to a BT-free area, are all able to reduce the risk of introducing one or more viraemic
animals, both considered singularly or in combination.
• A quantitative estimation of the ﬁnal risk of introducing a viraemic animal following the above
described procedure would be of limited utility, given the high levels of uncertainties affecting
all variables and the large range of epidemiological conditions inﬂuencing the ﬁnal risk. Given
the current uncertainty level, the development of any quantitative model based on a series of
assumptions (e.g. the level of infection in the population of origin, the period of the year, the
vaccination policy in the country of origin, the speciﬁc protocols used for vector protection and
the number of animals to be introduced) would make the outcomes rather unrealistic and
scarcely applicable in practice.
TOR 3. As regards protection from BTV vectors and vector-based provisions for exemption
from the exit ban applicable to movements of live animals from a restricted zone
ToR 3.1. Review and update previous opinions as regards vectors ecology (models for distribution/
density), in order to have more accurate and applicable criteria for the determination of the seasonally
vector-free period.
Vector ecology
Conclusions
• Table 10 below reports the assessment of the validity of the conclusions of the EFSA opinion
on bluetongue vectors and insecticides (EFSA, 2008).
Table 10: Assessment of the conclusions from the EFSA opinion on bluetongue vectors and
insecticides (EFSA, 2008), (left column), and their endorsement or the new modiﬁed
version (right column)
Conclusions from EFSA opinion (2008) Endorsement or new version of the conclusions
The distribution of the main vector species is well
known in each of the BTV affected countries
No precise distribution maps are yet available, but maps
will be available in the framework of Vectornet
project(a). However, there is still a need to know
detailed distribution of the species included in the
Obsoletus assemblage (C. obsoletus, C. scoticus,
C. chiopterus and C. dewulﬁ)
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Conclusions from EFSA opinion (2008) Endorsement or new version of the conclusions
The distribution of C. imicola is well documented in the
southern European countries.
According to phylogeographical studies, this species has
been present in the Mediterranean basin for
10,000 years and in southern Europe for at least
100 years. Therefore, the concept of recent invasion
seems to be not valid for the European Mediterranean
countries. The northward expansion of this species
seems to be very limited in France, and inexistent in
Italy
The distribution of C. obsoletus/C. scoticus includes all
the countries in Europe, although it is relatively more
abundant in the northern regions. In the southern
regions of Europe, the distributions of C. imicola and
C. obsoletus/C. scoticus overlap
This conclusion is still valid
C. dewulﬁ, C. chiopterus and C. pulicaris (sometimes
not differentiated from C. lupicaris) are also widespread
in Europe, especially in the northern countries.
Nevertheless, their abundance as estimated on the
basis of light traps has been always reported as being
lower than C. obsoletus/C. scoticus, except in
Mediterranean areas where C. imicola and/or
C. newsteadi is usually dominant
This conclusion is still valid
Present data indicate that the biting activity of the
majority of the vector species in Europe primarily
occurs during the crepuscular and nocturnal hours
This conclusion is still valid
There are indications, however, that under suitable
meteorological conditions and particularly during the
latter part of the season, diurnal feeding activity of
potential vector species of Culicoides may occur
This conclusion is still valid
The implications for BTV transmission of vector daylight
activity are at present unclear as trapping programmes
based only on light traps are not adequate to provide
information regarding the daylight biting activity
Recent studies suggest that daylight biting activity is
limited and not relevant compared to the crepuscular
activity. However, in some scenarios day activity may
underestimate BTV-infected females which will be not
captured by UV traps
Dispersion of vector species of Culicoides at the farm
level is still very poorly understood, but assumed to be
short distances from the breeding sites
The dispersion of Culicoides may be higher than
originally thought
Long distance dispersion of vector Culicoides on winds
over scores or even hundreds of km has been reported
by several workers but the proportion of a population
that are involved is thought to be very small.
This conclusion is still valid
Distribution and abundance data almost solely obtained
by only using UV light traps may underestimate some
species important for the transmission of BTV
This conclusion is still valid
Northern Palaearctic species of Culicoides are able to
transmit BTV
This conclusion is still valid
To date, the speciﬁc vector(s) of BTV in these areas
have not been identiﬁed, although strong circumstantial
evidence implicates C. obsoletus, C. scoticus,
C. dewulﬁ, C. chiopterus and species of the Pulicaris
assemblage as the likeliest candidates. This list is
probably not exhaustive and the identiﬁcation of
additional vector species is likely
Further studies (PCR detection) have given more
evidence of the role as vectors of the Obsoletus and
Pulicaris assemblages
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Recommendations
• Table 11 below reports the assessment of the validity of the recommendations of the EFSA
opinion on bluetongue vectors and insecticides (EFSA, 2008).
Conclusions from EFSA opinion (2008) Endorsement or new version of the conclusions
To date, standardised and appropriate testing protocols
to determine the vector competence levels of Culicoides
species for BTV in Europe have not been applied. In
northern Europe this has led to the use of pool-based
real-time RT-PCR investigations on ﬁeld-caught parous
female midges to imply vector competence levels
This conclusion is still valid for all EU (north and south)
These methods have several technical drawbacks and
do not provide a measure of vector transmission in the
ﬁeld. Similarly, studies from southern Europe, based
around cell-based isolation of virus, while superior to
those using real-time RT-PCR, are still difﬁcult to
interpret due to the use of pool-based isolation
methods and an inability to accurately assess viral
dissemination levels
This conclusion is still valid
Recent publications that allow high-throughput
processing of Culicoides for virus isolation may allow
some of these issues to be addressed and also enable
standardisation between laboratories
This conclusion is still valid
Laboratory-based studies on vector competence remain
time consuming and difﬁcult to perform outside the
areas of BTV transmission as they require specialist
laboratory accommodation
This conclusion is still valid
Vector competence is just one element of the vector
capacity of a species for BTV transmission. Other
elements some of which have been assessed in
southern Europe include host preferences, biting rates,
vector survival, location of breeding sites, temporal and
spatial distribution, and abundance
Host preferences, biting rates, location of breeding
sites, temporal distribution and abundance are currently
known for the major vector species in whole Europe.
More updated spatial distribution of vectors will be
available from the work done by the Vectornet project
An integrated assessment of all of these elements is
required to gain a realistic idea of the importance of
each potential vector species
This conclusion is still valid
(a): http://ecdc.europa.eu/en/healthtopics/vectors/VectorNet/Pages/VectorNet.aspx
Table 11: Assessment of the recommendations from the EFSA opinion on bluetongue vectors and
insecticides (EFSA, 2008) (left column), and their endorsement or the new modiﬁed
version (right column)
Recommendations from EFSA opinion (2008)
Endorsement or new version of the
recommendations
In order to better understand the current
distribution of the species included in the ‘Obsoletus
assemblages’, it is recommended to perform
co-ordinated European surveys using the molecular
identiﬁcation of C. obsoletus/C. scoticus females to
species level. In addition, the routine identiﬁcation of
males from these species is also advisable to have a
better picture of each species distribution. These
data should be made available in the EU centralised
database (BT-Net)
This recommendation is still valid for most of the European
countries
The current VectorNet initiative covers this issue
Bt-Net is no longer available, and current updating of
vector distribution is covered by Vectornet consortium
An increased number of sampling sites around the
known northern limits of the range of C. imicola is
recommended to improve understand of the role of
this species in the northward spread of BTV
This recommendation is no longer relevant, considering
the role of transmission of Northern European species and
considering that C. imicola is not experiencing a quick and
relevant spread to northern countries
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Vector-free period
Conclusions
• Available data demonstrate that some Culicoides species, in some geographical areas in
Europe, are active throughout the year and that an absolute SVFP does not exist. However,
there are periods of the year when the abundance of the Culicoides vector species is extremely
low, mainly coinciding with winter time. Long-standing practical experience demonstrates that
transmission of BTV is substantially reduced or halted during these periods.
• The criteria considered by the Regulation (EC) 1266/2007 for the deﬁnition of the SVFP include
the complete absence of adult C. imicola and less than ﬁve parous females captured in light
traps for the other Culicoides species. Temperature conditions that impact on the behaviour of
the vectors activity and related temperature thresholds are considered possible additional
criteria for the deﬁnition of the SVFP.
• Although the available data do not allow the identiﬁcation of more accurate and applicable
criteria for the deﬁnition of the SVFP, the analysis of the data produced by the Italian
entomological surveillance programme agrees with the current provisions of the Regulation
(EC) 1266/2007, as no seroconverted sentinels were observed in the absence of C. imicola or
with less than 5 captured Culicoides.
• In relation to the possible deﬁnition of a temperature threshold, the results of the available
studies and analysis of the risk of BT transmission through the calculation of the R0 indicate a
possible temperature threshold value for BT transmission between 9.0 and 12.0°C. This
temperature values cannot be taken in absolute way, without considering the different
Culicoides species involved and the eco-climatic conditions of the territory of concern.
Recommendations from EFSA opinion (2008)
Endorsement or new version of the
recommendations
Molecular techniques should be used for the
differentiation of species from the Obsoletus and
Pulicaris assemblages, especially in epidemiologically
relevant areas. Where possible these techniques
should be integrated into surveillance schemes
This recommendation is still valid, particularly to apply
molecular techniques in a routine basis to national
surveillance programs
Training on dipteran taxonomy is additionally also
recommended to be conducted at a European level.
Varying levels of circumstantial evidence has linked
C. imicola, C. obsoletus, C. scoticus, C. dewulﬁ,
C. chiopterus and species of the Pulicaris
assemblage with BTV transmission in Europe.
Consequently, targeted surveys should be
undertaken for deﬁning their temporal and spatial
distributions across Europe
Information has been improved in most European
countries, and speciﬁc actions on BTV vector taxonomy
should be carried out where there are still knowledge
gaps
A standardisation of techniques to implicate ﬁeld-
caught Culicoides vectors in BTV transmission is
required. It is recommended that this be used to
harmonise studies across Europe as, to date, testing
methods, in northern Europe particularly, have been
inadequate
Common protocols for analysis of potential BTV vector
species are recommended across Europe. Ring trials
among national reference laboratories are also
recommended
Laboratory testing for vector competence should be
carried out, where possible, in parallel with ﬁeld-
based testing (EFSA, 2008)
This recommendation is still needed. Efforts on establish a
Palaearctic species colony different of the current available
of C. nubeculosus is strongly recommended to progress on
the understanding of vector competence at the European
level
Analyses of the vector competence of particular
species should be made with reference not only to
the ability of the vector to become infected by,
replicate and transmit the virus but also to its wider
ecological requirements (i.e. its vector capacity),
which may vary with region and season
This recommendation is still valid
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Recommendations
• Since an in-ﬁeld validation of the criteria currently used for the SVFP deﬁnition is needed, the
availability of long-term entomological data, coupled with serological or virological surveillance
results in the same locations on animal host and vectors, would be necessary for the main
European eco-climatic zones and different Culicoides species involved.
ToR 3.2. Review and update previous opinions as regards over-wintering mechanisms and the
duration of the BT viraemia.15
Conclusions
• Continuous Culicoides activity could occur almost throughout the year, at least during years
when temperatures allow that, in Mediterranean areas and in mild-winter areas. The
occurrence of a probable continuous BTV transmission was established in Sardinia (Foxi et al.,
2016), and could thus theoretically occur in other European areas during years with mild-
winter temperatures.
• Continuous Culicoides activity and long-lived infected female could collectively contribute to the
BTV overwintering in the European areas characterised by mild-winter temperatures.
• According to the opportunity maps as shown, in northern Europe, low winter temperatures
mainly inhibit Culicoides life cycle over a period of at least 3 months, and would not allow
continuous transmission or survival of females infected during the prior transmission season.
This is in agreement with ﬁeld data were adult populations of Culicoides are in general absent
from January to April in most of North European countries.
Recommendations
• Seasonal maps of presence/absence of the major vector species in Europe are recommended
to be developed.
• Validated models based on long-term ﬁeld data of seasonal captures for predicting the vector
seasonality, particularly periods of absence and/or low abundance of the major BTV vector
species across Europe in relation with environmental variables is also recommended.
• The survival rates of adult Culicoides at low temperatures is recommended to be further
investigated under laboratory conditions.
• The inﬂuence of temperature on BTV replication in Culicoides should be investigated to
establish if BTV could infect females under the detection threshold and replicate later when
temperatures increase.
• Systematic analysis of BTV presence in vector females collected during winter months is
recommended to elucidate if those vector females suppose an interseasonal bridge for BTV in
periodically infected areas in Europe. Further, the development of new age-grading methods is
recommended to assess if females collected during winter could have been infected during the
prior transmission season.
ToR 3.3. Review and update previous opinions and provide a scientiﬁc assessment of the
appropriateness of the use of insecticides and repellents against Culicoides as BT competent vectors,
including an assessment of their efﬁcacy and recommendations of adequate protocols for their uses, in
particular, as regards their suitability to protect animals against attacks by vectors performing at least
equal to the protection provided by vector-proof establishments – without the need to keep animals in
a vector protected facility.
Conclusions
• To date, there is no conclusive evidence that the use of insecticides or repellents when applied
singularly reduce the transmission of BTV in the ﬁeld. In speciﬁc scenarios, however, they have
been shown to either kill Culicoides or reduce host/vector contact and hence are used as a risk
mitigation measure where vaccines are unavailable. Their use is modiﬁed by both logistics and
cost.
• Treatment of animals with pour-on insecticides causes mortality in a proportion of feeding
Culicoides but the effect is transient and necessitates frequent application.
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• Treatment of animals with true repellent products (e.g. DEET) has been less investigated,
largely due to the logistics of reapplication every few hours. This is unlikely to be feasible
except for very high value stock.
• Stabling is effective in reducing host/vector contact where a high level of containment can be
attained. Insecticide-treated meshes applied over windows in stables were found to kill
Culicoides quickly enough to inhibit entry and ﬁeld trials demonstrated substantial reductions in
populations found in stables. These studies primarily addressed horses, however, and the
logistics and reduced coverage provided to ruminants may lessen this effect.
• Treatment of the environment with insecticides to kill either adult or larval Culicoides has not
been studied since the previous EFSA scientiﬁc opinion from 2008 and is unlikely to be
effective due to the ubiquitous nature of Culicoides larval development sites in Europe.
• Habitat modiﬁcation techniques have been trialled for dung heaps and the impact of covering
on the emerging adult Culicoides population was limited.
• According to scientiﬁc literature reviewed in this opinion, high level of efﬁcacy (up to 86%) of
pour-on insecticides is difﬁcult to achieve, particularly under ﬁeld conditions, and little
information is available about the effect of reduction on the numbers of engorged Culicoides
females in relation to BTV transmission.
• By only using pour-on insecticides, protection of animals is lower than the one provided by the
VPE which is at least 10% higher.
Recommendations
• Further studies would be needed to estimate the risk reduction provided by application of
insecticide treatment under ﬁeld conditions.
• Protocols of usage of insecticides and repellents on animals should be harmonised in the EU
and supported by ﬁeld evidence.
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Glossary
Herd prevalence The number of test positive herds of the total number of tested herds
Prevalence at the animal level The number of test positive animals of the total number of animals.
Infection prevalence
(or virus prevalence)
Prevalence of positive animals with detectable virus or its nucleic acid
Serological prevalence Prevalence of seropositive animals (with detectable antibodies against
BTV)
Epidemiological phase In the course of a BTV infection in a region, three fundamental steps can
be distinguished: introduction, establishment and spread in a
geographical sense (EFSA AHAW Panel, 2011a). During these steps, the
prevalence of infected animals in a region changes, since, upon
introduction into a BTV-free region, the prevalence in a geographical
unit rises from zero to a maximum (plateau prevalence) and
subsequently drops again either to zero, in case the infection fades out,
or to a level determined by endemic infection in the region. In relation to
the expected prevalence, different epidemiological phases can be
distinguished, each with a speciﬁc goal for monitoring and surveillance.
Design prevalence Minimal detectable prevalence speciﬁed for detection of infection at a
speciﬁed level of conﬁdence
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 89 EFSA Journal 2017;15(3):4698
Endemic occurrence Constant presence of an infection in a population
Epidemic Series of outbreaks in a region
Outbreak The holding or place situated in the territory of the European
Community where animals are assembled and where one or more
cases of BTV has or have been ofﬁcially conﬁrmed tested in a region
Restricted zone Demarcated zone considered BTV infected
Abbreviations
AHL Animal Health Law
AHSV African horse sickness virus
AMLS Animal Movements Licensing System
BT bluetongue
BTV bluetongue virus
c-ELISA competitive -enzyme linked immunosorbent assay
CFU colony-forming unit
CIN Commercial Inactivated Vaccine
CLA Commercial live-attenuated Vaccine
CPI coefﬁcient of protection
CTS Cattle Tracing System
ED50 median effective dose
EHDV epizootic haemorrhagic disease virus
EIP extrinsic incubation period
ELISA enzyme-linked immunosorbent assay
EX Experimental vaccine
HDPE high-density polyethylene nets
IIT Incompatible Insect Technique
ITN insecticide-treated nets
IIV Iridescent virus
LD50 median lethal dose
LST Land Surface Temperature
LT90 lethal time 90
MPD minimum protection day
MS Member State
NUTS Nomenclature of Units for Territorial Statistics
PD50 50% protective dose
PROMETHEUS PROmoting METHods for Evidence Use in Scientiﬁc assessments
RNAi RNA interference
rg reverse genetics
RIDL Release of insects carrying a dominant lethal genetic system
RT-PCR reverse transcription polymerase chain reaction
S/P sample-to-positive ratio
SAMS Scottish Animal Movements System
SIT Sterile Insect Technique
SLR systematic literature review
SNT serum neutralization test
SVFP SVFP seasonally vector-free period
TCID50 50% tissue culture infective doses
TOT transovarial transmission
TPT transplacental transmission
VNT virus-neutralisation test
VPE vector proof establishments
VT vertical transmission
WHO World Health Organization
wt wild-type
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Appendix A – Modelling the transmission of bluetongue virus within and
between farms
A.1. Data
A.1.1. Demographic data
Data for farms in Great Britain (GB). The location and number of cattle and sheep on each farm
were obtained from June agricultural survey data for 2006. Animal movement data for 2006 were
extracted from the Cattle Tracing System (CTS) for cattle, from the Animal Movements Licensing
System (AMLS) for sheep in England and Wales and from the Scottish Animal Movements System
(SAMS) for sheep in Scotland. These represent a normal year for animal movements (i.e. there were
no major disease outbreaks).
Data for farms in other EU member states. Farm-level data could not be obtained for other EU
member states. Accordingly, regional-level data were used to generate synthetic farm-level data sets
for each country of interest (i.e. France, Spain and Italy). More speciﬁcally, the number of holdings
with cattle, the number of cattle, the number of holdings with sheep and the number of sheep for
each NUTS (Nomenclature of Units for Territorial Statistics) level 2 (NUTS2) region in Europe for 2010
were extracted from Eurostat. A location for each farm in a region was generated by sampling a point
uniformly at random from within the boundary of that region, while a herd or ﬂock size was generated
by sampling from an exponential distribution with mean equal to the mean holding size for the region
(EFSA, 2012). Although this could, in principle, generate herds or ﬂocks of unlimited size, in practice,
the largest herd comprised 1,434 cattle and the largest ﬂock comprised 3,295 sheep (both in the
synthetic data set for France). The synthetic data sets were generated using the maptools (Bivand and
Lewin-Koh, 2013) and spatstat (Baddeley and Turner, 2005) packages in R (Team RC, 2014).
Animal movement data could not be obtained for any of the countries of interest (i.e. France, Spain
and Italy).
Seasonal calving and lambing patterns. Seasonal patterns of calving and lambing for each country
(France, GB, Italy, Spain) were extracted from those reported by EU member states to EFSA (EFSA, 2012).
A.1.2. Climate data
Data for GB. Daily mean temperatures were obtained from the UK Climate Projections (UKCP09)
gridded observation data sets for 2007. These cover the UK at 5 km by 5 km resolution, with farms
using the temperature data for the grid square in which they are located.
Data for other EU member states. Temperature data were obtained from the European Commission
Joint Research Centre MARS Meteorological Database, which provides daily meteorological data
spatially interpolated on a 50 km by 50 km grid. Speciﬁcally, we extracted the daily minimum and daily
maximum temperatures for 2011 and computed the midpoint of these for each grid square. Farms
used the temperature data for the grid square in which they are located.
A.2. Within-farm transmission of bluetongue virus
The dynamics of BTV within a farm are described using a stochastic compartmental model that includes
two ruminant host species (cattle and sheep) and a single Culicoides vector (Szmaragd et al., 2009).
The cattle and sheep populations are subdivided into the number of susceptible (i.e. uninfected),
infected and recovered animals, denoted by X(i), Y(i) and Z(i), respectively, where the superscript i
indicates cattle (C) or sheep (S). To allow for a more general gamma distribution for the duration of
viraemia, the infected host population, Y(i), is subdivided into a number of stages, with newly infected
hosts entering the ﬁrst stage and then passing through each successive stage. If the time spent in
each stage follows an exponential distribution with mean 1/niri, the total length of time spent in the ni
stages follows a gamma distribution, with mean 1/ri and variance 1/niri
2 (Anderson and Watson, 1980).
The vector population (N) is subdivided into the number of adult female midges that are
susceptible (i.e. uninfected), latent (i.e. infected, but not infectious) and infectious, denoted by S, L
and I, respectively. To allow for a more general gamma distribution for the extrinsic incubation (i.e.
latent) period (EIP) (Carpenter et al., 2011), the latent class is subdivided into a number of stages in a
similar approach to that described above for the duration of host viraemia. Vector mortality occurs at
the same rate in all classes and is balanced by the recruitment of susceptible vectors, so that the total
vector population (N) remains constant during the vector season.
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The force of infection for host species i, ki, is given by,
kiðtÞ ¼ ba/imihðtÞ
IðtÞ
N
(A1)
where b is the probability of transmission from an infected vector to a host, a is the reciprocal of the
time interval between blood meals for the vector (assumed to be equal to the biting rate), mi(= N/Hi)
is the vector-to-host ratio and I/N is the proportion of bites which are from infectious vectors. The
proportion of bites on cattle and sheep is given by
/C ¼
HC
HC þ rHS ; /S ¼ 1 /C (A2)
respectively, where r is the vector preference for sheep relative to cattle. The seasonal vector activity
(Sanders et al., 2011b) on day t is given by
hðtÞ / exp b11 sin 2pt365
 
þ b21 cos 2pt365
 
þ b12 sin 4pt365
 
þ b22 cos 4pt365
  
(A3)
normalised so the maximum value is one. The force of infection for vectors, kV, is
kV ðtÞ ¼ bahðtÞ /C
Y ðCÞðtÞ
HC
þ /S
Y ðSÞðtÞ
HS
 
(A4)
where b is the probability of transmission from an infected host to a vector and Y(C) and Y(S) are the
total number of infected cattle and sheep, respectively.
Parameters in the model are summarised in Table A.1. Most parameters (see Table A.1) were
estimated by ﬁtting the BTV model to the summary outbreak data for Great Britain in 2007 (DEFRA,
2008) using approximate Bayesian computation (ABC) sequential Monte Carlo (SMC) sampling
(McKinley et al., 2009; Toni et al., 2009). The reciprocal of the time interval between blood meals (a),
the vector mortality rate (l) and the reciprocal of the mean EIP (v) were assumed to vary with the
local temperature (see Table A.1 for details).
Population sizes in the model take integer values, while transitions between compartments are
stochastic processes (Table A.2). The number of transitions of each type during a small time interval dt
was drawn from a binomial distribution with population size n and transition probability q (the
appropriate per capita rate multiplied by dt) (Table A.2). However, binomial random variables are
computationally expensive to simulate and an approximating distribution was used wherever possible.
If: (i) nq(1  q) > 25; (ii) nq(1  q) > 5 and 0.1 < q < 0.9; or (iii) min(nq, n(1  q)) > 10, an
approximating normal variate with mean nq and variance nq(1  q) was used, while if q < 0.1 and
nq < 10, an approximating Poisson variate with mean nq was used (Forbes et al., 2011).
A.3. Transmission of bluetongue virus between farms
To describe the spread of BTV between farms, a stochastic, spatially explicit model with a daily time
step was used. Transmission between farms was assumed to occur via two routes: movement of
infected animals or dispersal of infected vectors.
A.3.1. Movement of infected livestock
Movement of infected livestock was modelled by the following sequence of steps. For each farm
with infected cattle or sheep:
• determine the number of batches of animals moved off the farm that day, which depends on
the number of animals on the farm and on the month;
• for each batch, determine the batch size (i.e. number of animals moved) and then determine
the number of infected animals in the batch (sampling without replacement);
• if there is at least one infected animal in the batch, determine where it is moved to:
– select the county to which the batch is moved based on the relative frequency of
movements from the county in which the farm is located to all counties (including that in
which the farm is located);
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– select a herd or ﬂock at random from the county and test if it buys-in animals that day
(repeating as necessary until a farm does buy-in animals), where the probability depends on
the number of animals on the recipient farm and on the month;
– if the herd or ﬂock buying-in animals is uninfected, it acquires infection (i.e. the number of
infected animals in the batch).
The distributions and parameters required for each step are described in detail bellow. Parameters
were estimated using data on cattle and sheep movements for GB (Tables A.3 and A.4).
Step 1: Number of off-moves. The probability that a farm moves a batch of animals off the farm (i.e.
makes an off-move), pOFF, is given by,
loge
pOFF
1 pOFF
 
¼ a0 þ a1H þ a2ðmÞ (A5)
where a0 and a1 are constants, H is the herd or ﬂock size and a2(m) is the log odds ratio for selling
animals in month m (reﬂecting seasonality in animal movements) (Table A.3). If a farm does make an
off-move, the number of off-moves made that day is drawn from a multinomial distribution, which was
computed empirically from the observed number of off-moves (Table A.4).
Step 2: Batch size distribution. For each off-move the batch size (B) was determined by sampling from
a negative binomial distribution, that is,
PrðB ¼ bÞ ¼ Cðk þ bÞ
b!CðkÞ
k
k þ l
 k l
k þ l
 b
(A6)
where l and k are the mean and dispersion parameter, respectively. These were estimated by ﬁtting
the distribution to the observed batch sizes (cattle: l = 2.02, k = 0.33; sheep: l = 38.2, k = 0.66).
The number of infected animals in the batch (J) are drawn from a hypergeometric distribution, so that,
PrðJ ¼ jÞ ¼
Y
j
 
H  Y
B  j
 
H
B
  (A7)
where H is the herd or ﬂock size and Y is the number of infected animals in the herd or ﬂock
(determined from the simulated within-farm outbreak).
Step 3a: Selecting a county for an on-move. The county for each on-move was selected based on the
relative frequency of movements from the county in which the affected ﬂock is located to all counties.
Step 3b: Probability of an on-move. The probability that a farm makes an on-move (i.e. buys in
animals), pON, was given by,
loge
pON
1 pON
 
¼ b0 þ b1N þ b2ðmÞ (A8)
where b0 and b1 are constants, N is the herd or ﬂock size and b2(m) is the log odds ratio for buying-in
animals in month m (reﬂecting seasonality in animal movements) (Table A.3).
A.3.2. Dispersal of infected vectors
Dispersal of infected vectors between farms was modelled as a diffusion process (Backer and
Nodelijk, 2011). As such, the dependence of the probability of transmission by this route on distance
between farms reﬂects the diffusive movement of vectors. In addition, the probability of transmission
allows for seasonal variation in vector activity and, importantly, incorporates the probability that a
dispersing midge will survive for long enough to reach an at-risk farm. In this case, the force of
infection of farm j infected onfarm k on day t was given by
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kðxjk ; tÞ ¼ c
Xt
t 0¼sj
hðt 0ÞIðt 0Þ  exp 
Xt
t 00¼t 0
lðTðt 00ÞÞ
 !

(
1
4pDðt  t 0 þ 1Þ exp 
x2jk
4Dðt  t 0 þ 1Þ
 !)
; (A9)
where c is the transmission parameter, sj is the day on which infectious vectors were ﬁrst present on
farm j, h(t) is seasonal vector activity (given by equation (A3)), I(t) is the number of infectious vectors
on the farm, l(T(t)) is the (temperature-dependent) vector mortality rate (see Table A.1), D is the
diffusion coefﬁcient and xjk is the distance between the farms.
The vector dispersal parameters (c and D) were estimated by ﬁtting the BTV model to summary
outbreak data for GB in 2007 (Defra, 2008) using ABC SMC sampling (McKinley et al., 2009; Toni
et al., 2009). The posterior mean (95% credible interval) for c was 0.57 (0.25, 0.92) while for D it was
2.57 (0.57, 4.65) km2/day.
A.4. Host demography
Cattle. Natural (i.e. non-BTV-associated) mortality was assumed to occur at a constant rate in a
herd (equal to the reciprocal of the mean life expectancy, assumed to be 5 years). Disease-associated
(i.e. BTV-related) mortality was assumed to occur at a constant rate while an animal was infected.
Host reproduction in cattle was assumed to be continuous, with the number of replacements born
each day chosen to restore the herd size to its initial level.
Sheep. Natural mortality was assumed to occur at a constant rate in a ﬂock (equal to the reciprocal
of the mean life expectancy, assumed to be 4 years). Disease-associated mortality was assumed to
occur at a constant rate while an animal was infected. Host reproduction in sheep was assumed to be
seasonal with a single period of births each year. For simplicity, this was represented in the model as a
single pulse on a particular day each year, with the number of replacements chosen to restore the
ﬂock size to its initial level. The timing of the pulse for each ﬂock was generated by sampling a month
of birth based on reported lambing patterns for each country (see EFSA, 2012, their appendix H) and
then sampling a day uniformly from that month.
A.5. Overwintering of BTV
Overwintering of BTV was assumed to occur only through vertical transmission in the ruminant
host. It was assumed not to occur through long-lived adult infected vectors. For Culicoides obsoletus,
this was reﬂected in the model by assuming all adult vectors die at the end of each vector season. For
Culicoides imicola, this was not applied, but temperatures are such the vector mean life-span is
typically less than 40 days in winter and much shorter during summer.
Vertical transmission of BTV in the ruminant host was modelled as follows. The number of animals
of species i infected via vertical transmission on day t was assumed to depend on the number of
infected animals at the time of conception, the probability of vertical transmission and the probability
of the dam surviving the gestation period, so that,
Y ðiÞðtþÞ ¼ Y ðiÞðtÞ þ Y ðiÞI ;
Y ðiÞI Hypergeometric ðHð0Þi  HiðtÞ;Y iV ;HiðtÞÞ
Y ðiÞV Binominal ðY ðiÞðt  T ðiÞG Þ; pi expðwiT ðiÞG ÞÞ;
where Y(i)(t) is the number of infected hosts at time t, Hð0Þi is the initial herd or ﬂock size, Hi(t) is the
total number of animals at time t, pi is the probability of vertical transmission in an infected host, wi is
the natural host mortality rate and T ðiÞG is the duration of the gestation period (assumed to be 280 days
for cattle and 150 days for sheep). For cattle, vertical transmission occurred throughout the year, while
for sheep it occurred only on the day on which seasonal reproduction occurred. The probability of
vertical transmission in cattle and sheep was assumed to be 10% (De Clercq et al., 2008).
A.6. Vaccination
If vaccination was implemented, an additional vaccinated class (V(i)) was included for each species,
with animals in this class assumed to be immune to infection with BTV.
Vaccination was assumed to be implemented for all farms on the 1 May in the year following the
initial incursion and on the 1 May for a number of years subsequently (up to a further 4 years). We
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assume that vaccinated animals will be fully protected before virus circulation resumes in a region. In
the ﬁrst year of the vaccination campaign, each farm is vaccinated with probability given by the farm-
level coverage. If the farm is vaccinated, an animal of species i is moved into the vaccinated (and
protected) class with probability given by the vaccine effectiveness for the species (ei). In subsequent
years, a farm which has vaccinated previously was assumed to revaccinate all animals, with the
probability that an animal is protected given by 1  (1  ei)y (where y is the number of years for
which vaccine has been used). This increase in vaccine effectiveness over time is used to allow for an
increase in effectiveness following repeat vaccination. For farms which did not vaccinated previously,
they do so in the next year with probability given by the farm-level coverage and with vaccine
effectiveness as described above.
Farm-level coverage was assumed to be 80% or 95%. Vaccine effectiveness for each species (ei)
was sampled uniformly from ranges based on the outcome of challenge experiments (Gubbins et al.,
2012). For cattle, the range was 0.60–0.85, while for sheep it was 0.89–1.0.
A.7. Applying the model to other EU member states
When the model was applied to EU member states other than GB, it was modiﬁed in two ways.
First, transmission between farms was via dispersal of infected vectors alone. Transmission by
movement of infected animals was excluded (Section 3.1), because the necessary data to
parameterise this part of the model could not be obtained. However, this route accounts for only a
small proportion of spread (around 10%) and the focus of the modelling in this opinion was on the
temporal rather than spatial dynamics of BTV infection. Second, the vector parameters were adapted
to reﬂect the principal Culicoides vectors in the country. The principal vector species in France are the
same as in GB and, accordingly, the same parameter values were used (Table A.1). For Spain and
Italy, however, the principal vector species is Culicoides imicola and, hence, parameter values
appropriate to this species were used (Table A.5).
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Table A.2: Transitions, probabilities and population sizes in the model for the transmission of
bluetongue virus within a farm
Description Transition Probability Population size
Hosts
Infection X ðiÞ ! X ðiÞ  1
Y ðiÞ1 ! Y ðiÞ1 þ 1

kidt X
(i)
Completion of infection stage j (j = 1,. . ., ni1) Y ðiÞj ! Y ðiÞj  1
Y ðiÞjþ1 ! Y ðiÞjþ1 þ 1
(
niridt Y
ðiÞ
j
Mortality during infection stage j (j = 1,. . ., ni) Y ðiÞj ! Y ðiÞj  1 didt Y
ðiÞ
j
Recovery Y ðiÞni ! Y ðiÞni  1
ZðiÞ ! ZðiÞ þ 1
(
niridt Y
ðiÞ
ni
Vectors
Infection S ! S  1
L1 ! L1 þ 1

kVdt S
Completion of extrinsic incubation period (EIP),
stage j (j = 1,. . .,k1)
Lj ! Lj  1
Ljþ1 ! Ljþ1 þ 1

kvdt Lj
Vector mortality during EIP (j = 1,. . ., k)
(and compensatory recruitment)
Lj ! Lj  1
S ! S þ 1

ldt Lj
Completion of EIP Lk ! Lk  1
I ! I þ 1

kvdt Lk
Mortality of infectious vectors (and compensatory
recruitment)
I ! I  1
S ! S þ 1

ldt I
Table A.3: Parameters in the logistic regression models for the probability of a farm moving
(off-move) or receiving (on-move) cattle and sheep
Parameter
Moving Receiving
Cattle Sheep Cattle Sheep
Intercept 4.77 4.71 4.95 6.33
No. animals 1.96 9 103 4.48 9 104 2.13 9 103 3.38 9 104
Month
January 0 0 0 0
February 0.15 0.15 0.20 8.21 9 103
March 0.27 0.19 0.31 0.17
April 0.46 0.13 0.54 0.11
May 0.46 4.44 9 103 0.58 9.42 9 102
June 0.25 4.96 9 103 0.36 0.15
July 0.13 6.30 9 102 0.21 0.18
August 0.19 0.48 0.22 0.11
September 0.29 0.77 0.35 0.19
October 0.42 0.70 0.53 0.16
November 0.48 0.51 0.50 0.78
December 1.31 9 102 4.52 9 102 1.99 9 103 0.11
Table A.4: Probability distribution for the number of batches of cattle or sheep moved off a farm
which moves any livestock on a given day
No. batches 1 2 3 4 5 6 7
Cattle 0.62 0.18 0.09 0.05 0.03 0.02 0.01
Sheep 0.97 0.03 0 0 0 0 0
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Appendix B – Scenarios of bluetongue dynamics in vaccinated population
in France, Italy and Spain
As indicated in Section 3.1.2 of this opinion, in this Appendix the ﬁgures of the simulations
performed for the scenarios in France, Italy and Spain are reported (Figures B.1–B.9). The spread
between farms was via dispersal of infected vectors only and that via movement of infected animals
was not included in the simulations. The model was run for 5 years following the initial incursion. For
France, the model was applied to the whole of the country, with an incursion into a randomly selected
farm in Nord-Pas-de-Calais, Lorraine or Champagne-Ardenne (chosen to reﬂect the previous incursion
of BTV-8). For Italy, the model was applied to Sardinia alone, with an incursion into a randomly
selected farm in the region. Finally, for Spain, the model was applied to Andalusia alone, with an
incursion into a randomly selected farm in the region.
The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure B.1: Prevalence of infected farms in simulated epidemics of bluetongue in France (following
an incursion into the north-east of the country) and the impact of vaccination
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 99 EFSA Journal 2017;15(3):4698
The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure B.2: Prevalence of infected cattle in simulated epidemics of bluetongue in France (following an
incursion into the north-east of the country) and the impact of vaccination
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 100 EFSA Journal 2017;15(3):4698
The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure B.3: Prevalence of infected sheep in simulated epidemics of bluetongue in France (following
an incursion into the north-east of the country) and the impact of vaccination
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 101 EFSA Journal 2017;15(3):4698
The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure B.4: Prevalence of infected farms in simulated epidemics of bluetongue in Andalusia and the
impact of vaccination
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 102 EFSA Journal 2017;15(3):4698
The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure B.5: Prevalence of infected cattle in simulated epidemics of bluetongue in Andalusia and the
impact of vaccination
Scientiﬁc opinion on bluetongue
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The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure B.6: Prevalence of infected sheep in simulated epidemics of bluetongue in Andalusia and the
impact of vaccination
Scientiﬁc opinion on bluetongue
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The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure B.7: Prevalence of infected farms in simulated epidemics of bluetongue in Sardinia and the
impact of vaccination
Scientiﬁc opinion on bluetongue
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The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure B.8: Prevalence of infected cattle in simulated epidemics of bluetongue in Sardinia and the
impact of vaccination
Scientiﬁc opinion on bluetongue
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The vaccination strategy simulated is indicated in the title for each panel (farm-level coverage and
number of years for which vaccine is used). Each plot shows the mean prevalence (%) based on 100
replicates of the model.
Figure B.9: Prevalence of infected sheep in simulated epidemics of bluetongue in Sardinia and the
impact of vaccination
Scientiﬁc opinion on bluetongue
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Appendix D – Opportunity map for vector activity in Europe
Opportunity map for vector activity in Europe considering minimum temperature above 10°C, where
the blue zones represent the areas in which the temperature is considered to be hampering vector
activity and the shades of green indicate number of days in the month in which conditions are
favourable for vector activity (darker colours indicating longer periods in the month with favourable
conditions), black represents regions with no information on temperature for that year.
Figure D.1: Opportunity maps considering temperature from year 2009
Figure D.2: Opportunity maps considering temperature from year 2010
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 120 EFSA Journal 2017;15(3):4698
Figure D.4: Opportunity maps considering temperature from year 2012
Figure D.3: Opportunity maps considering temperature from year 2011
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 121 EFSA Journal 2017;15(3):4698
Figure D.6: Opportunity maps considering temperature from year 2014
Figure D.5: Opportunity maps considering temperature from year 2013
Scientiﬁc opinion on bluetongue
www.efsa.europa.eu/efsajournal 122 EFSA Journal 2017;15(3):4698
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